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This thesis is also dedicated in memory of my great grandmother Florence Adelaide 
Strangleman (1898 – 1930). She died of sepsis aged 32 following unsuccessful 
management of dental caries at a time when effective dental care was only available 
to those who could afford to pay for it. The poverty that contributed to her early death 
was compounded after her loss, leaving an indelible mark on the generations that 
followed. 
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Dental caries is a preventable, yet extremely prevalent, non-communicable oral 
disease. The clinical manifestations (i.e. carious lesions) and their sequelae bring a 
significant health burden including loss of function, pain, discomfort, reduced quality 
of life and tooth loss. This health burden also has a negative social and economic 
impact on individuals and societies. Although the aetiopathogenesis of the disease is 
now better understood, with effective preventive strategies identified and developed, 
uncertainty surrounds how best to manage the lesions when they arise for both short-
term and long-term health and wellbeing.  
 
Relevant research has not always resulted in widespread adoption of novel techniques 
and approaches. This is, in part, due to limitations arising from the avoidable waste 
resulting from issues with the conduct of the research. 
 
This thesis explores the problem of research waste in carious lesion management 
research and identifies ways in which this can be mitigated to increase the value of 
clinical research and, ultimately, improve clinical care for patients. 
The thesis begins with a narrative review of dental caries including the 
aetiopathogenesis and prevention of the disease. The changing epidemiology and 
current treatment philosophies are also presented. Thereafter, the problem of 
avoidable waste in healthcare research is explored, within the context of the proposed 
Global Evidence Ecosystem for Oral Health (GEEOH). Specifically, how the problem of 
inconsistent outcome selection and reporting in both primary (e.g. Randomised 
xviii 
Controlled Trials) and secondary research (Systematic reviews) can be addressed to 
contribute to the building of an effective and efficient evidence ecosystem. 
A systematic assessment of relevant systematic reviews (SRs) is presented in chapter 3. 
This chapter highlights the growing problem of overproduction of systematic reviews 
and the failure to appropriately update these reviews. An analysis of updated 
systematic reviews is presented which shows that several problems arise from the 
primary literature on which they are based. Inconsistent outcome selection and 
reporting is one of those problems. Solutions to the issue of overproduction of 
uninformative reviews are presented, including a coordinated move towards living 
reviews (LSRs) incorporating Network Meta-Analysis (NMA).  
For future results to be meaningful for dental care providers and patients in clinical 
decision making, the outcomes of importance to these groups needed to be 
established. The central project in this thesis is the development of an agreed Core 
Outcome Set (COS) to help harmonise outcome selection and reporting in primary and 
secondary research in the field of carious lesion management. This COS was developed 
by following the methodological framework proposed by the Core Outcome Measures 
in Effectiveness Trials (COMET) initiative (1). 
The systematic review of randomised controlled trials (RCTs) was conducted to 
complete stage 4(i) identify existing knowledge, of the COMET framework. From this 
review 76 unique outcomes were identified from 605 RCTs involving over 250,000 
patient participants. An analysis of the selection and use of trial outcomes is also 
presented. The 76 outcomes identified in this stage were taken forward to the two-
xix 
step consensus process. Two consensus methods were combined to fulfil the COMET 
initiative’s stages: 4(ii) Filling gaps in knowledge and 4(iii) Eliciting views about 
important outcomes in a consensus process and 4(iv) Holding a face to face meeting to 
finalise the recommended core outcome set. 
The international e-Delphi survey involved 88 participants (21 patients and 67 dental 
professionals or researchers) who prioritised 24 outcomes to be taken forward to the 
face to face meeting. 
The face to face consensus meeting was held in Dundee and involved 13 participants 
(seven patients and six dental professionals and researchers). At this meeting, 23 
outcomes were discussed in a modified Nominal Group Technique meeting prior to 
selecting the core outcome set by anonymous electronic voting. Views on a final 
outcome were sought from the same group via email after the original meeting. In 
alphabetical order the seven outcomes agreed by the stakeholder group are: 
‘Irreversible Pulpitis’, ‘Oral Function’, ‘Patient Satisfaction’, ‘Quality of Life’, 
‘Remineralisation of the Lesion’, ‘Survival of the Restoration’, and ‘Tooth Survival’. 
To help reduce outcome heterogeneity and improve the integration between primary 
and secondary research, this core outcome set should be used for future randomised 
controlled trials and systematic reviews. Translation of this evidence to help inform 
patient care will be improved if these can be successfully applied in future research. 
The agreed COS is then mapped to the outcomes selected for relevant Cochrane 
reviews. This analysis shows that none of the relevant Cochrane reviews maps directly 
xx 
to the COS. Furthermore, they also show outcome heterogeneity between Cochrane 
reviews. This highlights the need to align all stages of the GEEOH, including evidence 
syntheses, to the agreed COS. 
A “new normal” is needed in healthcare research generally, and carious lesion 
management research specifically, to increase value and reduce waste. A coordinated 
approach to synchronising methodologies, including outcome selection, in all stages of 
the GEEOH is recommended. Cochrane are ideally placed to co-ordinate these aspects 
of the GEEOH. Should the COS developed in this thesis be adopted by Cochrane Oral 
Health in future living systematic reviews and network meta-analyses, it would 
represent an important step in harmonising outcome selection and reporting within 
the GEEOH. Researchers conducting primary research should be encouraged and 
supported to use standardised methods and outcomes to allow synthesis into living 
network meta-analyses. Evidence gaps should be addressed by broad global 
collaborations rather than narrow, competing attempts to be the first to publish 
results. It is suggested that researchers throughout the GEEOH must become more 
willing to share knowledge and skills with each other and be less protective of their 
own interests. Advocates for this coordinated way of working are now needed at each 
stage of the GEEOH to support this change to research culture.  
xxi 
Components of the work presented in this thesis have already been disseminated 
nationally and internationally. 
The results of the systematic review of randomised controlled trial outcomes 
presented in Chapter 4 has been published in BMC Trials in 2017 (2). A sister 
publication presenting a network analysis of comparator choice within the same trials 
arose from the same database of randomised controlled trials (3). This analysis is not 
reported in this thesis. These works led to a book chapter about the wider research 
waste problem within caries research which I co-authored (4). 
Stages of the Core Outcome Set (COS) development work have been presented at 
three IADR (International Association for Dental Research) congresses. In 2016, the 
preliminary results of the systematic review of trial outcomes review was presented in 
Seoul. In 2017, the complete analysis of the systematic review was presented in San 
Francisco. In 2019, the results of the eDelphi were presented in Vancouver. An abstract 
had been accepted for the cancelled IADR congress in Washington DC in 2020, where 
the final agreed COS was due to be presented. 
1 
Dental decay (caries) is one of the world’s most prevalent diseases. Consequently, the 
prevention and management of this disease is a large part of the work of dental 
professionals throughout the world. Although dental caries is preventable, it is 
common, with an estimated global prevalence of untreated disease of 35% (2.4 billion 
people) (5). Billions more have had experience of, and treatment for, this disease. It 
carries with it a significant health burden for the individual including pain, discomfort, 
infection, tooth loss and reduced quality of life (6). In addition, the treatment of the 
disease is expensive and requires lifelong maintenance and replacement. As a result, 
there is a high societal and individual cost over time (6, 7). Despite this large impact 
and established means of prevention, there is still disagreement about how best to 
manage carious lesions once they have become established (i.e. clinically detectable) 
(8, 9). This picture has been complicated by the realisation that all types of operative 
intervention (such as dental fillings or restorations) will fail and so cycles of restoration 
need to be planned and accounted for. This has led to a minimally invasive (MI) 
treatment philosophy gaining momentum. Furthermore, the Covid 19 pandemic has 
exposed the high level of risk associated with many operative techniques resulting 
from aerosol generating procedures (AGPs). The profession is rapidly looking for ways 
to manage dental disease whilst minimising AGPs (10, 11). The balance of the 
economics and practicalities of conventional treatment versus MI approaches have 
shifted. These will quite possibly favour MI approaches in the long term. However, 
what remains clear, is that the cariology research community must fill evidence gaps 
2 
and undertake further, high quality research in the area of lesion management to 
inform guidelines and best practice (9). 
While I was an undergraduate dental student in Dundee, the Hall technique for 
managing carious primary molars was becoming more widely known and practiced. 
Much of the evidence to support its use was produced from the School of Dentistry in 
Dundee around that time (12-14). This novel treatment for decay in primary molars 
had been developed using a contemporary understanding of the caries process and 
how it’s life course could be changed biologically (15). Earlier discoveries from basic 
science supported a change of clinical approach that challenges conventional wisdom 
and established practice. At the time I was aware of the controversy that surrounded 
this intervention despite growing evidence to support its use (16, 17). Critics of this 
emerging technique were rebutted using evidence, not anecdote (18, 19).  Combined 
with an overall ethos in the curriculum of minimal intervention, I realised that research 
evidence can begin to change established norms and professional opinion, making a 
positive contribution to the health of patients globally. This could only be done 
because attention was being paid to the quality of the evidence being produced.  
The theme of this thesis lies at the interface that sparked my interest as an 
undergraduate dental student: cariology and improving the quality and applicability of 
clinical research. Now, as a clinical lecturer, I teach the next generation of dental care 
providers about how to prevent and manage dental caries, laying down the foundation 
of their understanding and future practice. Students, well-versed in the need to 
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provide evidence-based practice, are often surprised and a little disappointed by the 
evidence when they find it. It is not as strong or convincing as they had imagined.  
 
The scale of this problem in healthcare research was starkly demonstrated to me in 
September 2015, when I attended the REWARD (Reduce Research Waste and Reward 
Diligence) conference organised by the EQUATOR network (Enhancing the Quality and 
Transparency Of health Research) in Edinburgh. This was a healthcare methods 
conference which discussed and endorsed the recommendations published in the 
Lancet series on research waste (20-26). I was disappointed to hear about the level of 
research waste across the entire ecosystem of healthcare research. Speaker after 
speaker from laboratory science right through to clinical trials and evidence synthesis 
spoke about the wasted effort and lost opportunity in their area. It was at this 
conference, and in subsequent discussions with colleagues in Dundee, that I became 
aware of the role of Core Outcome Sets (COS) as a way of improving healthcare 
research methods and reducing waste. Combining my research, teaching and clinical 
interests, I began to investigate developing a COS for caries. This resulted in the work 
presented in this thesis. 
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To identify and describe sources of avoidable waste in relation to outcome selection in 
carious lesion management research and to explore how this can be addressed in 
future. 
 
1. To provide an overview of the current understanding of the aetiopathogenesis and 
epidemiology of dental caries as well as current treatment methods to manage the 
disease. 
2. To describe the problem of avoidable waste in healthcare research and set it within 
the context of the proposed Global Evidence Ecosystem for Oral Health (GEEOH). 
3. To investigate evidence syntheses within cariology for signs of research waste. 
4. To develop a core outcome set (COS) for effectiveness trials investigating the 
management of established carious lesions. 
5. To assess the scale of the challenge ahead by mapping the COS developed in 
objective 4 to current “best evidence”. 
 
Throughout this thesis I use terminology according to the consensus paper published 
by Innes and colleagues in 2016 (27). In this manner, the term “caries” refers to the 
biochemical disease process and the term “carious lesion” refers to the clinical 
5 
manifestation of this disease process. I am aware that terminology around dental 
caries has been controversial and that other authors have more recently 
recommended slightly different taxonomies (28). The focus of this thesis is the 
development of a COS for the treatment of clinically detectable lesions. The term 
“carious lesion management” is used throughout this thesis to include both operative 
(e.g. fillings or restorations) and non-operative interventions to arrest, slow or restore 
tooth tissue (lesions) damaged by the caries process. Where the prevention of lesions 
arising is described, the term, “primary prevention” is used for clarity. 
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7 
Dental caries has a significant global impact on individuals and populations (5, 7). It is 
the most prevalent disease in humans, affecting 2.4 billion people worldwide (5). 
Although we know that it is common, we also know that it is preventable (29). Dental 
caries is a disease caused by a complex bacterial biofilm which adheres to the tooth 
surface (30). When regularly exposed to fermentable dietary carbohydrates the 
bacteria in the biofilm produce acids which demineralise the underlying tooth 
structure, leading to weakening of the surface and cavitation. The visible change on 
the tooth surface that arises from this is called the carious lesion (27). In the presence 
of frequent sugar exposures, an ecological shift occurs within the biofilm towards more 
acidogenic (acid producing) and aciduric (acid tolerant) species. This shift is sometimes 
called dysbiosis and explains why not all plaque causes rapid destruction of the 
underlying tooth (31). If the rate of tooth structure destruction is rapid, pulpal pain can 
develop leading to a significant impact upon the affected individual. Left untreated, it 
can also lead to infection which, in more extreme cases, can become life threatening 
due to sepsis (32). Ultimately, the uncontrolled carious process can lead to tooth loss 
with the associated functional and aesthetic impairment which that brings (33). 
Treatment of dental caries both at the patient and tooth level, is expensive (6, 34) and 
has a high economic impact through lost days at school (35, 36) and work (37). 
8 
This biochemical process within a cariogenic plaque biofilm is called “dental caries” 
(27). Once the biochemical production of acid is established and demineralisation of 
tooth structure has occurred, we have a “carious lesion” (27) within the tooth 
structure. The terms “dental caries” or simply “caries” and “carious lesion” have been, 
and continue to be used interchangeably (27). However, this is no longer 
recommended use of terminology (27, 28). The term “dental caries” or simply “caries” 
refers to the pathological biochemical process occurring in plaque, while the “carious 
lesion” or “caries lesion” is the clinically detectable damaged tooth tissue which is 
affected by the biochemical process (27, 28). 
Carious lesions vary in severity by surface area and volume, and degree of mineral loss. 
The shape can vary depending upon the position of the lesion on the tooth as well as 
how long they have been active (33). As a result, the severity of the disease and impact 
upon the patient can also vary considerably. Regardless of the shape and size, their 
progression is always driven by the cariogenic biofilm on the tooth surface (31). This is 
key to an understanding of how the disease is prevented and the resultant lesions 
managed. The association of carious lesions with micro-organisms has been 
understood since Antonie van Leeuwenhoek first used microscopy to examine dental 
plaque in the late 1600s (38). Examining dental plaque under magnification, he noted 
multiple “animalcules”, which we now understand to be bacteria. Despite this 
longstanding knowledge, the relative importance of different bacteria and exactly how 
they cooperate and function within the “consortium” of the biofilm is growing, though 
still not fully understood (31, 39).  
9 
The initiation of a carious lesion can occur on enamel or dentine (in the case of a root 
surface carious lesion). Commonly, the progression of a lesion is described from the 
perspective of a coronal carious lesion first initiated on enamel (Figure 1.1). In this 
case, the initial enamel lesion begins with marked dissolution of the calcium from the 
hydroxyapatite crystals that make up the enamel structure. At this very early stage, 
lesions such as this can be visually detected by removing the overlying plaque, drying 
and illuminating the tooth surface (40). The lesion will appear as a white, matt area 
contrasting with surrounding normal tissue (41-43). The surface is rough (matt) due to 
the dissolution of calcium at the surface. Visually, it appears white as the optical 
properties (refractive index) of the enamel have been altered, resulting in a contrast to 
the surrounding normal enamel which can be detected by the human eye. In the 
presence of a supersaturated solution of calcium, phosphate and fluoride (such as is 
contained in saliva) the surface of the lesion has the potential to remineralise (44). This 
remineralisation of the surface gives rise to what is termed the “surface zone” of the 
enamel lesion (45). This zone contains a higher mineral content than the underlying 
zones as a result. Beneath this is the “body of the lesion” (45). The body of the lesion is 
more porous (i.e. demineralised) than the surface zone and it is this that preserves the 
visual contrast of the lesion even if the activity of the carious lesion is arrested. Deep 
to the body of the lesion lie the dark zone and translucent zones (45). These are so-
called due to their appearance in polarised light when examined in quinoline. These 
zones are more porous than normal enamel but less porous than the body of the 
lesion. While the surface zone remains intact, the lesion can be arrested, that is 
progression halted, by simple modification of the biochemical processes within the 
10 
 
 
biofilm or its removal from the tooth surface (44). Cavitation of the surface occurs 
when the underlying body of the lesion becomes so weakened that it can no longer 
support the surface zone (45).  
 
 
The acid-producing plaque biofilm on the surface of the tooth (purple) drives the demineralisation 
of the underlying enamel. The four zones of the enamel lesion are shown: Surface zone, Body of the 
Lesion, Dark Zone and Translucent Zone. (Illustration by Andrew G Mason and modified by Colin 
Levey, with permission). 
 
Even before the enamel becomes cavitated, the dentine responds to the potential 
attack of an advancing carious lesion (46). Unlike enamel, dentine is a vital tissue 
comprising tubules which contain cellular processes from odontoblasts whose cell 
11 
 
 
bodies line the wall of the pulp chamber. The first line of defence is set up by vital 
odontoblasts as they lay down more dentine within the tubules that make up the 
micro-structure of dentine. This is called peri-tubular dentine and results in tubular 
sclerosis, reducing the permeability of the dentine to bacteria which may follow as the 
lesion progresses. Only when the demineralised advancing front of the enamel lesion 
reaches the amelodentinal junction does the first sign of dentine demineralisation 
appear. At this stage, the demineralisation is still driven by the biochemical activity in 
the plaque biofilm at the surface of the enamel. Without cavitation at the surface, the 
lesion can still be arrested through the removal or biochemical alteration of the 
surface biofilm. That is to say that the tissue damage can be halted by positive changes 
to the environmental conditions at the tooth surface. 
 
When the surface zone of the enamel lesion collapses, two issues arise that result in 
more rapid progression of the lesion. Firstly, the bacteria now invade the lesion and 
gain direct access to the dentinal tubules. For the first time, dentine has become 
infected. Secondly, the bacterial biofilm on the walls of the cavity are now more 
protected which results in an ecological shift towards even more aciduric, acidogenic 
and anaerobic bacteria (15, 31). This biofilm has greater cariogenic potential and can 
lead to the rapid demineralisation of underlying tooth structure. 
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The boundary between the enamel and underlying dentine is relatively well defined. 
However, the dentine is inextricably linked to the pulp contained within the tooth as 
components of the odontoblast cells are found in both tissues. Furthermore, excessive 
damage to the dentine can result in death of the underlying pulp. It is for these 
reasons that, together, they are often described as the pulpodentinal complex and 
should be considered together. 
 
Cavitation of the enamel allows the biofilm to become more protected and it can begin to invade 
the underlying dentine. The outer layer of the dentine lesion is referred to as the “zone of 
destruction” or the “necrotic zone” (Dark Blue). Beneath this there is bacterial ingress into the 
tubular structure of the dentine. This has been referred to as the “zone of penetration” or the 
“contaminated zone” (light blue). Together, these zones have been collectively called the “infected 
dentine”, although the clinical descriptor of “soft dentine” is preferred today (blue). The dentine 
demineralised by the bacterial acids lies deeper to these and is called the “demineralised zone” and 
is given the clinical description of “leathery” or “firm” dentine (orange). The translucent zone 
beyond (white) has greater density due to tubular sclerosis and corresponds to clinically “firm” 
dentine.  (Illustration by Andrew G Mason and modified by Colin Levey, with permission.) 
13 
 
 
Once the bacterial biofilm encounters the dentine, the dentine in direct contact 
becomes necrotic and heavily contaminated. This has been referred to as the “zone of 
destruction” or the “necrotic zone”. Beneath this there is bacterial ingress into the 
tubular structure of the dentine. This has been referred to as the “zone of penetration” 
or the “contaminated zone”. Together, these zones have been collectively called the 
“infected dentine”, although the clinical descriptor of “soft dentine” is preferred today 
(27). This layer contains areas of liquefaction causing transverse clefts or separation of 
the dentine along incremental lines of development which clinically cause dentine to 
“flake away” along these clefts. Beneath these zones where bacteria have invaded lies 
the demineralised dentine. Bacterial acids demineralise tooth structure in advance of 
bacterial invasion causing it to become softer (47). Compared with the overlying 
necrotic and contaminated zones, this zone has very few detectable microorganisms 
and few nutrients for bacterial metabolism (47). The clinical relevance of this finding is 
that, when caries removal is planned, this zone does not need to be removed as the 
remaining bacteria can be left in situ provided a well-sealed restoration is placed. The 
bacteria entombed under the restoration do not have adequate access to the nutrients 
to multiply and continue tissue destruction. This has formed the basis for development 
of minimally invasive approaches to lesion management (48). Clinical descriptors of 
this level of carious dentine include “leathery dentine” progressing to “firm dentine” 
deeper in the tooth. This contrasts with “hard dentine” or “sound dentine” found 
beyond the extent of demineralisation. This hard or sound dentine is not considered to 
be part of the lesion.  
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If the rate of lesion advancement is slow, the pulpal odontoblasts not only lay down 
dentine in tubules (peri-tubular dentine) causing tubular sclerosis as a defence against 
the advancing front of bacteria. They also lay down tertiary dentine on the pulpal wall 
adjacent to the advancing lesion (Figure 1.2). This dentine increases the thickness and 
decreases the permeability of the hard tissue between the advancing front of the 
lesion and the pulp. However, if the rate of lesion progression is faster than the rate of 
tertiary dentine formation, the pulp may become inflamed and cause pulpitis (i.e. 
pain). 
 
When acids, toxins or the bacteria themselves reach odontoblast processes or the pulp 
they will respond to maintain vitality. If the lesion is slow progressing and low-grade, 
the result will be chronic inflammation. If the progression is faster, then acute 
inflammation will result. This type of inflammation is associated with dilation of pulpal 
blood vessels producing increased pressure within the fixed dimensions of the pulp 
chamber. When this occurs, pain often results. In some cases, this will lead to necrosis 
of the pulpal tissues allowing spread of inflammation, and later infection, to periapical 
tissues via the apical foramen of the tooth root. 
Carious involvement with the pulp can produce pain of various types which collectively 
are referred to as “toothache”. Clinically, there are two presentations of pain 
commonly described as “reversible pulpitis” and “irreversible pulpitis”. The former 
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elicits short, sharp pain which is classically brought about by cold stimuli. The latter is 
described by sufferers as a constant or spontaneous ache and is more often associated 
with both hot and cold stimuli. As the names suggest, in cases of reversible pulpitis the 
pulp may recover with appropriate treatment, while in irreversible pulpitis, this is not 
possible. Irreversible pulpitis pain causes significant impact upon the patient including 
sleep disturbance which may interfere with daily activities and reduce quality of life 
(49). This is the severe “toothache” classically described by patients throughout history 
(50). It also signals the death of the pulp tissue, leaving the space vulnerable to 
bacterial contamination and infection. 
 
Following the death of the pulp tissue through chronic or acute inflammation, the pulp 
chamber and root canals can become colonised with bacteria (Figure 1.3). In this space 
they are protected within a stable environment and can spread beyond the apex of the 
root, resulting in inflammation or infection of the tissues that support the tooth. 
Periradular periodontitis, abscesses and spreading infection may result. The bacterial 
colonies within the root canal system cannot be reached by systemic antibiotics as no 
blood supply to the area remains. As a result, root canal treatment or removal of the 
tooth is required. If uncontrolled and untreated, spreading infection can become a life-
threatening condition (32). 
 
 
 
 
16 
 
 
 
When the biofilm (purple) colonises the pulp space (Lilac), the bacteria move towards the apices of 
the tooth roots causing inflammation (Periradicular periodontitis) or infection (Periradicular 
abscess). Once bacteria spread beyond the apex of the tooth root through the apical foramen, there 
is potential for systemic spread of infection. (Illustration by Colin Levey) 
 
Dental caries has a high global prevalence affecting large numbers of people in high- 
and low-income countries (5). In fact, evidence published by Marcenes and colleagues 
supports its status as the most prevalent disease in adults globally (51). This review 
also suggested that the tenth most prevalent disease was caries of the deciduous 
teeth, thought to affect nine percent of the global population (51). While it is clearly a 
large global problem, accurate quantification of the global epidemiology of dental 
caries has been lacking in the literature. Furthermore, reliable assessment of global 
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trends in prevalence is scarce (52). Part of the reason for this has been the change in 
presentation, detection, diagnosis and measurement of carious lesions over the last 50 
years (52). Therefore, meaningful comparison of historical with contemporary data is 
fraught with challenge. This was supported by the findings of a recent umbrella review 
by Frencken and colleagues (53). They found that different indices and disease 
thresholds were used which complicated comparisons. This also revealed a lack of 
agreement about whether current disease alone was counted (rather than past and 
present experience as with DMFT).  This umbrella review of the caries epidemiology 
literature yielded only two eligible systematic reviews of carious lesion prevalence. 
These systematic reviews estimated, using a statistical meta-regression model, the 
global age-standardised prevalence of untreated, cavitated dentine carious lesions in 
the permanent dentition. This was estimated to have been relatively static at 35% over 
the period 1990 to 2010. The disease prevalence peaked at age 25 although a second 
peak at age 70 was also found as adults are now retaining more teeth for longer. 
Frencken and colleagues also searched for relevant data in the WHO (World Health 
Organization) database on dental caries epidemiology and found 12 suitable records 
(53). Trend studies identified through this search demonstrated a dramatic reduction 
in the prevalence and severity of cavitated dentine carious lesions in young children, 
adolescents and adults over the last 30-40 years. This is particularly evident in middle- 
and high-income countries. The authors of this review reflect on the fact that the 
burden of untreated carious lesions has shifted in recent years from childhood to 
adulthood. As more people retain their teeth for longer because of a reduced caries 
rate, more people have more teeth which can be affected by this disease in adulthood 
(53). 
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Overall, the disease burden for dental caries has a significant socio-economic gradient 
with the poorest sectors of the global population suffering the greatest prevalence of 
disease (5, 51, 54). This is true for both primary and permanent teeth. In the primary 
teeth of one to six year olds, the prevalence of “severe early childhood caries” is 
estimated to be 24.8% in Switzerland but 74.4% in Vietnam. Although the overall 
picture is stark, there has been significant reduction in prevalence in several higher 
income countries such as the UK, Sweden and South Africa. In the UK, caries 
prevalence amongst five year olds has dramatically reduced since 1973 with a 46% 
reduction rate in dmft (decayed, missing or filled primary teeth) by 2013. Although 
overall prevalence within some countries has reduced, there are significant disparities 
between the richest and poorest within nations. In Scotland, there has been an overall 
increase in the proportion of children who have “no obvious decay experience” from 
53% of 11-12 year olds in 2005 to 80% in 2019 (55). However, in 2019, 69.5% of the 
most deprived children aged 11-12 had no obvious decay experience. The caries free 
prevalence amongst the least deprived was 88.1% (55). There is a clear socioeconomic 
gradient that has persisted despite overall improvements in all groups. In Scotland, the 
increase in the prevalence of caries-free children is attributed to targeted caries 
prevention interventions such as the Childsmile programme (56). In 2018, 71% of five 
and six year olds in Scotland had no obvious decay, up from 45% in 2002 (57). A 
socioeconomic gradient exists at this age too, with 55.8% having no obvious decay 
experience in the most deprived areas, compared with 85.9% in the least deprived 
(57). The effect of this increased caries prevalence rate deepens inequality by bringing 
functional and aesthetic disadvantages (33). Further, the treatment burden for these 
children has a high economic impact in terms of expense of care (6, 34) as well as 
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through lost days at school for the child themselves (35, 36) and work for the parent 
who brings them for care (37). 
 
In the same way that caries is not uniformly distributed in the population, neither are 
all tooth surfaces equally affected. The occlusal pits and fissures of posterior teeth are 
the most susceptible to caries due to the protected environment afforded to the 
bacteria (15, 58). This is followed by the approximal surfaces of posterior teeth where 
the teeth contact one another (58). Again, the bacterial biofilm in these sites is well 
protected, allowing a dysbiosis or ecological shift towards a more cariogenic 
composition (15, 31). Smooth surfaces of anterior teeth have a low caries risk in all but 
the most high-risk patients. As caries experience in a population decreases, the 
severity of the disease in the least susceptible sites decreases considerably more than 
in high risk sites (e.g. pits and fissures). This means that, broadly speaking, the majority 
of lesions across the population are in pits, fissures and approximal sites in posterior 
teeth. 
 
Prevention of the biological process of dental caries is important if carious lesions and 
their sequelae are to be avoided. This is sometimes referred to as “primary 
prevention” (28). Even when a carious lesion has become established, the application 
of interventions to modify this biological process are key to halt progression of the 
lesion. This is sometimes referred to as “secondary prevention” or “caries control” 
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(28). Throughout this thesis, the term “primary prevention” will be applied to 
interventions targeted at halting demineralisation before a clinically detectable lesion 
develops. 
 
The growing realisation that prevention or control of the carious process cannot be 
completely separated from the management of the established carious lesion itself, 
has led to a shift towards non-operative management strategies. Biofilm modification 
in the form of mechanical and chemical disruption is essential to control the disease 
and limit its impact. Changes in diet to reduce the fermentable carbohydrates or non-
milk extrinsic sugar (NMES) content favours a shift in the biofilm towards a non-
cariogenic microflora with reduced levels of acid production. Commonly affected sites 
such as occlusal pits and fissures can be sealed to prevent accumulation of a biofilm in 
non-cleansable and protected micro-niches. If a lesion develops, many of these 
interventions should be applied to control the caries process before operative 
treatment and restoration can be considered. Placement of a restoration is sometimes 
required to facilitate biofilm modification or removal as well as the restoration of 
aesthetics and function of the tooth. In the dental community it is well known that the 
management of dental caries has developed significantly since the times of Greene 
Vardiman Black (59).  He expounded the benefits of complete carious lesion removal 
and, in some cases, sound tooth structure to allow placement of a suitable and durable 
restoration. It was thought that the diseased tooth tissue was weak and mechanically 
unsuitable for the placement of a restoration. Indeed, the restorative material could 
be considered superior to tooth tissue and so “extension for prevention” was 
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advocated: the placement of large restorations replacing tooth surfaces likely to 
develop caries again in the future (59). However, a contemporary understanding of the 
carious lesion and its life course has resulted in a philosophy of a minimal intervention 
(MI) (48, 59, 60). We now know that no restoration lasts forever and is subject to 
failure due to biological (e.g. new carious lesions), mechanical (e.g. material fracture) 
and aesthetic factors (e.g. patient satisfaction). Over-zealous restorative management 
of the initial disease and subsequent failures leads to what has been termed “the 
death spiral” (61) of repeated failure leading to early tooth loss. This is also referred to 
as “the restorative cycle” (62). The MI concept has been established to reduce the risk 
of premature tooth loss due to cycles of lesion management interventions. Combined 
with new materials which adhere to tooth structure creating a biological seal, 
complete caries removal and “extension for prevention” can no longer be supported as 
best practice (62). This emphasis on the conservation of as much tooth structure as 
possible has supported the development of biological techniques for management of 
active lesions. When combined with secondary prevention, it is possible to preserve 
tooth tissue whilst also reducing the risk of new lesions developing adjacent to the 
restoration or on de novo sites elsewhere in the mouth. 
 
There is debate surrounding how much of carious lesion should be removed to 
maximise longevity of the restoration and the affected tooth. This has been 
complicated by a lack of clear definitions of different types of carious tissue removal. In 
2016, a consensus recommendation paper was published by Innes and colleagues (27), 
setting out clear and agreed terminology and definitions which should allow clinicians 
and researchers to communicate and compare results with greater consistency and 
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clarity. The authors acknowledge that there is a poor link between clinical visual 
appearance and specific histopathology of the lesion. Despite this, the agreed 
terminology is linked to the clinical visual and tactile appearance of dentine lesions 
because clinical decisions are made based on these signs during caries removal and not 
in response to laboratory analysis of the carious lesion (27). The three main 
approaches to carious tissue removal were defined as; 
  
1) —including selective removal to soft 
dentine and selective removal to firm dentine;  
2) —including stage 1, selective removal to soft dentine, and 
stage 2, selective removal to firm dentine 6 to 12 months later; and  
3) —formerly known as complete caries 
removal (technique no longer recommended) 
 
Uncertainty exists as to whether approaches one or two listed above provide the 
better clinical outcome and which is most cost-effective (27). Issues also arise around 
radiographic lesion diagnosis and assessment of lesion activity when demineralised 
tissue is left under a new restoration as part of these approaches. There is a risk that 
patients may have unnecessary treatment if these methods are not accepted into 
common practice and understood by practising dentists throughout the world. 
 
A consensus paper published by Schwendicke and colleagues in 2016 (62) provides 
contemporary recommendations for carious tissue removal within the scope of the 
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minimal intervention philosophy of care. Beyond early detection and diagnosis of 
lesions, the cornerstones of this approach were defined as: 
 
• Control of the underlying disease process 
• Preservation of dental tissues 
• Avoidance of initiating the restorative cycle of restoration replacements 
• Preservation of the tooth itself as far as is possible  
 
Non-cavitated lesions should be managed without operative intervention where 
possible since modification or removal of the biofilm by the patient should be 
sufficient to arrest the lesion. Since the visual evidence of the disease does not 
disappear in all but the earliest enamel lesions, monitoring of the lesion activity is 
important part of the clinical care plan. 
 
For cavitated lesions which are not cleansable by the patient, there is a strong 
recommendation to utilise restorative-based interventions. The aim of using a 
restorative approach should be to: 
  
“1. Aid plaque control and thereby manage caries activity at this specific location: 
2. Protect the pulp-dentine complex and arrest the lesion by sealing it; and 
3. Restore the function, form and aesthetics of the tooth” (62) 
 
This type of management usually involves removal of carious tissue in order to provide 
sound tooth for the restorative material to be packed against or bonded to and to 
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remove infected tissues to eliminate as many bacteria as possible from the tooth. 
Nowadays, the evidence would not support these aims without careful consideration. 
Instead, the group recommend that the following guiding principles should be borne in 
mind when removing carious tissue (62): 
 
• “Restorative treatments are carried out to aid biofilm control; protect the pulp-
dentine complex; and restore the function, form, and aesthetics of the tooth, while 
causing no unnecessary harm. The carious tissue removal stage aims to create 
conditions for a long-lasting restoration, preserve healthy and remineralizable 
tissue, achieve a sufficient seal, maintain pulpal health, and maximize success of 
the restoration. However, this does not necessarily mean that close to the pulp, all 
bacterially contaminated or demineralized tissues need to be removed (strong 
recommendation).  
 
• In deeper lesions in teeth with pulps that are sensible (vital), preserving pulpal 
health should be prioritized, while in shallow or moderately deep lesions, 
restoration longevity might be more important factor (strong recommendation).” 
 
Clinically, the dentist or dental care professional (DCP) must make a judgement about 
when to stop removing further tooth tissue. This clinical procedure is completed 
without histological sampling or with reliable tests that give a specific and 
unambiguous diagnosis. Instead, they must use indicators like hardness, colour, and 
moisture content to make a clinical judgement. In this consensus paper, a weak 
recommendation is made to use dentine hardness as the primary method of assessing 
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and describing the level of tissue removal (e.g. soft, leathery, firm or hard) (62). In the 
earlier example of selective carious tissue removal, there could be differences in 
outcome between tissue removal to soft, leathery or firm dentine. Therefore, 
researchers must use more specific definitions to describe this than simply “selective 
removal” in trial reports (62). 
 
There are several methods to restore function, form and aesthetics of a tooth after 
selective carious tissue removal has been completed. In general, this is usually a 
directly placed plastic material such as amalgam, resin composite, glass ionomer or 
resin-modified glass ionomer. These materials have somewhat different properties and 
have developed rapidly at different times in their history. As a result, there is no 
definitive evidence to support one over another and the choice of material is often 
subject to external factors such as cost, local and international legislation, payment 
systems and patient/operator preference (63). What is agreed with respect to the use 
of these materials is that it is not always necessary to remove the whole restoration in 
the case of local failure or the development of a new carious lesion. In this case repair, 
rather than replacement, should be considered first within the MI approach outlined 
earlier (64-66). 
 
Although the caries process in the biofilm is the same in the primary and permanent 
dentition, the aims of lesion management may be different. In the case of primary 
teeth, they have a limited lifespan in most patients. The exception to this is patients 
with developmentally absent successor teeth (Hypodontia), where the primary teeth 
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may be retained into adulthood. However, in most cases the goal for management of 
the primary dentition is to maintain a pain and infection-free dentition which 
maintains the appropriate space for the developing permanent dentition (67). Ideally 
this should be achieved without subjecting the child to unpleasant or negative 
experiences which could result in the development of dental anxiety or phobia (67). 
Primary teeth may only be required to survive for around 10 years before they are lost. 
In the permanent dentition, the teeth may be expected to last for upwards of 80 years. 
The goal is quite different in this respect and the importance of reducing cycles of 
restoration, key. 
The disease process is relatively well understood in terms of the stages of lesion 
progression as well as the dynamics of disease initiation and activity. The need for 
caries control and tissue conservation are broadly accepted amongst opinion leaders 
and increasingly so across the profession (68). Resistance still remains to wholly 
embracing an MI approach with many professionals still opting for invasive treatment 
when less invasive options are available (68). However, uncertainty remains about the 
best way to manage carious lesions which maximises biological and patient-important 
outcomes (69). Despite the growing acceptance that minimal intervention and caries 
control is the way forward, barriers remain in terms of implementation of best 
evidence with many insurance and healthcare systems failing to reward minimal 
intervention above traditional and accepted treatments. Whilst change may be forced 
by the Covid-19 pandemic (10, 11), there is still a need for well-conducted, pragmatic 
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clinical trials conducted in primary care which compare appropriate interventions and 
measure important outcomes. The interventions being compared should aim to 
establish the most appropriate level of carious tissue removal where it is indicated and 
the most suitable material to restore function and aesthetics. What is important to 
measure should be determined by a variety of stakeholders including patients, 
clinicians and researchers (9). 
 
In this chapter, the aetiology and epidemiology of dental caries and the impact of 
carious lesions on individuals and societies has been presented. Based on a changing 
understanding of the disease process, the development of new treatment methods has 
been described. As a result of the changing treatment approaches, there are new 
questions yet to be answered.  
 
In the next chapter, the broader context of evidence production and synthesis in 
health research will be discussed. There are challenges which must be overcome if we 
are to generate high quality evidence to answer the questions that this chapter has 
raised. 
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The development of evidence which can be applied to the clinical care of patients is a 
complex ongoing process. Beginning with a clinical problem and developing an 
understanding of the disease mechanism(s) involved, creating new interventions using 
innovation and knowledge, and testing them to establish their impact. The data from 
these tests is then collated and synthesised, providing evidence for guidelines and 
policy. These result in new clinical problems, and so this process forms a continual loop 
in what has been described as an “evidence ecosystem” (70). 
An ecosystem is a complex network or interconnected system where the overall 
function is too great and too complex for one component part to deliver alone. This 
interconnection is seen in nature and is also replicated in man-made systems. The 
development of a Global Evidence Ecosystem for Oral Health (GEEOH) has been 
proposed. It is to be formed by the collaboration of individuals, teams and 
organisations from across the world who are each interested in improving the 
production, synthesis, dissemination, implementation and evaluation of research 
evidence in oral health (71, 72). It was proposed in advance of the International 
Association for Dental Research (IADR) general session in Vancouver in 2019 and brings 
together researchers seeking to align and improve the components of the cycle in 
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which they are involved. Figure 2.1 shows the proposed structure of the GEEOH. It 
indicates where public health bodies, oral health research organisations and other 
professional associations might begin to co-ordinate aspects of the cycle.  
 
Evidence ecosystem model adapted for Oral Health research from the conceptual framework 
developed by MAGIC (MAking GRADE the Irresistible Choice). (Modified by Colin Levey and reprinted 
with permission) 
 
The GEEOH initiative is led by Cochrane in collaboration with the non-profit MAGIC  
foundation (MAking GRADE the Irresistible Choice) (70) . The mission of MAGIC is to 
increase value and reduce waste in healthcare and considers the interaction of all 
stakeholders within the ecosystem with the aim of producing “trustworthy evidence 
that is globally adaptable to the needs of end-users by co-ordinating common 
methodological standards, using digitally structured data platforms and establishing a 
culture of sharing and innovation” (70, 71). By refining the quality of the product and 
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reducing waste at each stage, the overall value and efficiency of the ecosystem 
improves to the benefit of patients, clinicians, healthcare funders and policy makers. 
This approach, sometimes referred to as the “Marginal Gains”, or “1% improvement“ 
model (4, 73), is illustrated in Figure 2.2. This focus on marginal gains at each stage will 
add up to significant overall improvements in the translation of evidence into practice 
and a reduction in avoidable waste. The work presented in this thesis is one such 
marginal gain that can contribute to the efficient and effective functioning of the 
GEEOH.  Since the availability of the “best evidence” is a cornerstone of evidence-
based-practice (74, 75), it is essential that it is of the highest quality. This best evidence 
can then be combined, by way of good clinical communication, with patient priorities 
and professional judgement to provide optimum, individualised clinical care (76). 
Provided that the best evidence and professional opinion are contextualised for an 
individual patient and they are given the opportunity to question and consider their 
options, the resultant plan agreed is considered to be evidence-based practice (74-76). 
 
 
 
 
 
 
 
 
 
 
31 
 
 
 
The Marginal Gains or 1% Improvement model shows how small improvements in sequential steps 
of evidence production aggregate improve the quality of the evidence base. This will increase value 
and reduce avoidable waste. (Reprinted with permission) 
 
Availability of high-quality evidence is essential to inform clinical discussions and 
decision making between professionals and patients. There are several different ways 
in which evidence is produced to answer clinical research questions. These methods 
are often summarised in the “evidence hierarchy” as shown in Figure 2.3. In this 
pyramid, the “best” methods are at the apex of the pyramid (77). That is, study designs 
shown nearer the top are considered to estimate truth with greater precision. Whilst 
this is a useful guide for the researcher searching for an appropriate study design to 
answer their research question, it is often misused. Not all questions can be answered 
in a randomised controlled trial (RCT). Not all randomised controlled trials are well 
designed; some exhibit poor internal validity. Not all systematic reviews (SRs) are well 
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conducted and reported. Furthermore, study types found at the base of the pyramid 
may offer more accurate estimations of “truth”, if they are well conducted, than 
poorly conducted study types found nearer the apex of the pyramid.  
 
 
Adapted from the original proposed in 1994 by Guyatt et al. This figure shows the most robust 
methodology towards the peak of the pyramid, with less robust or relevant methods at the base. 
 
However, in healthcare the randomised controlled trial is, in general, considered to be 
the best design of clinical trial for testing clinically available interventions against one 
another. At the next stage of the cycle, systematic reviews and meta-analyses are 
commonly undertaken by searching for, then synthesising, the results of randomised 
controlled trials. This is one link in the chain of evidence synthesis, and one part of the 
cycle proposed by GEEOH in figure 2.1 (70). For the purposes of this thesis, I will focus 
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on this part of the pathway but place it within the wider context of guideline 
development and application of evidence into clinical practice. 
 
Randomised Controlled Trials (RCTs) are a type of primary research considered to be 
the gold-standard method for assessing healthcare interventions (4, 9, 74, 75, 78). In 
an RCT, eligible patients are randomly allocated to intervention and control groups. By 
randomly allocating participants before they receive treatment, selection bias is 
reduced (79). As with any form of bias, it can result in over or underestimation of how 
well the intervention works and gives an inaccurate estimate of truth. Selection bias 
means that researchers may consciously or unconsciously select patients who they 
think will do well in one group and not the other (79). Randomisation mitigates this 
risk and ensures that each group in the trial has balanced numbers of participants, or 
units of analysis, at baseline. Allocation to the groups can be “blinded” at various levels 
so that those delivering the intervention or assessing the outcome are unaware of the 
allocation to reduce the risk of performance or detection bias respectively. In addition, 
patients may also be blind to the intervention they have received to mitigate the 
Hawthorne effect (80). The Hawthorne effect is a type of performance bias and is 
observed when patients who have been selected for a study or new treatment alter 
their behaviour due to their awareness of being observed (80). The impact of this can 
be unpredictable (80) but can lead to bias within the study. It stands to reason that 
there are some differences between interventions that can be easily detected and so 
cannot be blinded (e.g. amalgam vs composite restoration). If this is the case, then it is 
simply an unavoidable limitation of the study findings.  
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As with all clinical dental research, the RCT should address a clear research question 
and be conducted in a way that will allow the authors to answer it. Commonly, we 
refer to a “PICOT question” to focus the aim and inform the design of the RCT. 
 
PICOT stands for Participants, Intervention, Control, Outcomes and Timeframe. This 
acronym helps researchers define their research questions and design their trial. 
Participants in the trial should be clearly identified and representative of the 
population that the intervention is expected to apply to in the real world. Effectiveness 
trials will often seek participants which represent a more general population rather 
than a highly selected homogenous group. New Interventions are tested against a 
Control intervention which should usually be a “gold-standard” established 
intervention (81). Outcomes are selected to assess the relative effects of the 
intervention and control and should be of importance to patients, clinicians or 
policymakers. They should not be selected solely because they are easy to measure or 
likely to show a statistically significant difference. Follow up of these outcomes in the 
patients who receive the intervention, or the control should be followed-up for an 
appropriate Timeframe. This is particularly important where the outcome of interest 
may not appear for some time after the intervention. Short timeframes increase the 
feasibility and reduce the cost of RCTs but may miss important effects on the outcome 
of interest. Choosing an appropriate timeframe helps to ensure that the results are 
relevant for clinical decision making as part of evidence-based practice (74, 75, 78, 81). 
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The PICOT question is very important as it will determine much about the conduct, 
generalisability of findings and economic cost of the trial. 
 
Patients and clinicians want to know how effective a given intervention is. That is, they 
want a “real-world” estimate of how much better off the patient will be after they 
receive an intervention or treatment. This is known as effectiveness. This is different 
from efficacy, although this distinction is poorly understood by evidence producers as 
well as end-users (82). 
 
Efficacy trials investigate whether or not interventions work under ideal or near ideal 
circumstances (82). They may be conducted on highly selected patients without other 
diseases which may affect the treatment outcome. They are often conducted in 
specialist secondary care centres or university clinics and are more likely to compare a 
new intervention with a placebo or no treatment (82). Interventions which show 
promise in efficacy trials do not always translate into effective real-world 
interventions. This phenomenon could be the result of the interventions being poorly 
translated to the context in which they will normally be delivered. Efficacy studies 
often have short follow up periods as the aim is to identify an effect, rather than long 
term improvement in a clinically important outcome (82, 83). Outcomes in efficacy 
studies are more likely to be based on the pathophysiology of the disease and report 
changes in disease biomarkers linked to the disease being treated. 
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Effectiveness trials investigate interventions delivered to a general population in a real-
world setting. The patient sample may include people who have multiple morbidities, 
taking multiple medications or undergoing concurrent treatment for other conditions. 
They should compare the intervention with the established gold-standard or best 
practice to assess the relative effectiveness. The setting of a trial should be the same 
as where most of this type of care is delivered. For the management of carious lesions, 
this is usually primary care. It should also be delivered by the normal care provider 
which, for carious lesion management, is a general dental practitioner (GDP). In 
general, the follow up period in effectiveness trials are longer and the outcomes 
assessed more relevant to the clinical impact of the disease and less commonly short-
term changes in disease biomarkers. 
 
Efficacy trials are an important part of the evidence ecosystem to establish whether 
new interventions have the potential to supersede existing treatments and help us to 
understand the underlying mechanisms at work. However, promising interventions 
identified in efficacy studies must then be assessed in large clinical trials suitable for 
synthesis and incorporation into guidance. Failure to conduct these effectiveness trials, 
and instead needlessly repeating small efficacy studies, is a waste of scarce human and 
economic research resources. What is required in carious lesion management 
research, are well conducted clinical trials investigating different interventions to 
assess the relative effectiveness of these approaches in a real-world setting. Research 
syntheses have demonstrated that there is insufficient data to draw firm conclusions in 
this area (69). There is a strong case for new, well-conducted effectiveness trials in 
carious lesion management research. This part of the GEEOH must generate the 
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evidence for synthesis and all that follows from there. What must be considered is how 
we reduce research waste and maximise quality in RCTs and SRs.  
 
Traditionally, several clinical studies would be summarised in narrative reviews. 
Subject experts would use their experience to assimilate the available literature and 
produce a synopsis of the evidence base for readers to then apply to their clinical care 
of patients. Whilst this method still has some applications, it is prone to being 
incomplete and influenced by the attitudes or biases of the author. Systematic reviews 
are different. This type of review involves the systematic search, appraisal and 
assimilation of the available evidence as is sometimes referred to as “Secondary 
Research”. In a similar way to well-designed RCTs, this type of review is more rigorous 
and is planned to answer a predefined PICOT question. The PICOT question determines 
the search terms used to find potentially relevant studies in continuously updated 
electronic databases of published trials. Potentially relevant studies are collected and 
investigated further to establish whether they fulfil inclusion criteria agreed a priori. 
Those that meet the inclusion criteria are read in full and their quality appraised. Data 
from the included primary research is extracted before the overall findings are 
combined, where appropriate, and presented. Combining effect size estimates from 
multiple small studies, allows reviewers to increase the precision of the combined 
effect size estimate. This is known as meta-analysis. It is important that the included 
trials measure similar outcomes in similar ways, otherwise the results cannot be 
combined. This type of research waste will be discussed later in the chapter. 
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In the 1970s, Professor Archie Cochrane, epidemiologist and early proponent of 
evidence-based medicine, advocated that there should be continually updated, subject 
specific critical summaries of relevant RCTs (84). The purpose of this was to ensure 
that clinicians always had access to the most up to date “best evidence” to apply on 
the clinic. Sadly, Cochrane did not live to see his idea become a reality. However, in 
1993, the Cochrane Collaboration was formed under the leadership of Sir Ian Chalmers 
to help deliver this goal, five years after the death of Cochrane. Since then, the 
Cochrane Collaboration (now known as Cochrane) has undertaken many thousands of 
systematic reviews across healthcare. The methods developed by Cochrane are 
considered to be the gold standard in evidence synthesis and are known for 
transparent and rigorous methodology in systematic reviews (85). Since 1993, the 
systematic review methods have been constantly evolving and now a common 
methodology is employed throughout healthcare and related research (85). Cochrane 
Oral health, located in Manchester, is the group which co-ordinates Cochrane 
systematic reviews in dentistry and oral health.  
 
Whilst sound evidence is required to carry out evidence-based practice, there appears 
to be too many new trials and reviews published in healthcare for the busy practitioner 
to keep up to date. In an analysis published in 2010, authors found that publication 
rate for all healthcare trials and reviews in 2010 was very high (86). They found that 
there were 75 new trials and 11 systematic reviews published every day (86). It is not 
possible to read, critically appraise and implement the findings as a busy clinician. 
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Therefore, the findings of these studies are incorporated into clinical guidelines to 
assist clinical colleagues in the practice of evidence-based healthcare. Guidelines are 
practice recommendations based on available “best evidence”. They form the next link 
in the chain of evidence or the global evidence ecosystem. High quality guidelines 
should be developed using rigorous and transparent methodology considering the 
quality of the available evidence from primary and secondary research as well as issues 
like patient values, resource use and feasibility of implementation. The strength of the 
practice recommendation is dependent on the quality and relevance of the 
underpinning primary and secondary research. It therefore stands to reason that poor-
quality evidence translates to weak recommendations in clinical guidelines. It is 
estimated that 30-50% of general medicine decisions are based on RCTs (79). This 
figure drops to 10-20% for surgical decisions (84). There is clearly a lack of quality 
evidence on which to base recommendations for the clinical care of patients 
throughout healthcare, including dentistry.  
 
Clinical guidelines are published and disseminated, yet the recommendations are not 
always implemented by practitioners with an estimated 30-40% of patients not 
receiving care according to available evidence and 20-25% receiving care which is 
unnecessary or harmful across all healthcare areas (87, 88). In dentistry, practitioners 
have a growing awareness of evidence behind minimal intervention approaches but 
struggle to implement them in their daily work (83). Busy clinicians may not be aware 
of the guidelines unless they are widely distributed and publicised. Even if they are, 
there are real and perceived barriers to changing established practice (80, 88). Policy 
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makers can help shift the balance in favour of change if the guideline becomes 
accepted as policy. Adherence to the policy may be continuously measured and 
evaluated to encourage changes in practice. In a final part of the ecosystem, challenges 
identified in the practical application of evidence generate new questions which can be 
posed in new primary research studies, closing the GEEOH circle shown in Figure 2.1. 
  
The problem of research waste within the GEEOH has been alluded to throughout this 
chapter so far. In common with any system, the oral health ecosystem is not 100% 
efficient. At each level of the cycle, there is lost energy. That is, not all data produced 
in each level is carried forward to the next. This ‘waste’ in research is problematic and 
reduces the efficiency of the system. In more striking terms, limited research grant 
funding is wasted at each stage of the system. 
 
The problem of research waste has long been known (81, 89) and is a significant drain 
on already limited funding for research. In a series published in the Lancet in 2014 (20-
26), it was estimated that 85% of life sciences funding was wasted due to poor 
methodology, poor reporting or by asking the wrong research questions (20, 25). 
Figure 2.4 is taken from the Lancet series and shows the issues that contribute to 
research waste. In 2015, the REWARD statement (Reduce rEsearch Waste And Reward 
Diligence) was agreed and endorsed by the EQUATOR network (Enhancing the QUAlity 
and Transparency Of health Research) at a congress in Edinburgh. The purpose of this 
was to increase the quality of conduct and reporting of research in life sciences and 
healthcare research with identifiable actions to monitor and enforce this.   
41 
 
 
 
Flowchart from The Lancet series on research waste. This figure summarises the sources of 
avoidable research waste at each stage of the planning, conduct and reporting of biomedical 
research. (Reprinted with permission) 
 
Research waste is an endemic problem that does not simply arise from ill-informed or 
poorly trained investigators willfully conducting bad research (20, 89). It is enabled and 
encouraged by the “publish or perish” culture, the need to obtain grant funding to 
secure employment, promotional structures encouraging short term impact over 
quality within academic institutions, the proliferation of commercially driven research 
degrees, University and Institutional needs for external funding and the publications 
market economy (20, 26, 89). To put it another way, the ecosystem in which the 
researcher exists exerts influence upon their behaviour and this can be negative. An 
ecological shift is required with the involvement of all stakeholders in research to 
enable quality to flourish (25). A system needs to be designed to make it easier to 
produce good quality research.  
 
In this thesis I will focus particularly on the problem of avoidable waste in the 
selection, handling and reporting of outcomes within RCTs. In addition, I will explore 
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the issue of research waste in systematic reviews and consider how harmonisation of 
outcome selection and reporting can increase the efficiency and effectiveness of the 
GEEOH. 
 
In dentistry, many of the RCTs undertaken are a blend of efficacy and effectiveness 
trials (83). Whist this is to a large extent inevitable due to the continuum between 
these types of trial (82), there is a tendency towards the efficacy end of the spectrum 
(83). There are many reasons for this including cost and other external pressures 
outlined earlier. One area where this is especially evident is in outcome selection. This 
will be investigated further in the systematic review of outcomes from randomised 
controlled trials for the prevention and management of carious lesions. This is 
reported in Chapter 4. At this point, the general principles of outcome selection and 
reporting will be discussed and the implications for research waste described. 
 
It is recommended practice to publish a research protocol before beginning a clinical 
study (90). A research protocol is a project plan and explains the methodology and 
rationale of the study based on the PICOT question. It is published, subject to peer 
review, and is subsequently publicly available for scrutiny. Peer review provides 
opportunity for challenge to the methodology, further enhancing the robustness of the 
study design. When published in a searchable database, it also prevents other 
researchers from duplicating effort unnecessarily and adding to the research waste 
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problem (23). Furthermore, it assists peer review of the final published manuscript as 
it allows comparisons of what was done with what was planned to be done. This 
mitigates the risk of outcome reporting bias, and alterations to sample size calculations 
due to under-recruitment to the study (91). This improves quality of the evidence and 
reduces research waste (23). 
A key component of the published protocol is a clear statement of the outcomes that 
will be measured (92). The primary outcome should be stated as such and the sample 
size should be calculated based on this outcome (92). The protocol should also indicate 
which measurement tools will be used to assess each outcome and, where possible, a 
validated tool should be used. The power calculation for the sample size should be 
made to detect a clinically important difference in the primary outcome. Secondary 
outcomes should also be listed and include the planned method of measurement.  
 
Defining planned outcomes, including the primary outcome, and how they will be 
assessed a priori reduces the risk of outcome reporting bias. Outcome reporting bias 
occurs when trialists publish favoured outcomes from the original list of recorded 
outcomes based on knowledge of the results (91, 93, 94). Typically, this appears as 
suppression of statistically insignificant findings and favoured reporting of statistically 
significant findings. Outcome reporting bias threatens evidence-based dentistry and 
contributes to the global research waste problem which is discussed later in this 
chapter.  
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Selective outcome reporting occurs when researchers measure multiple outcomes but 
only report the statistically significant findings in published works (93, 94). This type of 
bias can only be detected with comparison of the research protocol with the final 
report. A priori protocol publication is one method the research community has 
employed to reduce the risk of this bias and improve transparency. Indeed, the 
Declaration of Helsinki states protocol publication as a necessity before recruitment of 
the first subject (90).  Selective outcome reporting is a problem because when the 
pooled data from RCTs is analysed during the synthesis phase, it will tend to suggest an 
effect where there may not be one, because the negative or statistically non-significant 
findings are not available or have been suppressed.  
 
Publication bias is the recognised phenomenon of the increased likelihood of 
manuscript acceptance if the research demonstrates a positive, statistically significant 
result (95, 96). Again, this will tend to skew the data available for synthesis towards an 
effect for an intervention and is more likely to underestimate harms to patients. 
Publication bias is driven in part by the commercial interest of publishers to produce 
positive and exciting results for their readers. A journal full of statistically insignificant 
or negative findings could be uninspiring and commercially non-viable. The Journal of 
Negative Results in BioMedicine (JNRBM) was a journal which aimed to “provide a 
platform for publication of non-confirmatory and “negative” data, as well as 
unexpected, controversial and provocative results in the context of current tenets” 
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(97). It published between 2002 and 2017, ceasing because “JNRBM has succeeded in 
its mission and there is no longer a need for a specific journal to host these null 
results”. It is not clear whether any systematic assessment of this had been 
undertaken prior to the closure of the journal or if it simply no longer had the 
readership to make it viable. These issues around the marketisation of publishing 
demonstrates the problem highlighted earlier in the chapter of the context for the 
research. The prevailing culture can influence the behaviour of researchers in a 
negative way. 
 
Selective outcome reporting and publication bias skew the literature towards 
intervention effect: overestimating benefits and underestimating harms. This is 
potentially harmful, yet avoidable, research waste. 
Appropriate outcome selection for RCTs is fundamental to the applicability and 
external validity of the findings (81). In the context of effectiveness trials, using 
outcomes of convenience or of little importance to end users (patients and clinicians) 
does not improve the clinical discussion around treatment options and ultimately does 
not improve clinical care (1).  
 
Oral Health research is not the only medical field where there has been poor outcome 
selection in trials. In the early 1990s, researchers in Rheumatology identified a 
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problem with inconsistent outcome selection and reporting in effectiveness trials. To 
address this an organisation called OMERACT (originally Outcome MEasures in 
Rhuematic Arthritis Clinical Trials) was established. Using the mantra “Clinical Trials are 
only as credible as their endpoints”, OMERACT (now standing for Outcome Measures in 
Rheumatology) used a conference setting to discuss, debate and agree a minimum set 
of outcomes that every effectiveness trial should measure for specific rheumatological 
diseases, beginning with Rheumatoid Arthritis (98). This would facilitate evidence 
synthesis in secondary research and increase confidence in the effect size estimates 
around important outcomes. Initially, this list of “core” outcomes was agreed amongst 
researchers and clinicians but was eventually expanded to include patients in the 
discussion and consensus (98-100). Involvement of patients demonstrably changed the 
list of outcomes identified as the most important the first time they were involved (99, 
100). This demonstrated that people with lived experience of a disease know what is 
important to others who also suffer from the disease and are better positioned than 
researchers or clinicians to make this judgement (1).    
 
The work of OMERACT has been developed by a growing movement of researchers in 
life and health sciences research to standardise outcome selection where possible. 
Defining a list of essential and important outcomes for each healthcare or disease 
area, it provides researchers with an evidence-based resource for outcome selection 
and reporting. This minimum list of important outcomes is called a Core Outcome Set 
(COS) (1).  
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The COMET (Core Outcome Measures in Effectiveness Trials) Initiative was established 
to provide a platform for people interested in the development and application of core 
outcome sets to share learning and evidence around COS development (1). The state 
aim of COMET is: 
 
“to collate and stimulate relevant resources, both applied and methodological, to 
facilitate exchange of ideas and information, and to foster methodological research in 
this area.”(1) 
 
COMET provides evidence-based methodological support for COS developers as well as 
a forum to develop the methodology (1). The COMET Initiative also maintains a 
searchable database of registered COS projects to prevent duplication of effort and to 
improve transparency of the process. The role of COS developers, supported by 
COMET, is to identify the outcomes that are important to patients, clinicians and 
healthcare providers that would be relevant in a discussion about clinical care. 
Sometimes the outcome identified at this stage is referred to as the “outcome 
domain” as it is usually a broader concept (e.g. quality of life or pain) which must be 
measured in some way as described in Figure 2.5. At this stage, COS development is 
not concerned with the instrument, scale or tool used to measure it.  
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Problems can still arise when there is agreement about which outcomes should be 
measured because of incompatible methods of measuring them. Work is being carried 
out to harmonise outcome measurement tools through the COSMIN initiative 
(COnsensus-based Standards for the selection of health Measurement INstruments) 
(101, 102). In a complementary relationship with the COMET initiative, COSMIN brings 
together researchers to develop recommendations for the standardisation of outcome 
choice (102). Once a COS has been agreed, COSMIN methodologies can help to identify 
the best measurement instrument for each outcome domain by appraising existing 
measurement instruments and, if required, assist in developing new instruments. 
According to the COSMIN taxonomy, measurement tools must be reliable, valid, 
responsive, feasible and interpretable (103). An overview of the COSMIN taxonomy for 
instrument properties is shown in Table 2.1 (103). 
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Measurement Property Definition according to COSMIN Taxonomy 
Reliability  
Internal consistency The degree of interrelatedness among the items 
Reliability The degree to which the measurement is free from measurement 
error 
Measurement error The systematic and random error of a patient’s score that is not 
attributed to true changes in the construct to be measured 
Validity  
Content validity 
(including face validity) 
The degree to which the content of a measurement instrument is 
an adequate reflection of the construct to be measured 
Structural validity The degree to which the scores of a measurement instrument are 
an adequate reflection of the dimensionality of the construct to 
be measured 
Hypothesis testing The degree to which the scores of a measurement instrument are 
consistent with hypotheses based on the assumption that the 
measurement instrument validly measures the construct to be 
measured 
Cross Cultural validity The degree to which the performance of the items on a translated 
or culturally adapted measurement instrument are an adequate 
reflection of the performance of the items of the original version 
of the measurement instrument   
Criterion validity The degree to which the scores of a measurement instrument are 
an adequate reflection of a ‘gold standard’ 
Responsiveness  
Responsiveness The ability of a measurement instrument to detect change over 
time in the construct to be measured 
Interpretability  
Interpretability The degree to which one can assign qualitative meaning – that is, 
clinical or commonly understood connotations – to an 
instrument’s quantitative scores or change in scores. 
Feasibility  
Feasibility The degree to which the measure can be applied easily in its 
intended setting, given constraints of time, money, and 
interpretability 
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Often, measurement tools are selected for convenience or tradition without being 
carefully appraised according to the taxonomy listed in table 2.1. The use of tools 
which do not measure the domain effectively and cannot be combined with others is 
another area where research effort is wasted in the evidence ecosystem. This will not 
be considered in detail in this thesis as the focus is on the harmonisation of outcomes 
at the level of the outcome domain (level 1 in figure 2.5). 
 
 
The levels of specification for any given outcome, using mental health as an example. This type of 
description of outcomes is rarely found in dental literature. Level 1 of the specification is the 
construct being measured. Levels 2-4 relate to the measurement of this construct. This thesis is 
concerned with gaining consensus on level 1 of the specification: the outcome domain. (Reprinted 
with permission) 
 
In the levels of specification outlined in figure 2.5, COMET relates to level 1 and 
COSMIN relates to level 2 and beyond. For outcomes to be relevant and suitable for 
meta-analysis they must be important at level 1 and consistent throughout all levels of 
specification (2-4) (104). There are many aspects of outcome choice that can lead to 
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loss of information and research waste. Concerted effort will be required to harmonise 
outcomes and reduce waste (1, 20, 25, 98, 101-104). 
 
The problem of inadequate reporting in publications associated with RCTs has been 
known since the late 1980s (105). Attempts to assess the quality of RCTs in the early 
1990s encountered difficulties when it was discovered that key aspects of the 
methodology were not regularly reported by authors. This discovery led to attempts to 
standardise reporting of clinical trials, culminating in the first CONSORT statement 
(CONsolidated Standards Of Reporting Trials) first published in 1996 (106). The 
awareness of CONSORT in academia became greater after the first update was 
published in the Lancet in 2001 (107). The discovery of new concerns, such as selective 
outcome reporting, led to the development of the latest iteration of the CONSORT 
statement, published in 2010 (108). The CONSORT statements are broadly accepted by 
high impact journals who insist on adherence to the reporting criteria before 
acceptance for publication. Failure to fully report clinical trials can present challenges 
at the evidence synthesis stage. When trials are inadequately reported it is not 
possible to know whether the trial has been undertaken appropriately or not. To put it 
another way, the quality of the evidence cannot be assessed. Failure to report the 
methodology may be simply just that. Alternatively, it could be a sign of problems with 
the methodology and conduct of the research, raising questions about the validity of 
the results. This has implications for the assessment of quality and risk of bias 
necessary in secondary research. This, in turn, contributes to avoidable research 
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waste. It would appear that dental journals have some way to go in terms of fully 
promoting adherence to reporting guidelines (109). 
 
It is important that trial reports account for every participant who was randomised as 
well as those that received the intervention or control treatment even if they are 
subsequently lost to follow up. Failure to assess or analyse the reasons that 
participants did not receive the intervention or complete the trial contribute to bias 
and compromise the validity of the study findings (23, 110). The missing data may be 
related to an important failure which may impact upon an important outcome (e.g. 
loss of the tooth under treatment). The size and direction of this effect varies with the 
intervention and disease under study and is consequently challenging to account for in 
the analysis. Ensuring that each participant is accounted for in a trial report reduces 
research waste. The Lancet series also recommends that participant-level data is made 
publicly available for new analysis and synthesis by other groups (21). This would 
ensure that studies are not repeated because outcome data has simply not been 
reported in a peer reviewed publication.  
 
Transparent reporting and availability of outcome data would help mitigate the effects 
of outcome reporting bias in primary trials: effects like overestimation of benefit and 
underestimation of harms. If this data also included the data for the relevant core 
outcome set, then more clinically important outcome data would be available for 
synthesis (21).  
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As discussed earlier in this chapter, even several well-conducted RCTs can have 
conflicting results and so there is a need to summarise and combine data from these 
studies to achieve a more accurate estimate of effect size (84, 111). Archie Cochrane 
suggested in the early 1970s that these reviews should be kept up to date as new 
evidence emerged. This would ensure that the evidence available to healthcare 
professionals would be both robust and contemporaneous (81). From these early days 
of RCTs, the intention was for reviews to be regularly updated, based on new, 
emerging evidence. In the light of the research waste problem, we must decide if we 
are keeping these summaries sufficiently up to date with new evidence or not. Failure 
to update as well as failure to find new evidence from primary research could both be 
signs of research waste. Recently, issues related to the conduct and reliability of 
systematic reviews (SRs) has been questioned with a growing concern that there are 
too many new SRs being published (112). Small, hastily planned and conducted 
reviews are sometimes sought in postgraduate research degree theses or to justify an 
already planned clinical study. Sometimes they are used to achieve a high impact peer-
reviewed publication, avoiding the ethical approvals and practical challenges of 
conducting high quality primary research. Some have voiced concern about the 
methodology of some of these SRs including poor quality primary studies (RCTs) or a 
focus on efficacy rather than effectiveness, as the SR was originally intended to assess 
(113). Together, these issues emphasise the continuing importance of conducting high 
quality RCTs where evidence or quality is lacking rather than simply re-synthesising the 
same primary research in different ways.  
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Earlier in this chapter the evidence hierarchy was discussed and highlighted that 
although systematic reviews are found at the apex of the pyramid, they can be poorly 
conducted and are vulnerable to inappropriate methodology as with any other type of 
research. Murad and colleagues even proposed in a 2016 article published in the BMJ 
Evidence Based Medicine, that systematic reviews should be removed from the apex 
of the hierarchy of evidence altogether (114). Instead of being seen as the pinnacle of 
research validity, they should be considered a means of observing and viewing 
evidence from other types of primary research. Their scheme for a new pyramid of 
evidence is shown in Figure 2.6. 
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The new evidence hierarchy proposed by Murad et al, 2016.  
(A) The traditional pyramid proposed by Guyatt in 1994. (B) Revising the apex of the pyramid: lines 
separating the study designs become wavy (Grading of Recommendations Assessment, 
Development and Evaluation) and systematic reviews are removed from the pyramid. (C) The 
revised pyramid: systematic reviews are a lens through which evidence is observed and assessed. 
(Reprinted with permission) 
 
 
Of course, SRs have an important role to play in developing primary research methods 
and perform a quality assurance role which can sometimes detect research misconduct 
(115). They are also identified as an important way of reducing research waste by 
ensuring that researchers search for existing evidence before embarking on costly 
clinical trials which are unnecessary due to the availability of already sufficient 
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evidence (20). There is growing tension here between using SRs to mitigate research 
waste without themselves becoming part of the waste problem (112, 113, 115). The 
relationship between RCTs and SRs within the GEEOH is a key area to address in terms 
of quality and reducing avoidable waste. Trialists and reviewers must be involved in 
the dialogue and develop common standards, if progress is to be made in this area. 
 
Generating, testing and implementing new interventions requires an ecosystem of 
people and organisations, each with unique contributions to make to the cycle shown 
in Figure 2.1. The process is so complex that it cannot be undertaken by one individual 
or one research group alone. Therefore, a common language and method of working, 
coordinated by research groups and associations, needs to be established if this 
process is to be efficient and prevent research waste. Marginal gains are required at 
each level with an understanding of how each step articulates with the next. In the 
management of carious lesions, there is a lack of evidence about which interventions 
are most effective for primary and permanent teeth. This deficiency in the evidence 
has been established through systematic reviews (69) and so well-conducted trials in 
primary care are required to answer these questions about effectiveness. This chapter 
has highlighted some of the potential problems that might be faced within and 
between RCTs and SRs.  
 
There is a need to establish how much research waste exists at the level of systematic 
reviews within cariology and whether this highlights a lack of appropriate high-quality 
primary research being undertaken.  
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The next section of this thesis (Section B) will examine the volume and breadth of the 
systematic review literature to assess the likely level of research waste. 
 
Following that, in Section C, the problem of outcome selection and reporting in 
primary research (RCTs) within cariology is investigated and a Core Outcome Set (COS) 
for carious lesion management trials developed. 
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Despite the significant global impact of dental caries outlined in Chapter 1, well-
conducted systematic reviews (SRs) addressing aspects of the prevention and 
management of carious lesions have been unable to demonstrate strong, high quality 
evidence for commonly used interventions (69, 116-121). At the same time, there has 
been a proliferation of published systematic reviews in healthcare research which 
some have questioned the value of (112, 113). In the previous chapter, I discussed how 
this proliferation of SRs is thought by some to be a sign of research waste while others 
consider systematic reviews to be an essential part of resolving the research waste 
issue (112, 113, 115). The purpose of this chapter is to use a systematic approach to 
identify the SR literature with respect to dental caries and to detect signs of research 
waste. The findings are used to consider how to increase the efficiency of this stage of 
the proposed GEEOH.  
 
There are several reasons why there may be research waste in this phase of the 
GEEOH. One potential reason for the failure of systematic reviews (SR) to demonstrate 
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high quality evidence is related to inconsistent outcome selection, measurement and 
reporting in both randomised controlled trials (RCTs) and systematic reviews. There 
could be a mismatch between the outcomes selected in RCTs and their syntheses. In 
turn, this might signify differing priorities between trialists and reviewers. The failure 
of outcomes to match across each link of the evidence chain represents a loss of 
energy, and a lost opportunity, within the GEEOH described in Chapter 2 (4, 9, 73). This 
can occur because trialists and reviewers are not effectively communicating or aware 
of the interplay between these key components of an evidence ecosystem (122). 
 
When undertaking a systematic review of RCTs, clinically important outcome domains 
should be identified a priori and the relevant effect size data extracted from each 
eligible trial where it exists (85). The outcomes selected for systematic reviews should 
be a clinically useful assessment of intervention effect based on therapeutic benefit in 
the same way as for clinical trials (107, 108). Trivial, indirect, surrogate or otherwise 
unimportant outcomes should be excluded to increase the efficiency and applicability 
of the results (123, 124). The timing of outcome measurement should also be 
considered as this can have direct influence on the results of the review (125). The 
Cochrane handbook for systematic reviews of interventions states that a review should 
have no more than seven main outcomes (85). From that list, between one and three 
should be considered as primary outcomes i.e. the main measure of intervention 
effect. Ideally, outcomes selected in clinical trials, through reviews and guideline 
development, would have direct relevance to clinical care (73). It would therefore be 
anticipated that outcome domains used in reviews should align with outcome 
selection in primary trials while also addressing clinically important questions (108).  
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Another source of research waste in SRs may be that too many reviews are being 
undertaken without reference to previously published syntheses. That is, similar 
reviews are being published based on the same pool of primary research reports. 
Furthermore, reviews which have been updated may be inappropriately updated. It is 
arguably wasted effort to undertake a full review if there are no new primary studies 
to include or if clear and consistent evidence of benefit has already been established.  
Archie Cochrane originally stated that the results of RCTs should be summarised and 
that this summary should be updated, saying: “It is surely a great criticism of our 
profession that we have not organised a critical summary, by specialty or subspecialty, 
adapted periodically, of all relevant randomised control trials.”. The questions of what 
should be considered as a “relevant randomised control trial” is subject of some 
debate (112) and perhaps accounts for the over-production of SRs where the PICOT 
question and inclusion criteria are altered based on variable opinions between 
research groups or authors to include different subsets of the primary research. 
However, a key recommendation from Professor Cochrane is the need to “adapt 
periodically” or “update” the reviews (81, 126). The reason for this is that these 
reviews should contain the most up to date evidence in each field. Failure to consider 
appropriate updates means that they could be out of date and potentially misleading. 
It has been suggested that 23% of reviews are out of date at two years and 70% after 
ten years (127). Cochrane reviews can take so long to complete (median 2.8 years; 
range 1-8 years) that they may even be out of date at publication (128). Robust criteria 
for assessing the need for an update should be considered to prevent unnecessary 
duplication and reduce research waste. These criteria could have generic 
considerations for all reviews as well as subject-specific adjustments depending on the 
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quality and volume of primary research being undertaken in the specialty. The 
research community should consider if failure to find new eligible RCTs in a review 
update means that this research effort has been wasted. Conversely, some consider it 
wasteful to fail to publish searches that yield no new primary research which might 
prevent other researchers from needlessly duplicating this effort whilst highlighting a 
lack of primary research (113). These are complex questions to resolve. 
 
A systematic approach to the location of systematic reviews in cariology was used to 
map the field. An umbrella review methodology (129-131) was chosen to 
systematically locate SRs of interventions for the primary prevention of caries or the 
management of established carious lesions. Umbrella reviews are often used to 
examine the body of evidence on a given topic or are used to identify and explain 
inconsistent findings between systematic reviews on the same topic (129, 131). 
Umbrella review methodology is similar to that of a SR. However the literature search 
is conducted to locate SRs, rather than RCTs. Inclusion criteria are set, and in some 
cases, effect size data is extracted and combined. In this thesis, the umbrella 
methodology was originally chosen as a basis to locate and appraise the syntheses of 
RCTs and allow comparison of outcome choice across the RCT to SR stage of the 
GEEOH.  
 
The Umbrella method can also be used to assess the quality of reporting and conduct 
of the reviews. There are several ways that methodological assessment of the SRs 
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within the umbrella review can be undertaken. This usually involves using a critical 
appraisal tool designed for evaluation of systematic reviews.  
 
The most commonly used critical appraisal tools to assess the constituent systematic 
reviews in Umbrella syntheses are PRISMA (132), AMSTAR 2 (133) and ROBIS (134).  
 
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is a 27-
item reporting checklist for systematic reviews last updated in 2009. The 
accompanying statement provides guidance on the use of the tool (132). The 
statement stresses that it is a reporting standard and not a quality assessment tool. 
Poor compliance with the PRISMA statement may reflect the inability of the authors to 
write in a coherent manner rather than reflect deficiencies in the conduct of their 
review. As a result, there is a clear need for guidelines that evaluate the conduct of 
systematic reviews. It is for this reason that AMSTAR, and its successor, AMSTAR 2 (A 
MeaSurement Tool to Assess systematic Reviews) were developed (133). That being 
said, PRISMA can be appropriately employed to assess the reporting of the review and 
can highlight areas of potential methodological concern within the review which 
require further investigation. 
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AMSTAR 2 is a tool which can be used to assess the methodological quality of 
systematic reviews (133). It is a 16-item checklist that can be used to assess the 
methodology and, ultimately, allow the reader to assign a level of confidence in the 
results. There were no specific items related to outcome handling other than one item 
to ensure that all elements of the PICO question were used in the research question 
and inclusion criteria. The authors caution against using the checklist as a scoring 
system as this could mask critical weaknesses in an individual review (133). Taken 
together, these issues limit the utility of this tool in the context of this umbrella review.  
 
The ROBIS (Risk Of Bias In Systematic reviews) tool is a three phase process to assess 
risk of bias (134). The assessment matrix used in ROBIS is shown in Appendix 1. The 
first phase of the tool is “Assessing the relevance”. In a conventional Umbrella review 
this ensures that the SR is relevant to the umbrella review question. Phase two, 
“identifying concerns with the review process”, is a 21-question matrix covering four 
domains (Study eligibility criteria, identification and selection of studies, data 
collection and study appraisal, synthesis and findings). For each question, there are 
five possible responses which depend upon completeness of reporting and the detail 
of what was described; Yes, Probably yes, Probably no, No and No information.  Based 
on the scores within each domain, an overall level of concern is stated; Low, high or 
unclear. Phase three is where the reader states the overall risk of bias for the review 
based upon the level of concern within each domain. There are three additional 
questions to help the reader make this final, overall assessment. ROBIS is the most 
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recently developed tool and is the most comprehensive assessment of risk of bias. As a 
result, this was selected as the planned method of assessing the value of the included 
reviews. 
 
The planned umbrella review protocol was registered in PROSPERO in 2017 
(CRD42017074705).  
  
The aim of this review was to use an Umbrella methodology to identify and appraise 
the systematic reviews related to the primary prevention and management of carious 
lesions. Specific assessments were planned to include: 
• Extraction of outcome domains used within each review was planned to allow 
comparison with the SR of RCTs reported in Chapter 4.  
• Assessment of the quality of the reviews was planned to assess the level of 
research waste in evidence syntheses through inappropriate conduct. 
• Assess the number and frequency of review updates, a cornerstone of the 
evidence synthesis framework described by Archie Cochrane (126).  
• Evaluate the updated reviews for their usefulness in terms of the inclusion of 
new studies and changes to review conclusions.  
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The literature was searched for systematic reviews on carious lesion management and 
primary caries prevention with no date restrictions in order to locate all relevant 
systematic reviews. Inclusion and exclusion criteria were designed to mirror the 
criteria for the systematic review of randomised controlled trials reported later in 
Chapter 4 to allow useful comparisons across this link of the ecosystem. Furthermore, 
only reviews of RCTs and quasi-RCTs were selected to ensure that mapping was 
appropriate and was not unduly influenced by other types of primary study design. 
Criteria for what would be considered a “systematic” review were developed to 
provide consistency when eliminating pseudo-systematic or narrative reviews. These 
conditions, along with inclusion and exclusion criteria are shown in table 3.1. 
 
Eligibility criteria were agreed a priori and are shown in table 3.1. 
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Inclusion criteria 
Systematic reviews of randomised and quasi randomised control trials 
For a review to be considered “systematic” they must; 
• Have a clear research question (PICO or similar) 
• Search at least two electronic databases 
• Have a clear search strategy reported 
• Have clear eligibility for included studies 
Population – Adults, children or both. Primary or permanent dentition or both 
Any setting 
Investigation interventions for the prevention or management of dental caries 
English language reviews 
No publication date restrictions 
Exclusion criteria 
Non-systematic or narrative reviews 
Systematic reviews of case control, cohort, observational studies, theoretical studies or 
published opinion. 
Systematic reviews of a combination or RCTs and other study designs will be considered 
only if the outcomes from the RCTs can be separated. 
 
Most systematic reviews are published in English, so only reviews reported in the 
English language were considered for inclusion (130).  
 
The following electronic databases were searched between 13/11/17 and 16/11/17: 
MEDLINE, LILACS, TRIPS, Embase, Web of science, SCOPUS, Cochrane database of 
systematic reviews, Joanna Briggs library, PROSPERO and DARE. Bespoke search 
strategies were developed for each of the databases according to the input style 
required. Table 3.2 shows an example of the search strategy developed for MEDLINE. 
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Search Boolean search Results 
S8 
(AB systematic review OR TI systematic review OR AB meta-analysis 
OR TI meta-analysis OR AB cochrane) AND (S6 AND S7)  
702 
S7 
AB systematic review OR TI systematic review OR AB meta-analysis OR 
TI meta-analysis OR AB cochrane  
177,732 
S6 (caries) AND (S1 OR S2 OR S3 OR S4 OR S5)  52,168 
S5 (MM "Root Caries") OR (MH "Dental Caries+")  41,280 
S4 
AB dental N5 deminerali* OR AB dental N5 cavit* OR AB dental N5 
decay OR AB dental N5 lesion OR AB dental N5 carious OR AB dental 
N5 caries OR AB dental N5 reminerali*  
12,225 
S3 
AB dentin* N5 deminerali* OR AB dentin* N5 cavit* OR AB dentin* N5 
decay OR AB dentine*l N5 lesion OR AB dentin* N5 carious OR AB 
dentin* N5 caries OR AB dentin* N5 reminerali*  
3,848 
S2 
AB enamel N5 deminerali* OR AB enamel N5 cavit* OR AB enamel N5 
decay OR AB enamel N5 lesion OR AB enamel N5 carious OR AB 
enamel N5 caries OR enamel N5 reminerali*  
3,763 
S1 
TI caries OR AB caries OR AB tooth N5 deminerali* OR AB tooth N5 
cavit* OR AB tooth N5 decay OR AB tooth N5 lesion OR AB tooth N5 
carious OR AB tooth N5 caries OR tooth N5 reminerali*  
38,819 
 
 
The output from the database searches was exported into EndNote® (Thompson 
Reuters, Toronto, Canada) where duplicates were removed automatically using the 
integrated “deduplication” function. Duplicates were also removed by hand searching 
of the EndNote list by one researcher (CL). Screening of titles and abstracts were also 
undertaken in EndNote®. 
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Titles and abstracts yielded by electronic database searching were screened for 
relevance by two independent researchers (CL, NPTI, DNJR). One author (CL) 
consolidated the lists independently before exporting records of potentially relevant 
systematic reviews into Microsoft Excel® (Microsoft Corporation, Washington, USA) 
capturing the following data: 
• Title 
• Authorship 
• Year of publication 
• Journal 
• Citation details 
 
One author (CL) identified full texts and records were excluded at this stage if they did 
not meet the inclusion criteria shown in table 3.1. Included reviews were categorised 
according to their clinical focus:  
• Primary prevention 
• Management of carious lesions (including secondary prevention) 
• Combined primary prevention and lesion management 
• Unclear focus 
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A piloted data extraction form was developed to extract the relevant data from each 
SR report. This was developed to allow extraction of outcome domains and facilitate 
assessment of risk of bias using the ROBIS tool (134). The reviews were categorised for 
analysis according to their clinical focus and year of publication to chart any trends in 
the number of published systematic reviews in cariology.  
 
Full texts of potentially updated reviews were sought from the list of papers identified 
in the search. Similar or identical titles which appeared with multiple years of 
publication or similar authorship were considered suggestive of an updated review. In 
addition, any title or abstract containing phrases such as “an update” or “updated” 
were selected for full analysis. Where protocols were identified for new updates, hand 
searching was used to identify the subsequent update if it had been published. This 
accounts for several reviews presented with publication dates after the date of the 
literature searches.  
 
Updated reviews were identified with the number of, and interval between, updates 
recorded. A combination of qualitative and quantitative data was extracted from each 
publication. The number of individual studies included in the review and subsequent 
updates was recorded. In addition, the findings and conclusions were assessed for 
relevant differences and any reports of difficulties synthesising the primary studies 
were recorded. Where the methodology or inclusion criteria had been significantly 
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altered between updates, this was recorded. Comparisons were made between the 
original and updated reviews to determine whether new primary research had been 
identified and whether this had been sufficient to change the conclusions of the 
review. A change of conclusion was defined as a situation where the direction of effect 
changed or where the change in effect size was deemed to be important by review 
authors. In addition, situations where the strength of the evidence changed sufficiently 
to warrant increased confidence in the results was also counted as a change. Where 
authors had made comments about the quality or volume of the constituent primary 
research, this information was extracted. 
  
Electronic database searches yielded 2715 separate records. Following automatic and 
manual deduplication, 1467 unique titles were screened by title and abstract for 
eligibility. Exclusion of a further 1233 at this stage resulted in 234 records suitable for 
inclusion in the first analysis.  
 
Fifty two percent (n=122) were focused on primary prevention, 38% (n=90) focused on 
management of established lesions, 7.5% (n=18) were considered to overlap primary 
prevention and established lesion management, while 1.5% (n=4) had an unclear 
focus.  
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Figure 3.1 shows the number of publications by year for the included studies. This 
demonstrates a rapid rise in the number of systematic reviews published annually 
since the late 2000s. This increase is evident for publications regardless of focus on 
prevention or management of carious lesions. The oldest SR that was located was 
published in 1993 and compared toothpaste compositions for the prevention of dental 
caries (135). Up to two SRs were published each year until around 2000 when the 
annual number published increased. The number of systematic reviews published 
annually was less than ten until 2008. Since 2009 there has been a rapid rise in the 
number of reviews published each year within cariology. In 2016 alone, 40 systematic 
reviews were published which met our inclusion criteria. For lesion management-
focused reviews, 48 SRs were published between 2015 and 2017 inclusive. This 
represents more than 50% of the total number of such reviews identified in our 
literature search.  
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This chart shows the rise in the number of reviews published in each year 1993-2017. The green line 
shows the total number throughout cariology research. The grey line shows the number of 
publications related to the management of established carious lesions. This figure also illustrates 
that reviews tend to focus on either lesion prevention (orange) or lesion management (grey), with 
few combined, or “caries control” reviews (yellow). 
 
A large number of reviews were identified in the literature search (n=234). As a result, 
the planned analysis including extraction of outcome domains and assessment of risk 
of bias using the ROBIS tool, would have been extensive. Therefore, the umbrella 
review was refocused on the analysis of systematic review updates only. As a result, no 
analysis of the of the outcomes reported or the quality of the identified SRs was 
conducted. 
 
In the second analysis, nineteen original reviews were identified which had been 
updated at least once. Fifteen had been updated once, three had been updated twice 
and one review had been updated three times. Therefore, a total of 43 reviews were 
73 
 
 
included in the analysis of updated reviews. Original publication dates ranged from 
2002 to 2013, while updates ranged from 2008 to 2018. Updates published after the 
electronic search in November 2017 were located via protocol records and when 
sourcing full texts of Cochrane reviews. The mean interval between the original 
publication and first update was 6.9 years (range 2-13 years). For the four reviews 
which had been updated twice, the mean interval between updates was 4.75 years 
(range 4-9 years).  
 
Most original reviews were Cochrane reviews (n = 13, 68%). Other original reviews 
were published in The European Journal of Paediatric Dentistry, The International 
Journal of Paediatric Dentistry, Acta Odontologica Scandanavia, Journal of Oral 
Science, The Open Dentistry Journal and Clinical Oral Investigations. For the updated 
reviews, only one of the six reviews that were not Cochrane reviews was published in 
the same journal as the original publication (136, 137). These updated reviews were 
published in BMC Research Notes, International Journal of Paediatric Dentistry, 
European Archives of Paediatric Dentistry, The European Journal of Orthodontics, and 
the Journal of the South African Dental Association. 
 
Seven of the 19 original reviews (37%), focused on management of established carious 
lesions. The remaining 12 reviews (63%) were focused on the primary prevention of 
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new lesions developing. Three of the 4 reviews updated twice were primary 
prevention focused. The review updated three times was primary prevention focused. 
 
Eleven out of the 19 (58%) updated reviews did not have different conclusions when 
compared to the original review (Table 3.3). Of the four reviews which were updated 
for a second time, three did not have different conclusions between updates (75%). 
The conclusions did not change in any update of the review which was updated three 
times (138). The conclusions did not change between the first review published in 
2004 (139) and the most recent update in 2017 (138) despite 30 new RCTs being 
included in the analysis. The authors state that outcome heterogeneity in the primary 
trials was a significant problem and prevented conclusions about relative effectiveness 
of interventions (Types of sealants for preventing decay) being made.  
 
Table 3.3 shows the review titles with the number of studies included in the 
subsequent update. Of the 19 original SRs which were updated at least once, ten (53%) 
had more studies in the update than in the original review. Five (26%) had fewer 
studies in the first update than in the original SR. In these cases, this was due to 
changes in the scope or methodology for the update. In one case (140), only new RCTs 
published since the original review (141) were included in the analysis . This could be 
considered as two separate reviews with different search timeframes rather than a 
true update of a review. Four updated reviews (21%) had the same number of studies 
as in the original review. One SR was updated twice and neither update found more 
eligible studies than the original review (142-144).  
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Colour coding: Red indicates fewer studies in update, amber has the same number of studies, and green is more in the update 
Authors of Original 
Paper 
Title of original paper 
Year of 
original 
publication 
Year of 
update 
Number 
of studies 
in original 
number 
of studies 
in update 
Change to 
conclusions? 
Y/N 
Commentary 
S. Mickenautsch, 
V. Yengopal, S. C. 
Leal, L. B. Oliveira, 
A. C. Bezerra and 
M. Bönecker 
Absence of carious lesions at 
margins of glass-ionomer and 
amalgam restorations: A meta-
analysis. 
2009(145) 2011(146) 8 10 N 
"The extended scope of the review 
did not change the overall results" 
Z. Fedorowicz, M. 
Nasser and N. 
Wilson 
Adhesively bonded versus non-
bonded amalgam restorations 
for dental caries 
2009(147) 2016(121) 1 1 N No new clinical trials identified 
T. Pereira-Cenci, 
M. S. Cenci, Z. 
Fedorowicz and M. 
A. Marchesan 
Antibacterial agents in 
composite restorations for the 
prevention of dental caries 
2009(148) 2013(149) 0 0 N No new clinical trials identified 
D. P. Raggio, D. 
Hesse, T. L. Lenzi, 
A. B. G. C and M. 
M. Braga 
Is atraumatic restorative 
treatment an option for 
restoring occlusoproximal 
caries lesions in primary teeth? 
A systematic review and meta-
analysis. 
2013(137) 2017(136) 3 4 N 
One new study was found after 
searching additional databases and 
extending the date range of the 
searches. The update "Corroborates 
findings of the original review" 
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Authors of Original 
Paper 
Title of original paper 
Year of 
original 
publication 
Year of 
update 
Number 
of studies 
in original 
number 
of studies 
in update 
Change to 
conclusions? 
Y/N 
Commentary 
S. Twetman, S. 
Axelsson, H. 
Dahlgren, A. K. 
Holm, C. Kallestal, 
F. Lagerlof, P. 
Lingstrom, I. 
Mejare, G. 
Nordenram, A. 
Norlund, L. G. 
Petersson and B. 
Soder 
Caries‐preventive effect of 
fluoride toothpaste: a 
systematic review 
2003(141) 2009 (140) 54 15 Y 
Fifteen new papers analysed only. 
Conclusions similar between reviews 
but update states that daily fluoride 
use effect is boosted by supervised 
twice daily brushing with 1500ppm 
paste. Lack of data on primary teeth 
or concentrations higher than 
1500ppm 
V. Yengopal, S. 
Mickenautsch, A. 
C. Bezerra and S. 
C. Leal 
Caries-preventive Effect of 
Glass Ionomer and Resin-Based 
Fissure Sealants on Permanent 
Teeth: A Meta Analysis 
2009(150) 2011(151) 11 16 Y 
Original paper considered both 
clinical trials and systematic reviews. 
There were discrepancies in the 
update about the original article with 
reference to number of included 
papers and types of papers. Original 
paper reported no difference in 
caries preventive effect of GIC vs 
Resin. Updated review reported 2-3 
times higher chance of caries with 
GIC at 3 years, no effect at 4 years. 
Cumulative relative risk shows no 
difference at 5 years. "More RCTs 
required." 
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Authors of Original 
Paper 
Title of original paper 
Year of 
original 
publication 
Year of 
update 
Number 
of studies 
in original 
number 
of studies 
in update 
Change to 
conclusions? 
Y/N 
Commentary 
David Ricketts, 
Edwina Kidd, 
Nicola P T Innes, 
Jan E Clarkson 
Complete or ultraconservative 
removal of decayed tissue in 
unfilled teeth 
2006(152) 2013(69) 4 8 Y 
No change to conclusions about risk 
of pulp exposure in permanent teeth 
or pulpal symptoms in permanent 
teeth. Update identified insufficient 
evidence for difference between 
complete and partial, stepwise and 
partial caries removal. Insufficient 
evidence about restoration failure. In 
Primary teeth, no caries removal 
showed a difference compared with 
complete caries removal. Identified a 
lack of long term follow up in clinical 
trials.  
C. A. Yeung, J. L. 
Hitchings, T. V. 
Macfarlane, A. G. 
Threlfall, M. Tickle 
and A. M. Glenny 
Fluoridated milk for preventing 
dental caries 
2005(153) 2015(154) 2 1 Y 
Changes to search and protocol 
between reviews. Two ongoing 
studies identified in the update but 
no response from authors. Both 
reviews highlight "poor quality 
evidence", "insufficient studies" and 
"serious methodological limitations". 
Despite this, the original review 
suggested a caries preventive effect 
in permanent teeth only, while the 
update suggested that there may be 
a benefit for primary teeth only. 
V. C. Marinho, J. P. 
Higgins, S. Logan 
and A. Sheiham 
Fluoride gels for preventing 
dental caries in children and 
adolescents 
2002(155) 2015(156) 25 28 N 
Large effect on reduction of caries 
increment. Little data on adverse 
effects in either review. 
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Authors of Original 
Paper 
Title of original paper 
Year of 
original 
publication 
Year of 
update 
Number 
of studies 
in original 
number 
of studies 
in update 
Change to 
conclusions? 
Y/N 
Commentary 
V. C. C. Marinho, J. 
P. T. Higgins, S. 
Logan and A. 
Sheiham 
Fluoride mouthrinses for 
preventing dental caries in 
children and adolescents 
2003(157) 2016(158) 36 37 N 
"Regular, supervised use of fluoride 
mouthwash reduces caries increment 
in children". 26% fewer DMFS in 
original review, 27% fewer in update. 
No information on side effects in 
either review. 
V. C. Marinho, J. P. 
Higgins, S. Logan 
and A. Sheiham 
Fluoride varnishes for 
preventing dental caries in 
children and adolescents 
2002(159) 2013(160) 9 23 N 
"substantial" caries inhibiting effect 
of Fluoride varnish detected in both 
reviews. Little adverse effect data in 
either review. Quality of new 
evidence `appeared to be improving 
compared with original review. 
P. E. Benson, N. 
Parkin, D. T. 
Millett, F. E. Dyer, 
S. Vine and A. 
Shah 
Fluorides for the prevention of 
white spots on teeth during 
fixed brace treatment 
2004(161) 2013(162) 15 3 Y 
Changes to protocol between 
reviews meant that 14 out of 15 
studies included in original review 
were excluded. Two new studies 
were included which allowed authors 
to conclude that there was 
"moderate evidence that fluoride 
varnishes every 6 weeks is effective"   
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Authors of Original 
Paper 
Title of original paper 
Year of 
original 
publication 
Year of 
update 
Number 
of studies 
in original 
number 
of studies 
in update 
Change to 
conclusions? 
Y/N 
Commentary 
F. Bergstrand and 
S. Twetman 
A Review on Prevention and 
Treatment of Post-Orthodontic 
White Spot Lesions - Evidence-
Based Methods and Emerging 
Technologies 
2011(163) 2017(164) 25 8 Y 
Changes to scope and protocol 
between reviews changes 
conclusions. The original review was 
focussed on the prevention and 
management of post-orthodontic 
white spot lesions while the update 
only considered the management of 
established lesions. Both reviews 
highlight methodological 
inconsistencies in primary research 
and suggest further high quality, 
long-term studies with clear 
endpoints (outcomes) are needed. 
A. Ahovuo-
Saloranta, A. Hiiri, 
A. Nordblad, H. 
Worthington and 
M. Makela 
Pit and fissure sealants for 
preventing dental decay in the 
permanent teeth of children 
and adolescents 
2004(139) 2008(165) 8 16 N 
Sealants are effective but no 
conclusions could be drawn in either 
review about the relative effect of 
each type of material used. Caries 
into enamel considered sound in 
review. Caries affecting dentine used 
as threshold.  
A. Hiiri, A. Ahovuo-
Saloranta, A. 
Nordblad and M. 
Mäkelä 
Pit and fissure sealants versus 
fluoride varnishes for 
preventing dental decay in 
children and adolescents 
2006(166) 2010(167) 4 4 N 
No new clinical trials identified. 
Change to primary outcome of 
update but conclusions similarly state 
that there is scarce data and few 
recommendations about practise 
could be given. 
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Authors of Original 
Paper 
Title of original paper 
Year of 
original 
publication 
Year of 
update 
Number 
of studies 
in original 
number 
of studies 
in update 
Change to 
conclusions? 
Y/N 
Commentary 
N. P. Innes, D. N. 
Ricketts and D. J. 
Evans 
Preformed metal crowns for 
decayed primary molar teeth 
2007(168)  2015(117) 0 5 Y 
No conclusions could be drawn in 
original review as no studies were 
identified. Outcome heterogeneity 
identified. Core Outcome Set 
development recommended. 
G. Nadin, B. R. 
Goel, C. A. Yeung 
and A. M. Glenny 
Pulp treatment for extensive 
decay in primary teeth 
2003(169) 2014(170) 3 47 Y 
Original review recommends 
outcomes be chosen which have 
relevance to patients and parents, in 
addition to outcomes that indicate 
pathology. Significant problems 
encountered in both reviews with 
outcome heterogeneity between 
trials. No clear evidence of 
superiority of different interventions 
(techniques or materials) for pulpally 
involved primary molars. However, 
MTA and Ferric Sulphate may offer 
some benefit. Cost effectiveness not 
known. 
B. C. Bonner, J. E. 
Clarkson, L. 
Dobbyn and S. 
Khanna 
Slow-release fluoride devices 
for the control of dental decay 
2006(142) 2014(143) 1 1 N 
Weak and unreliable findings based 
on one low quality study 
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Authors of Original 
Paper 
Title of original paper 
Year of 
original 
publication 
Year of 
update 
Number 
of studies 
in original 
number 
of studies 
in update 
Change to 
conclusions? 
Y/N 
Commentary 
S. Mickenautsch, 
V. Yengopal and A. 
Banerjee 
Atraumatic restorative 
treatment versus amalgam 
restoration longevity: a 
systematic review 
2010(171) 2012(172) 7 20 N 
Amalgam not superior to ART. The 
overall results "confirm the findings 
of the original review" despite the 
broadening of the literature search 
and included study designs. Both the 
original article and the update state 
the need for further high quality 
randomised controlled trials. 
 
Table 3.3 also provides commentary on the issues that were identified within each systematic review.  
 
For those studies which were updated twice, table 3.4 shows the changes in number of papers and conclusions between the first and second update 
as well as a commentary on issues encountered and highlighted by the authors. 
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Colour coding: red indicates fewer studies in the second update, amber has the same number of studies, and green is more in the second update. 
Authors of Original 
Paper 
Title of original paper 
Year of first 
update 
Year of 
Second 
update 
Number 
of studies 
in first 
update 
number 
of studies 
in second 
update 
Change to 
conclusions? 
Y/N 
Commentary 
A. Ahovuo-
Saloranta, A. Hiiri, 
A. Nordblad, H. 
Worthington and 
M. Makela 
Pit and fissure sealants for 
preventing dental decay in the 
permanent teeth of children 
and adolescents 
2008(165) 2013(173) 16 34 N 
Sealant are effective compared with 
control. No conclusions could be 
drawn about the relative 
effectiveness of different materials. 
Still insufficient data. Mismatch 
between outcomes used in trials 
(often sealant retention) versus 
reviews (caries development and 
progression) 
A. Hiiri, A. Ahovuo-
Saloranta, A. 
Nordblad and M. 
Mäkelä 
Pit and fissure sealants versus 
fluoride varnishes for 
preventing dental decay in 
children and adolescents 
2010(167) 2016(174) 4 7 N 
"scarce data mean it is not possible to 
reach conclusions about whether to 
apply sealants or fluoride varnishes 
on occlusal surfaces of permanent 
molars" 
G. Nadin, B. R. 
Goel, C. A. Yeung 
and A. M. Glenny 
Pulp treatment for extensive 
decay in primary teeth 
2014(170) 2018(175) 47 87 Y 
Large number of small single centre 
trials with unclear or high risk of bias. 
Suggest MTA is most efficacious in 
pulpotomy. High success rate means 
large sample sizes needed. 
Recommend the development of 
Core Outcome Set (COS). Update 
justified by new known trials and 
changes in materials. 
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Authors of Original 
Paper 
Title of original paper 
Year of first 
update 
Year of 
Second 
update 
Number 
of studies 
in first 
update 
number 
of studies 
in second 
update 
Change to 
conclusions? 
Y/N 
Commentary 
B. C. Bonner, J. E. 
Clarkson, L. 
Dobbyn and S. 
Khanna 
Slow-release fluoride devices 
for the control of dental decay 
2014(143) 2018(144) 1 1 N 
Weak and unreliable findings based 
on one low quality study. No change 
since original review. 
 
 
Table 3.5 shows the data for the eight updated reviews related to the management of established carious lesions. Three did not have new 
conclusions (38%). Of these three, one did not have any new studies, one had fewer due to a change in scope, and another included 13 new studies 
which did not affect the overall conclusions of the review.  
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Colour coding in number of studies: red indicates fewer studies in update, amber has the same number of studies, and green is more in the update. 
Colour coding in changes to conclusions: Red indicates no change to review conclusions. Green indicates changes to review conclusions 
Reviews Focussed on the Management of Carious Lesions 
Authors of 
Original Paper 
Title of original paper 
Review 
publication 
year 
Subsequent 
update 
Number of 
studies in 
first 
publication 
number of 
studies in 
subsequent 
update 
Change to 
conclusions? 
Y/N 
Commentary 
Z. Fedorowicz, 
M. Nasser and 
N. Wilson 
Adhesively bonded versus 
non-bonded amalgam 
restorations for dental caries 
2009(147) 2016(121) 1 1 N No new clinical trials 
identified 
D. P. Raggio, D. 
Hesse, T. L. 
Lenzi, A. B. G. C 
and M. M. Braga 
Is atraumatic restorative 
treatment an option for 
restoring occlusoproximal 
caries lesions in primary 
teeth? A systematic review 
and meta-analysis. 
2013(137) 2017(136) 3 1 N 
Four papers in the update 
were new but all arose from 
the same study. Only these 
were analysed (7 papers 
total). The update 
"Corroborates findings of the 
original 
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Authors of 
Original Paper 
Title of original paper 
Review 
publication 
year 
Subsequent 
update 
Number of 
studies in 
first 
publication 
number of 
studies in 
subsequent 
update 
Change to 
conclusions? 
Y/N 
Commentary 
David Ricketts, 
Edwina Kidd, 
Nicola P T Innes, 
Jan E Clarkson 
Complete or 
ultraconservative 
removal of decayed 
tissue in unfilled teeth 
2006(152) 2013(69) 4 8 Y 
No change to conclusions about risk 
of pulp exposure in permanent 
teeth or pulpal symptoms in 
permanent teeth. Update identified 
insufficient evidence for difference 
between complete and partial, 
stepwise and partial caries removal. 
Insufficient evidence about 
restoration failure. In Primary teeth, 
no caries removal showed a 
difference compared with complete 
caries removal. Identified a lack of 
long term follow up in clinical trials.  
F. Bergstrand 
and S. Twetman 
A Review on Prevention 
and Treatment of Post-
Orthodontic White Spot 
Lesions - Evidence-
Based Methods and 
Emerging Technologies 
2011(163) 2017(164) 25 8 Y 
Changes to scope and protocol 
between reviews changes 
conclusions. The original review was 
focussed on the prevention and 
management of post-orthodontic 
white spot lesions while the update 
only considered the management of 
established lesions. Both reviews 
highlight methodological 
inconsistencies in primary research 
and suggest further high quality, 
long-term studies with clear 
endpoints (outcomes) are needed. 
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Authors of 
Original Paper 
Title of original paper 
Review 
publication 
year 
Subsequent 
update 
Number of 
studies in 
first 
publication 
number of 
studies in 
subsequent 
update 
Change to 
conclusions? 
Y/N 
Commentary 
N. P. Innes, D. N. 
Ricketts and D. J. 
Evans 
Preformed metal crowns 
for decayed primary 
molar teeth 
2007(168) 2015(117) 0 5 Y 
No conclusions could be drawn in 
original review as no studies were 
identified. Outcome heterogeneity 
identified. Core Outcome Set 
development recommended. 
G. Nadin, B. R. 
Goel, C. A. Yeung 
and A. M. Glenny 
Pulp treatment for 
extensive decay in 
primary teeth 
2003(169) 2014(170) 3 47 Y 
Original review recommends 
outcomes be chosen which have 
relevance to patients and parents, in 
addition to outcomes that indicate 
pathology. Significant problems 
encountered in both reviews with 
outcome heterogeneity between 
trials. No clear evidence of 
superiority of different interventions 
(techniques or materials) for 
pulpally involved primary molars. 
However, MTA and Ferric Sulphate 
may offer some benefit. Cost 
effectiveness not known. 
S. Mickenautsch, 
V. Yengopal and 
A. Banerjee 
Atraumatic restorative 
treatment versus 
amalgam restoration 
longevity: a systematic 
review 
2010(171) 2012(172) 7 20 N 
Amalgam not superior to ART. The 
overall results "confirm the findings 
of the original review" despite the 
broadening of the literature search 
and included study designs. Both the 
original article and the update state 
the need for further high quality 
randomised controlled trials. 
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Authors of 
Original Paper 
Title of original paper 
Review 
publication 
year 
Subsequent 
update 
Number of 
studies in 
first 
publication 
number of 
studies in 
subsequent 
update 
Change to 
conclusions? 
Y/N 
Commentary 
G. Nadin, B. R. 
Goel, C. A. Yeung 
and A. M. Glenny 
Pulp treatment for 
extensive decay in 
primary teeth 
2014(170) 2018(175) 47 87 Y 
Large number of small single centre 
trials with unclear or high risk of 
bias. Suggest MTA is most 
efficacious in pulpotomy. High 
success rate means large sample 
sizes needed. Recommend the 
development of Core Outcome Set 
(COS). Update justified by new 
known trials and changes in 
materials. 
 
Table 3.6 shows the updated reviews in which the conclusions changed. Table 3.7 shows the updated reviews in which no new conclusions were 
made. Most updates did not yield new conclusions. These tables demonstrate that the conclusions changed more often when the number of eligible 
studies had reduced, due to changes in the review protocol and methodology. This may reflect the increasing rigour of the review methodology or in 
the quality of the primary research available at the time of each review.  
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Reviews in which the authors conclusions changed in the update compared with the previous version of the review. Colour coding: red indicates fewer studies in the second 
update, amber has the same number of studies, and green is more in the second update. 
New conclusions 
Original paper Title of original paper 
Year of 
original 
publication 
Year of 
update 
Number 
of studies 
in original 
number 
of studies 
in update 
Change to 
conclusions? 
Y/N 
S. Twetman, S. Axelsson, H. 
Dahlgren, A. K. Holm, C. 
Kallestal, F. Lagerlof, P. 
Lingstrom, I. Mejare, G. 
Nordenram, A. Norlund, L. G. 
Petersson and B. Soder 
Caries‐preventive effect of fluoride toothpaste: a 
systematic review 
2003(141) 2009(140) 54 15 Y 
V. Yengopal, S. 
Mickenautsch, A. C. Bezerra 
and S. C. Leal 
Caries-preventive Effect of Glass Ionomer and Resin-Based 
Fissure Sealants on Permanent Teeth: A Meta Analysis 
2009(150) 2011(151) 11 16 Y 
David Ricketts, Edwina Kidd, 
Nicola P T Innes, Jan E 
Clarkson 
Complete or ultraconservative removal of decayed tissue 
in unfilled teeth 
2006(152) 2013(69) 4 8 Y 
C. A. Yeung, J. L. Hitchings, T. 
V. Macfarlane, A. G. 
Threlfall, M. Tickle and A. M. 
Glenny 
Fluoridated milk for preventing dental caries 2005(153) 2015(154) 2 1 Y 
P. E. Benson, N. Parkin, D. T. 
Millett, F. E. Dyer, S. Vine 
and A. Shah 
Fluorides for the prevention of white spots on teeth during 
fixed brace treatment 
2004(161) 2013(162) 15 3 Y 
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Original paper Title of original paper 
Year of 
original 
publication 
Year of 
update 
Number 
of studies 
in original 
number 
of studies 
in update 
Change to 
conclusions? 
Y/N 
F. Bergstrand and S. 
Twetman 
A Review on Prevention and Treatment of Post-
Orthodontic White Spot Lesions - Evidence-Based Methods 
and Emerging Technologies 
2011(163) 2017(164) 25 8 Y 
N. P. Innes, D. N. Ricketts 
and D. J. Evans 
Preformed metal crowns for decayed primary molar teeth 2007(168) 2015(117) 0 5 Y 
G. Nadin, B. R. Goel, C. A. 
Yeung and A. M. Glenny 
Pulp treatment for extensive decay in primary teeth 2003(169) 2014(170) 3 47 Y 
G. Nadin, B. R. Goel, C. A. 
Yeung and A. M. Glenny 
Pulp treatment for extensive decay in primary teeth 2014(170) 2018(175) 47 87 Y 
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Reviews in which the authors conclusions did not change in the update compared with the previous version of the review. Colour coding: red indicates fewer studies in the 
second update, amber has the same number of studies, and green is more in the second update. 
No new conclusions 
Original 
paper 
Title of 
original paper 
Year of original 
publication 
Year of 
update 
Number of studies in 
original 
number of studies in 
update 
Change to conclusions? 
Y/N 
S. 
Mickenautsc
h, V. 
Yengopal, S. 
C. Leal, L. B. 
Oliveira, A. C. 
Bezerra and 
M. Bönecker 
Absence of 
carious 
lesions at 
margins of 
glass-ionomer 
and amalgam 
restorations: 
A meta-
analysis. 
2009(145) 2011(146) 8 10 N 
Z. 
Fedorowicz, 
M. Nasser 
and N. 
Wilson 
Adhesively 
bonded 
versus non-
bonded 
amalgam 
restorations 
for dental 
caries 
2009(147) 2016(121) 1 1 N 
T. Pereira-
Cenci, M. S. 
Cenci, Z. 
Fedorowicz 
and M. A. 
Marchesan 
Antibacterial 
agents in 
composite 
restorations 
for the 
prevention of 
dental caries 
2009(148) 2013(149) 0 0 N 
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Original 
paper 
Title of original 
paper 
Year of original 
publication 
Year of 
update 
Number of studies in 
original 
number of studies in 
update 
Change to conclusions? 
Y/N 
T. Pereira-
Cenci, M. S. 
Cenci, Z. 
Fedorowicz 
and M. A. 
Marchesan 
Antibacterial 
agents in 
composite 
restorations 
for the 
prevention of 
dental caries 
2009(148) 2013(149) 0 0 N 
D. P. Raggio, 
D. Hesse, T. 
L. Lenzi, A. 
B. G. C and 
M. M. Braga 
Is atraumatic 
restorative 
treatment an 
option for 
restoring 
occlusoproxim
al caries 
lesions in 
primary teeth? 
A systematic 
review and 
meta-analysis. 
2013(137) 2017(136) 3 4 N 
V. C. 
Marinho, J. 
P. Higgins, 
S. Logan and 
A. Sheiham 
Fluoride gels 
for preventing 
dental caries in 
children and 
adolescents 
2002(155) 2015(156) 25 28 N 
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Original 
paper 
Title of original 
paper 
Year of original 
publication 
Year of 
update 
Number of studies in 
original 
number of studies in 
update 
Change to conclusions? 
Y/N 
V. C. C. 
Marinho, J. 
P. T. Higgins, 
S. Logan and 
A. Sheiham 
Fluoride 
mouthrinses for 
preventing 
dental caries in 
children and 
adolescents 
2003(157) 2016(158) 36 37 N 
V. C. 
Marinho, J. 
P. Higgins, S. 
Logan and A. 
Sheiham 
Fluoride 
varnishes for 
preventing 
dental caries in 
children and 
adolescents 
2002(159) 2013(160) 9 23 N 
A. Ahovuo-
Saloranta, A. 
Hiiri, A. 
Nordblad, H. 
Worthington 
and M. 
Makela 
Pit and fissure 
sealants for 
preventing 
dental decay in 
the permanent 
teeth of children 
and adolescents 
2004(139) 2008(165) 8 16 N 
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Original 
paper 
Title of original 
paper 
Year of original 
publication 
Year of 
update 
Number of studies in 
original 
number of studies in 
update 
Change to conclusions? 
Y/N 
A. Hiiri, A. 
Ahovuo-
Saloranta, A. 
Nordblad 
and M. 
Mäkelä 
Pit and fissure 
sealants versus 
fluoride 
varnishes for 
preventing 
dental decay in 
children and 
adolescents 
2006(166) 2010(167) 4 4 N 
B. C. Bonner, 
J. E. 
Clarkson, L. 
Dobbyn and 
S. Khanna 
Slow-release 
fluoride devices 
for the control 
of dental decay 
2006(142) 2014(143) 1 1 N 
S. 
Mickenautsc
h, V. 
Yengopal 
and A. 
Banerjee 
Atraumatic 
restorative 
treatment 
versus amalgam 
restoration 
longevity: a 
systematic 
review 
2010(171) 2012(172) 7 20 N 
A. Ahovuo-
Saloranta, A. 
Hiiri, A. 
Nordblad, H. 
Worthington 
and M. 
Makela 
Pit and fissure 
sealants for 
preventing 
dental decay in 
the permanent 
teeth of children 
and adolescents 
2008(165) 2013(173) 16 34 N 
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Original 
paper 
Title of original 
paper 
Year of original 
publication 
Year of 
update 
Number of studies in 
original 
number of studies in 
update 
Change to conclusions? 
Y/N 
A. Hiiri, A. 
Ahovuo-
Saloranta, A. 
Nordblad 
and M. 
Mäkelä 
Pit and fissure 
sealants versus 
fluoride 
varnishes for 
preventing 
dental decay in 
children and 
adolescents 
2010(167) 2016(174) 4 7 N 
B. C. Bonner, 
J. E. 
Clarkson, L. 
Dobbyn and 
S. Khanna 
Slow-release 
fluoride devices 
for the control 
of dental decay 
2014(143) 2018(144) 1 1 N 
A. Ahovuo-
Saloranta, A. 
Hiiri, A. 
Nordblad, H. 
Worthington 
and M. 
Makela 
Pit and fissure 
sealants for 
preventing 
dental decay in 
the permanent 
teeth of children 
and adolescents 
2013 2017 34 38 N 
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Several review authors highlighted problems with the primary research on which the 
SR was based. Several updated reviews cited outcome heterogeneity as a barrier to 
evidence synthesis and recommended a core outcome set be developed to address 
this problem (117, 170). The subject of the review by Innes et al was management of 
carious lesions in primary teeth with preformed metal crowns (117). The original 
review in 2007 demonstrated no RCTs investigating this intervention as it was not a 
well-established treatment at that time. By the time the update was published in 2015, 
five RCTs which met the inclusion criteria had been undertaken. This highlights the 
value of updating reviews in situations where new interventions are compared against 
established techniques in a rapidly changing field. Five new studies demonstrated that 
the primary research addressing this question is active and worthy of an updated 
synthesis. 
 
This systematic search of the literature generated many relevant systematic reviews 
(n=234) published since 1993 with rapidly increasing frequency since the mid-2000s. A 
systematic literature search of multiple databases to locate relevant SRs was 
considered the most comprehensive method of identifying relevant systematic reviews 
of RCTs. An umbrella review search methodology was selected to do this, and a broad 
range of electronic databases were searched. The lengthy process of screening of titles 
and abstracts was undertaken in duplicate to arrive at an agreed list of relevant 
papers. A more detailed analysis of this sample of systematic reviews focusing on 
outcome selection and risk of bias (using the ROBIS tool) for each review was planned 
but not undertaken. The rapid increase in the number of systematic reviews published, 
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particularly between 2015 and 2017, resulted in a large number of SRs to analyse 
(n=234). This would have required significant resources to undertake. The planned 
objective, to compare outcome choice in SRs compared with the RCTs reported in 
Chapter 4, did not justify the detailed analysis of all 234 SRs in this present research 
enquiry. 
The detailed analysis, including methodological assessment using ROBIS, required for 
all 234 included reviews, would have been time consuming and of limited value to this 
present exploration of research waste. The authors of AMSTAR 2 state that the 
checklist completion time for experienced reviewers varies from 15-32 minutes 
excluding the time to read the review (133). Assuming this would double the time 
taken for each review, this would be at least an hour for each review. If undertaken in 
duplicate, this would equate to around 468 human hours of analysis. In a study 
comparing the utility of ROBIS and AMSTAR 2, it was estimated that the time to 
complete ROBIS was around double that of AMSTAR 2 (176). In the present umbrella 
review, an estimated 1000 hours of analysis to use ROBIS was deemed to be of 
questionable value for this research enquiry. The authors of the publication also 
highlight the fact that the focus of AMSTAR 2 is on the methodology of the review. 
That is, questioning if correct procedure has been applied (176). Meanwhile, ROBIS is 
focused on the results section of the review questioning whether the procedure 
followed has had an impact upon the results or their validity (176).  Whilst it may be of 
interest to analyse this body of literature for these attributes, it is unlikely to yield 
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significant new insights beyond what is already observed in the conduct of systematic 
reviews more broadly (177). For that reason, no such analysis was undertaken. 
 
The first analysis arising from this systematic search shows that there has been a 
dramatic increase in the number of systematic reviews in caries research being 
published annually (figure 3.1). In the years 2010 to 2014 inclusive, the average ratio of 
systematic reviews to RCTs was 0.98 based on the findings reported in this chapter and 
in Chapter 4 (systematic review of RCTs). That is, almost one new SR is published for 
every potentially relevant RCT. There is clearly a problem when the number of 
evidence syntheses threaten to outnumber the primary research reports on which 
they could be based (178). In fact, given the tendency towards efficacy trials detected 
in the SR of RCTs reported in the next chapter, and the growing number of SRs since 
2014, it seems likely that there are fewer “relevant” RCTs, making it possible that the 
ratio is greater than one across clinical caries research more broadly. Furthermore, this 
simple analysis covers the spectrum of primary prevention through to invasive lesion 
management strategies. Therefore, this is likely to underestimate the level of research 
waste in some areas and for some types of interventions. The problem of the 
dominance of reviews over primary research has not been missed by commentators 
and editors in recent years (113, 115, 178, 179). The work reported in this chapter 
demonstrates that this trend appears to be evident within established lesion 
management research as well as the broader caries literature including primary 
prevention. 
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The second analysis contained within this chapter focused on the frequency and 
usefulness of updated reviews. Given the large number of reviews identified in the 
literature search (n=234), a relatively small number had been updated (n=19). The 
majority of these were Cochrane reviews (68%). These may have been more easily 
identified because Cochrane hold detailed records of previous versions of reviews and 
are transparent about the process of updating reviews. Other updates were only 
identified by similar or identical authorship and titles or where “updated”, or “update” 
was included in the title. It is possible that there are more review updates which do 
not display these features and so were not included in the analysis. However, this is 
estimated to be low in number and would have minimal impact on the analysis and 
overall conclusions. Explicit reporting that a new systematic review is an update of a 
previously published synthesis is not part of the PRISMA statement and checklist (132). 
However, the authors of the PRISMA statement suggest that it is “good practice” to do 
so. The PRISMA statement is scheduled for an update in 2020 so it is possible that this 
could be added in response to the rapid expansion of published SRs (180). 
 
A large proportion of the review updates did not have different conclusions to the 
original publication. There were various factors that led to this including searches 
which yielded no new primary research, or problems with the methodology of newly 
published primary research which inhibited synthesis. Of the review updates which did 
have different conclusions, some of these were due to changes in the methodology of 
the review itself. This may be because the availability and quality of the primary 
research had improved, or because the review methods had developed in the 
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intervening period. Overall, only five updates which contained more primary studies 
than the original review had different conclusions. Most of the reviews in which 
conclusions had changed had fewer studies in the update than the original. This is 
likely to be as a result of improvements in synthesis methodology, causing more 
studies to be excluded before the analysis.  
 
The global picture is that review updates often do not have different headline results 
when compared to the original review and that there are relatively few circumstances 
where there is additional primary research that changes the review conclusions. As a 
result, they are unlikely to lead to change in clinical care. 
 
The question arising from these findings is “why are so many systematic reviews, and 
so few high-quality primary studies worthy of inclusion in these secondary syntheses, 
being published?” For some time, systematic reviews have been at the apex of the 
evidence pyramid due to their methodological rigor and statistical power to detect 
differences between interventions (85, 114). As they have become more popular with 
researchers, students and funding bodies as a means of establishing existing 
knowledge prior to undertaking other work, the number of associated publications has 
grown. Indeed, this thesis also contains a systematic review of the primary literature, 
culminating in two associated publications (2, 3). Although time-consuming to conduct, 
they can be less resource intensive to perform than many clinical trials making them an 
attractive way to produce a potentially high quality, cost effective, influential and often 
cited publication (181). They are also more robust than simple narrative reviews, 
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making them a well-structured way to demonstrate the contemporary breadth of 
research undertaken in a field. As a result, they have become a popular contribution in 
the completion of a higher research degree. Some supervisors may consider 
“systematic” as a byword for quality. However, this is not necessarily the case, 
particularly if performed by a small team of inexperienced researchers (e.g. 
postgraduate students). The poor conduct of systematic reviews is a research waste 
problem.  Frequently flawed, with narrow search strategies, only 7% of SRs search for 
unpublished work (182) and less than half search trial registries (183). Systematic 
reviews are successfully used to demonstrate a lack of available evidence, thereby 
justifying the completion of further primary research to address a yet unanswered 
question to research funding bodies or ethics committees. However, the barriers to 
undertaking further primary research include funding challenges, the ethical approvals 
process, the clinical and professional resources to deliver the intervention and 
outcome assessments. Furthermore, lack of experience conducting trials in a relevant 
clinical setting may lead to the use of inferior methods which later inhibit synthesis or 
limit the ability to draw generalisable conclusions.  
 
There are two issues that need to be resolved to reduce research waste at the 
interface between RCTs and SR within the GEEOH if the ecosystem approach is to be 
effective. The first is to ensure that high quality syntheses continue to be undertaken, 
without overlap and overproduction, focusing on clear and important questions (177, 
184-186). The second issue to be resolved is the lack of new high-quality primary 
research. 
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To address the first problem, strategies to identify key subjects for review have already 
been developed by Cochrane helping to reduce research waste (187). The resultant 
reviews should be fewer in number but more consistent in quality. Syntheses should 
be updated but criteria for this should be established, agreed and adhered to. This 
must be with reference to known clinical trials being undertaken resulting from a 
coordinated dialogue between trialists and reviewers as part of an evidence 
ecosystem. As described in Chapter 2, research waste can be found when questions 
with already sufficient evidence to answer are asked and investigated again. An 
example of this might be a review which closely mimics another recently published 
review on the same question but with minor methodological differences (186). It can 
also be considered waste when it is not carried out to a high enough methodological 
standard to provide certainty that the question has been fully answered. Examples of 
this might be failing to search all relevant databases or failing to consider RCTs 
published in other languages where there is a high chance of finding a relevant 
publication (182, 183). Arbitrary date restrictions on database searches may be a way 
of reducing the volume of data to be analysed but may exclude key papers. Reviewers 
and trialists should set joint priorities for research and be familiar with challenges at 
the interface between these two parts of the GEEOH. This sort of collaboration would 
support a smooth transition from evidence production to evidence synthesis. Within 
the community created by an evidence ecosystem, newcomers and research students 
will be mentored by experienced practitioners across this interface, developing greater 
understanding of their unique role within the system (122). For example, trialists will 
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see their work as something which needs to be synthesisable if it is going to contribute 
to the evidence base in a meaningful way.  
 
The apparent lack of new high-quality primary research is the second issue to be 
addressed. For areas where intervention effectiveness remains in doubt, resources 
must be directed to the conduct of high quality RCTs using appropriate methodology 
to provide new evidence for future syntheses. The aim of these RCTs should be to 
provide evidence to answer the prioritised review topics and trialists should plan RCTs 
with the expectation that it will be later synthesised as part of the totality of evidence. 
The authors of the Lancet Series on research waste suggest that any new primary 
research should be preceded by a systematic search of the literature to reduce 
duplication of expensive clinical trials when sufficient evidence already exists (20, 181). 
Therefore, there is still a need to establish existing knowledge before conducting RCTs. 
However, that may mean identification of an existing systematic review of RCTs rather 
than undertaking a completely new SR. Where a systematic review already exists, 
researchers would be expected to locate it and refer to it in any grant application for 
funding and in subsequent trial reports (188). Widely available support manuals 
produced by organisations such as Cochrane make it easier for researchers to plan and 
undertake systematic reviews (85). So, while the proliferation of systematic reviews 
may superficially appear to be a positive trend (189), the lack of new RCTs and the 
apparent variable quality of SRs means that we may have a growing problem of 
research waste.  
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The Epistemonikos tool has been developed by researchers in Santiago, Chile to make 
it easier to locate the highest quality evidence for healthcare and provides an example 
of a potentially useful solution (190). The principal focus of the database is searching 
for evidence syntheses rather than primary research.  It is a searchable database of 
systematic reviews and other types of evidence “relevant for health-decision making” 
(190).  Epistemonikos means “what is worth knowing” and seeks to bring together 
evidence into an easily searchable database translated into the language of the user. 
Epistemonikos regularly updates from the databases listed in Table 3.8. 
 
 
Cochrane Database of Systematic Reviews (CDSR) 
Pubmed  
EMBASE  
CINAHL  
PsycINFO  
LILACS  
Database of Abstracts of Reviews of Effects (DARE)  
The Campbell Collaboration online library  
JBI Database of Systematic Reviews and Implementation Reports  
EPPI-Centre Evidence Library  
 
There is clearly significant overlap with the sources searched by Epistemonikos and 
those searched in this chapter and some are not normally relevant for dental research 
(e.g. PsychINFO). Epistemonikos use human screeners and a machine learning 
algorithm to identify and select systematic reviews. Articles are translated into nine 
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languages (Arabic, Chinese, Dutch, English, French, German, Italian, Spanish and 
Portuguese) by computer software. Pre-existing official translations are identified by 
automated and manual searches. Where the article has been translated, a symbol 
indicates how it has been translated (e.g. Machine translation or Official Translation). 
This project makes it easier for researchers to find relevant systematic reviews. The 
automatic location and assimilation of SRs by technologies such as machine learning 
could eliminate, or at least reduce, the time spent on extensive literature searching 
and screening by researchers. This reduces research waste and saves the researcher 
time, but it also decreases the likelihood of missing an SR that has already been 
completed and published when planning new research. Using the Epistemonikos tool, 
a search for systematic reviews published in the last 12 months from 14/07/20 using 
the search term “Caries” in the Epistemonikos database yielded 134 records. There is 
no sign that the number of SRs being published each year is stabilising, let alone, 
reducing.  
 
Considering the problems encountered in the overproduction of uninformative 
syntheses and the challenges of continuously updating reviews, perhaps a system like 
Epistemonikos could be developed, with machine learning, to locate and even select 
relevant RCTs. Further automation of the review process as far as possible would 
realise Archie Cochrane’s ambition of having the latest, best evidence available whilst 
also minimising research waste.  
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In 2016, Cochrane launched the Living Systematic Reviews Network, which aims to 
develop a suite of continually updated meta-analyses, called Living Systematic Reviews 
(LSRs) (191, 192). At the time of writing, there have been six LSRs published by 
Cochrane with 3 protocols for proposed LSRs. The LSR Network aims to promote the 
use of automated searching and machine learning to minimise human effort in 
conducting updated reviews. While automation is unable to perform all the aspects of 
eligibility assessment, the use of “crowds” to perform so called “micro-tasks” could 
divide labour and reduce waste (191). Cochrane has developed a citizen science 
platform called “Cochrane Crowd” which allows anyone to contribute to reviews by 
completing discrete tasks such as classifying primary research as RCTs or not (191). The 
automated system, using machine learning, can become more accurate based on the 
input of the “crowd”. The Crowd is helped by online training, and an agreement 
algorithm ensures that each record is classified multiple times before it is accepted to 
CENTRAL or rejected. Evaluations have shown 99% sensitivity (i.e. to identify RCTs 
correctly) compared to reference standard (191). Specificity is also high, at 99% (i.e. to 
reject records when they are not RCTs) (191).  
 
Furthermore, there is an increasing need for so-called “complex reviews” or network 
meta-analyses (NMA) which seek to map a whole field of interventions for a disease 
rather than focusing on specific pairwise comparisons. Using NMA, it is possible to 
compare intervention effect sizes against one another even when they have not been 
directly tested against one another in an RCT (193, 194). Promising new interventions 
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can be explored in this way without conducting expensive, time consuming, potentially 
unnecessary and therefore unethical, primary research. It has been suggested that an 
NMA approach would provide evidence rejecting the null hypothesis on average four 
years earlier than conventional pairwise analysis (194). All of this would help reduce 
research waste. 
 
By combining the LSR and NMA methods, it would be possible to have a continually 
updated map of an entire field (e.g. management of deep carious lesions) as new RCTs 
were incorporated, with some degree of automation, into the meta-analysis. This 
development could provide a significant reduction in research waste. Some raise 
concerns about the peer review process of such research, given that the review would 
not necessarily be re-published in a print journal when new RCTs are added to the 
analysis (191). This can often delay publication by several months which is counter to 
the philosophy of the LSR. Some have suggested that post-publication peer review 
would suffice, since the methodology of the LSR is not being altered. Whatever the 
problems, some amount of change in working practice and reward systems for 
academics will be necessary. Living reviews will not always generate publications in 
peer-reviewed publications: the currency in the economy of academia. However, the 
pressing need to translate effective interventions for Covid-19 into practice during the 
global pandemic has produced a live example of this type of work (195, 196). This 
demonstrates that, although under extreme circumstances, researchers can work 
together rapidly in this way to help answer pressing questions. 
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The widespread development of LSRs combined with an NMA approach will require co-
operation and planning (194). Since it is designed to reduce the proliferation of 
uninformative SRs, researchers will need to stop doing them outside this new system. 
Cochrane are ideally placed to develop, co-ordinate and lead this new way of working. 
By fostering links and promoting constant dialogue between reviewers, trialists and 
guideline developers, it has the potential to help smooth this key stage of the GEEOH 
and reduce research waste. 
 
In recent years, a large and increasing number of systematic reviews have been 
published in the cariology literature. In 2016, 40 systematic reviews were published 
which represents a dramatic increase in the number of new SRs published each year. 
In 1997, one SR was published, rising to 6 in 2007 before reaching 40 in 2016. There 
appears to be a developing issue with the ratio of secondary research to primary 
research within the caries literature that warrants further exploration. Updating 
systematic reviews is complex and rarely undertaken outside of Cochrane. Changes in 
synthesis methods seem to have greater effect on SR conclusions than the 
incorporation of new primary research. Living Systematic Reviews (LSR) and Network 
Meta-analysis (NMA) could be combined to assimilate primary research faster. More 
high-quality primary research suitable for synthesis into such reviews should be 
undertaken. There is a need to align the priorities for research in RCTs and SR to 
reduce research waste at this stage of the developing GEEOH.  
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The planned evaluation of the quality of and the outcomes selected in SRs was not 
undertaken due to the large number of SRs located. It will therefore not be possible to 
compare the outcome domain choice in all included SRs and compare them with the 
outcomes published in potentially relevant RCTS (Chapter 4). This chapter, therefore, 
does not seek to interpret the quality, suitability or justification for each review. No 
further mapping of alignment between the primary and secondary research has been 
undertaken. The issue of over-production of SRs is described only as a global ratio and 
does not address nuances in the focus of RCTs and SRs.  
 
When determining whether the conclusions had changed in updated reviews, a degree 
of subjectivity was involved in making this judgment. Whether or not the conclusions 
of the review had changed in the updated reviews was either stated by the authors or 
a judgement was made based on the conclusions of the review authors. Detailed 
analysis of the effect size data if meta-analysis was present, was not undertaken in the 
assessment of the included SRs. Criteria described in the method section were used to 
guide the decision. It is possible that other reviewers would have made slightly 
different decisions.  
 
This review exercise demonstrates that there has been a dramatic rise in the 
publication rate for systematic reviews in cariology. Due to the high ratio of SRs:RCTs it 
is likely that some of these reviews would fall within the Lancet Series definition of 
research waste (197). The relatively low number of new RCTs published each year 
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suggests that cariologists should invest more resource into conducting good quality 
primary studies, addressing a relevant PICOT question, with appropriate study design 
and statistical power to contribute meaningfully to well aligned secondary research 
programme. A Core Outcome Set (COS) would assist in improving the relevance of 
primary research and in the alignment with secondary research. Researchers 
undertaking syntheses should move towards a Living Systematic Review (LSR) 
combined with Network Meta-analysis (NMA) focused on the same COS. The next 
section of this thesis will present the work to establish a COS for carious lesion 
management. 
 
The analyses presented in this chapter build a picture of an excess of systematic 
reviews and too few high-quality primary studies being undertaken in caries research. 
In order to reduce unnecessary duplication of effort and research waste, the following 
recommendations are made. 
 
1. Researchers, Clinicians and Patients should develop, in partnership, priorities for 
clinical research which should include the entirety of the GEEOH.  
2. Organisations such as Cochrane should provide a forum for trialists and reviewers 
to collaborate, improve methodologies and align these stages of the GEEOH. 
3. Any new review should be aligned to these agreed priorities. 
4. New systematic reviews should cite and appraise similar or out-of-date systematic 
reviews in the same field through umbrella searches or using the Epistemonikos 
database.  
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5. The new systematic review protocols should state clearly why previously published 
systematic reviews are not adequate in order to justify an additional review. If the 
new review is justified, it should use Living Systematic Review methodology, 
incorporating a Network Meta-analysis where practicable. 
6. Cochrane systematic reviews due for updating should migrate to a Living 
Systematic Review with Network Meta-analysis framework. 
7. Once a Living Systematic Review (LSR) is established by Cochrane, other 
researchers should stop conducting SRs on that subject. 
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This section describes the Core Outcome Set development process for carious lesion 
management trials. The process comprises three linked projects which are described 
through Chapters 4, 5 and 6. Chapter 4 describes the process to identify existing 
knowledge. Chapters 5 and 6 describe the methods of developing consensus on 
important outcomes. 
 
In this chapter the rationale for the development of a core outcome set for carious 
lesion management effectiveness trials is presented. This chapter also describes the 
work conducted to identify outcomes used in randomised controlled trials (RCTs) that 
investigate interventions in caries research. This was done by conducting a systematic 
literature review. The characteristics of the included studies is also investigated and 
presented. 
 
In Chapter 2 (Reducing waste in the Global Evidence Ecosystem for Oral Health), the 
rationale for the development of Core Outcome Sets (COS) for healthcare research was 
described. In particular, the consequences of improving outcome selection and 
reporting. Furthermore, by seeking to include patients in the development process, the 
likelihood that outputs from effectiveness RCTs will impact positively on the clinical 
decision-making process increases. 
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As described in Chapter 2, the COMET Initiative seeks to support advances in the 
methodology for COS development. They also set out a process for conducting a COS 
which are outlined in Figure 4.1, adapted from the COMET Handbook 1.0 (1). Steps 1, 
2, 3 and 4(i) are reported in this chapter. These are Defining the scope of the COS; 
Register the COS in the COMET database; Develop a protocol; and Identify existing 
knowledge. Steps 4(ii), Fill gaps in knowledge, and 4(iii), Elicit views about important 
outcomes in a consensus process, are presented in Chapter 5. Step 4(iv), Hold a face to 
face meeting to finalise the recommended COS, is reported Chapter 6.  Step 5, 
determination of how to measure the outcomes identified in Steps 1 to 4, is beyond 
the scope of this present thesis. 
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COMET COS development framework modified to show where each stage of the process is reported 
in this Thesis. The context of what is reported in this thesis can be seen. This includes the need to 
agree “how to measure,” which is beyond the scope of this thesis. In parallel, implementation, 
assessment of uptake and updating and review are shown. This highlights the need for regular 
revalidation of the COS. 
 
When considering the scope of this COS, it is important to restate that caries is a 
biochemical process driven by bacteria within the biofilm and that a carious lesion is 
the clinically detectable manifestation of that disease process (27). Caries, the disease 
process, is a ubiquitous phenomenon at a subclinical level when the equilibrium of 
demineralisation and remineralisation is in balance. Only when this equilibrium is 
shifted towards demineralisation does a lesion manifest clinically (28). At all stages, 
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attempts to control the underlying disease process should be made to prevent clinical 
presentation of a lesion (primary prevention) or further tooth destruction (secondary 
prevention). The term “caries control” is often used to describe approaches designed 
to prevent clinically detectable lesions arising as well as halting progression of already 
established lesions (28). Whilst “caries control” is perhaps the preferred contemporary 
terminology, the term “primary prevention” has been used in the literature to describe 
the prevention of carious lesions becoming clinically detectable. The term “secondary 
prevention” has been used to describe the prevention of already established lesions 
from progressing. That is, secondary prevention is an attempt to arrest a clinically 
detectable lesion. Whilst this terminology has fallen from favour by some, the terms 
primary and secondary prevention have been consistently used throughout thesis for 
clarity. 
 
In planning this COS, it was agreed that it should focus on any intervention designed to 
manage an established carious lesion. That is, to treat the clinical manifestation of the 
caries process. This will sometimes involve an operative procedure (e.g. a filling or 
restoration) however,  it also encompasses non-operative interventions that can be 
described as secondary prevention (28). In order to capture all potentially relevant 
outcomes and take credence of the growing emphasis on non-operative strategies to 
manage carious lesions, all studies on both primary and secondary prevention were 
included in the literature search. This approach also allows analysis of the standard of 
reporting related to outcomes throughout randomised controlled trials in cariology. 
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The scope of this COS is deliberately broad. It includes carious lesions on any tooth 
surface in adults and children, permanent and primary teeth. Although the clinical 
impact of differences between tooth type, tooth site, tooth surface and patient age 
may be variable, it was agreed that fragmenting the COS according to these factors 
would limit the applicability and uptake of the resultant COS. The COS described in the 
following chapters does not impose limits on the setting of relevant studies but 
anticipates that future lesion management effectiveness RCTs will be undertaken in 
primary care where the majority of such treatment is delivered. 
 
As a result of inconsistent outcome selection and reporting, Cochrane reviews have 
highlighted the need for a carious lesion management COS (117, 170). The COMET 
initiative database was searched and found no ongoing carious lesion management 
COS development projects. A project and protocol were therefore registered in 2015 in 
the COMET database to form part of this thesis. 
 
 A protocol was developed and published in BMC Trials in 2015 (198). The COMET 
database entry was updated with the published protocol.  
 
The COMET initiative recommends that COS developers begin by identifying existing 
knowledge from already published work in the area of interest (1). This can either be 
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from primary or secondary research sources (typically RCTs or SRs). Alongside RCTs 
and SRs, COMET consider reviews of qualitative work and national audit datasets as 
sources of potentially important outcomes. In this case, we elected to search the 
primary research as we sought not only to identify potentially important outcomes but 
to analyse the conduct of primary studies in caries research. Due to changes over time 
in how dental caries is controlled, primary prevention and lesion management RCTs 
were included to ensure as many potentially relevant outcomes as possible were 
identified. 
 
The broad scope of this systematic review was to identify as many relevant, previously 
reported outcomes as the foundation of the consensus process to agree a core 
outcome set (COS) for carious lesion management. In addition, we sought to identify 
problems related to the use and reporting of outcomes within clinical caries research. 
 
The primary objective of this review was to identify outcomes which have been used to 
assess intervention effect in clinical cariology randomised controlled trials.  
 
The secondary objectives were:  
1. to summarise the features of included trials; and 
2. to assess compliance with the CONSORT statements (107, 108) in relation to 
outcomes: 
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a. sample size calculations and their relationship with the primary 
outcome; and 
b. trial registration (which might help identify outcome reporting bias). 
 
The protocol for this review was published in BMC Trials (198) and registered in 
PROSPERO (CRD42015025310) and on the COMET initiative website (199). The 
systematic review did not require ethical approval (see Appendix 2). 
 
There is a lack of agreement about which type of study should be used to identify 
outcomes to form the basis of the consensus process (1, 200). Randomised Controlled 
Trials were selected for analysis in order to meet the research objectives.  
 
No restrictions were placed on the types of participants involved in the studies as the 
COS would include adults and children, primary and permanent teeth. 
 
Two separate search strategies were developed; the first focused on the prevention 
(primary prevention) and the second on management of carious lesions, including 
secondary prevention (Tables 4.1 and 4.2 respectively). Searches were developed and 
run individually for Embase, Web of Knowledge, PubMed and CENTRAL in August 2015 
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without language restrictions. Hand searching or assessment of the grey literature was 
not conducted as it was considered unlikely to yield additional unique outcome 
domains due to the high number of publications already identified.  
 
 
Search (((((((((((((fluoride) OR sealant) OR sealing) OR remineralisation) OR 
remineralization) OR remineralise) OR remineralize) OR antibacterial) OR 
chlorhexidine) OR brushing) OR brush))) AND (((((((((((((progression) OR prevention) 
OR arrest) OR prevent) OR progress) OR activity)))) AND (decay) OR carious) OR dmft) 
OR dmfs)))) AND ((((((patients) OR clinical) OR randomized) OR randomised) OR 
random))))) 
 
 
Search (("Tooth"[Mesh]) AND "Dental Caries"[Mesh]) AND (((((((((("pit and fissure 
sealant" OR "pit and fissure sealants"))) OR ("Pit and Fissure Sealants"[Mesh])) OR 
"Dental Restoration, Permanent"[Mesh]) OR "Dental Restoration, Temporary"[Mesh]) 
OR (((ultraconservative[Title/Abstract] OR stepwise excavation*[Title/Abstract] OR 
atraumatic*[Title/Abstract] OR minim*[Title/Abstract])) OR (ultraconservative[Text 
Word] OR stepwise excavation*[Text Word] OR atraumatic*[Text Word] OR 
minim*[Text Word]))) OR "Dental Cements"[Mesh]) OR "Dental Amalgam"[Mesh]) OR 
"Resins, Synthetic"[Mesh]) 
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We included RCTs involving any intervention for preventing or managing carious 
lesions when compared to another or no treatment. Patient-centered outcomes were 
sought by also including studies comparing interventions to support patients 
undergoing procedures related to dental caries. An example of this type of study 
would be an RCT comparing different local anaesthetic techniques for operative 
treatment of a carious lesion in paediatric patients. Another example might be 
hypnosis in adult patients undergoing operative treatment of a carious lesion. No 
restrictions on setting, time of follow-up, age or dentition were made. Trials involving 
artificial lesions and ‘in situ’ studies were excluded. Screening of titles and abstracts 
was carried out independently and in duplicate by four researchers (CL, FS, GG and NI) 
with agreement of two authors required for inclusion.  
 
Data was extracted independently from the study reports by five authors (CL, FS, GG, 
NI and TL) following calibration using a pilot database. Data extraction was not 
undertaken in duplicate due to the high volume of included RCTs. Additionally, effect 
size data was not extracted and the risk of missing important outcomes was 
considered to be of low risk to the primary aim of this review. A 5% data check was 
undertaken and extraction fields conforming less than 90% were re-extracted after a 
further round of calibration. Due to the large number of included articles and the aim 
of our review, each article was included as a separate entity. No attempt was made to 
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combine publications linked to the same individual trial. Table 4.3 shows the data 
items extracted from each trial report. 
  
 
Trial details (author name, title, journal, date of publication); 
Trial characteristics; 
• Study setting 
• Number of participants 
• Age of participants (adults or children)  
• Dentition 
• Number of trial arms 
• Interventions compared 
• Trial focus 
o Primary prevention, or, 
o Management of established carious lesions 
Outcomes  
Presence of a sample size calculation  
The relationship of the sample size calculation to the primary outcome; and 
Reporting of trial registration or protocol. 
 
Studies were considered to be prevention focused if the interventions being compared 
were intended to stop the initiation of new lesions (primary prevention). Studies 
investigating interventions targeting established lesions at any stage were assigned to 
the management group for analysis (27, 28). This included secondary prevention. 
Where there was a degree of overlap in what has been termed “caries control” (28) 
the study was categorised based on the primary focus of the study as stated in the trial 
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report. An outcome was considered to be primary if it was explicitly expressed as the 
primary outcome, or where the report clearly focused on one outcome. If no primary 
outcome was identified or multiple outcomes were reported these were considered 
secondary outcomes for the purposes of the analysis. 
 
A list of outcomes was compiled and grouped into categories. This was done to 
facilitate useful analysis of the types of outcomes that have been assessed in the 
literature. Pilot category names were agreed before the first cycle of categorisation 
and refined through group consensus before all outcomes were re-categorised using 
the final agreed terminology.  
 
Trial outcomes were allocated to one of these outcome categories by discussion and 
agreement of two researchers (CL and NI). Where there was disagreement, consensus 
was established by consulting all five researchers (CL, NI, FS, GG and TL). A common 
area of difference was in deciding whether a particular outcome should be assigned to 
the caries experience or lesion activity outcome category. This perhaps reflects the 
overlap between primary prevention, caries control and what has been termed 
secondary prevention (28).  This was often related to whether the unit of analysis was 
the tooth or the patient. Therefore, in such circumstances, if the outcome was related 
to tooth level results, it was categorised as lesion activity (secondary prevention). If it 
was reported at the patient level using a caries experience index it was categorised as 
additional caries experience (28).  
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The electronic database searches yielded 5197 potentially relevant articles. After 
duplicates were removed using the automatic deduplication function in EndNote® 
(Thompson Reuters, Toronto, Canada), a further manual check was undertaken. After 
deduplication, 4774 unique publications remained. Following screening of titles and 
abstracts, there were 764 potentially relevant articles. Full texts of 731 of these were 
successfully located (96% retrieval rate) for full text analysis. A further 126 of the 
retrieved articles were excluded at this stage due to failure to agree with inclusion 
criteria or were not available in English or German. There were 13 full text articles 
which were neither in English or German (languages spoken by the study team). As 
these made up 1.7% of the total number of potentially eligible studies they were 
excluded without translation as they were unlikely to yield new outcome domains. 
 This left 605 full text articles in the final analysis (Figure 4.2). 
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Of the 605 included reports, the study setting was not reported in 131 (22%). Of the 
remaining 474, 73 (15%) were conducted in primary care and 195 (41%) in secondary 
care (specialist practice, hospital or university clinic). A further 188 (40%) were 
conducted in a non-practice setting (field or school) and 18 (4%) were conducted in a 
mixed setting (e.g. interventions delivered in a clinic and supplemented in schools). 
This is displayed in Figure 4.3 
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The total number of participants enrolled in all reports was 252,099 (range 7 – 8027 
participants per trial). The median number of participants was 102 and the mean 429 
(inter-quartile range [IQR] =284; Q1 = 44, Q3 = 328). Participant numbers were not 
normally distributed across the trials (Figure 4.4). The total number of participants 
enrolled in prevention trials was 208,817 (range 10 – 8027). The median was 257 
participants and the mean 735 (IQR = 512: Q1 = 99, Q3 = 611). The total number of 
participants enrolled in carious lesion management trial reports was 43,282 (range 7 – 
8027 participants per trial), median 52 participants, mean 142 (IQR = 87: Q1 = 33, Q3 = 
120). Seventeen percent of all participants in included trials had been enrolled in a 
carious lesion management- focused study. 
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Randomised Controlled Trials (RCTs) focused on primary prevention had larger numbers of 
participants than lesion management trials. Prevention refers only to primary prevention. 
Management refers to secondary prevention and operative management. 
 
Children (<18 years) were the only group studied in 416 reports (69%). Adults were the 
sole focus of 154 reports (25%). Both adults and children were included in 32 reports 
(5%). In three publications (0.5%) it was not possible to determine whether the 
participants were adults, children or both. This is shown in figure 4.5. 
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Although the majority of the trial reports involved children (n=448, 74%, 416 with 
children alone and 32 with both children and adults), the permanent dentition was the 
focus of the majority of trial reports (n=447, 74%). Of the 447 reports studying the 
permanent dentition, 349 (58% of total) solely focused on the permanent dentition 
and 98 (16% of total) included both primary and permanent dentitions. The primary 
dentition was the sole focus in 150 (25%) of the studies. In a small number of reports, 
it was unclear which dentition was being studied (n= 8, 1%). This is shown in figure 4.6. 
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The majority of trials were two-arm trials with 415 reports (69%) describing trials of 
this design. Around a fifth of included trials had three arms (n= 124, 21%) and 44 had 
four arms (7%). Twenty two (4%) of the reports had five or more trial arms. One trial 
had nine arms. 
 
More detail on the report characteristics of the included studies can be found in 
Appendix 3.   
 
The final list of outcome categories comprised 19 items: caries experience; clinical 
performance of the restoration; lesion activity; microbiological outcomes; clinical oral 
hygiene-related outcomes (e.g. plaque and gingival indices); reaction to treatment 
during treatment procedure; pulp-health related outcomes; resource efficiency e.g. 
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time, cost; systemic side effects; pain/discomfort after treatment; quality of life/ 
subjective value; patient behaviour outcomes e.g. toothbrushing frequency; patient 
knowledge; acceptability to operator; fluoride side-effects; aesthetics; service use; 
clinical diet related e.g. blood sugar levels; tooth survival; and “other”. 
 
There were 1363 outcomes reported in 605 published reports (Figure 4.7). After 
categorisation of these outcomes, “Clinical performance of the restoration” and 
“caries experience (e.g.  DMFT)” were the most common outcome categories 
reported; 481 (35%) and 344 (25%) respectively. “Microbiological outcomes” were the 
next most common category at 103 (8%). There were 87 “clinical oral-hygiene related 
outcomes” (6%), 76 “lesion activity” outcomes (6%) and 66 “patient reaction to 
treatment during treatment procedure” outcomes (5%). There was around a 10% 
reduction in the proportion of reports assessing “caries experience” and “clinical 
performance of the restoration from 1968-1980 to 2011-2015. At the height of their 
use (1981-1990) these outcome domains combined accounted for 79% of all reported 
outcomes, whilst in the most recent time bracket (2011-2015) this had fallen to 51%.  
Outcome domains that have increased in use include “lesion activity”, “microbiological 
outcomes”, “reaction to treatment during procedure”, “pulp health related 
outcomes”, and “resource efficiency”. 
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Primary outcomes were identified in 414 (68%) of included reports (Figure 4.8). Across 
the full term of the search (1968-2015), “clinical performance of the restoration” was 
measured in 151 (35%) of these reports and “caries experience” in 155 (36%). 
Together, these account for over two thirds of all outcomes measured. Outcomes 
categorised as “Lesion activity” were not measured in any of the included studies until 
1980. This then rose through 3% (1981-1990), 4% (1991-2000), and 6% (2001-2010) to 
16% in 2011-2015.  Smaller increases were seen in outcomes categorised as 
“microbiological outcomes”, “reaction to treatment during treatment procedure” and 
“pulp-health related outcomes”. 
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 This chart and table show the changes over time and the global proportions of outcome types. 
1968-1980 1981-1990 1991-2000 2001-2010 2011-2015 total
Caries experience (e.g. DMFT) 39.3% 42.9% 27.9% 17.6% 29.1% 25%
Clinical performance of the restoration 32.7% 36.3% 33.3% 41.8% 22.1% 35%
Lesion activity 0.9% 3.3% 6.2% 4.4% 10.5% 6%
Microbiological outcomes 3.7% 2.2% 11.2% 6.8% 8.9% 8%
Clinical oral hygiene-related outcomes
(e.g. plaque and gingival indices)
12.1% 8.8% 6.9% 4.0% 8.5% 6%
Reaction to treatment during
treatment procedure
0.9% 1.1% 2.9% 7.4% 3.5% 5%
Pulp-health related outcomes 0.0% 0.0% 1.4% 4.7% 4.7% 3%
Resource efficiency (e.g. cost, time) 2.8% 1.1% 2.2% 3.6% 4.7% 3%
Systemic side effects 2.8% 0.0% 0.0% 3.8% 0.4% 2%
Pain/discomfort at a distance to
treatment
0.0% 0.0% 2.5% 1.7% 0.8% 1%
Quality of life/subjective value 0.0% 0.0% 1.1% 1.1% 1.2% 1%
Patient behaviour outcomes (e.g.
toothbrushing frequency)
0.0% 2.2% 1.4% 0.8% 0.8% 1%
Patient knowledge 0.0% 0.0% 0.0% 0.9% 1.2% 1%
Acceptability to operator 2.8% 0.0% 0.0% 0.5% 0.0% 0%
Fluoride side-effects 0.9% 0.0% 0.7% 0.2% 0.0% 0%
Aesthetics 0.0% 1.1% 0.4% 0.2% 0.4% 0%
Service utilisation 0.0% 0.0% 0.0% 0.2% 0.0% 0%
Tooth survival 0.0% 0.0% 0.0% 0.0% 0.0% 0%
Other 0.9% 1.1% 1.8% 0.2% 3.5% 1%
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All reported outcomes (n = 1363) 
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This chart shows the primary outcomes by category showing the changes over time. This shows 
which outcomes researchers have historically placed greatest emphasis on in randomised controlled 
trials in cariology. 
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1968-
1980
1981-
1990
1991-
2000
2001-
2010
2011-
2015
total
Caries experience (e.g. DMFT) 76% 69% 46% 27% 31% 36%
Clinical performance of the restoration 20% 28% 33% 45% 30% 35%
Lesion activity 0% 3% 4% 6% 16% 8%
Microbiological outcomes 4% 0% 6% 9% 8% 7%
Clinical oral hygiene-related outcomes
(e.g. plaque and gingival indices)
0% 0% 3% 1% 0% 1%
Reaction to treatment during
treatment procedure
0% 0% 1% 5% 4% 3%
Pulp-health related outcomes 0% 0% 0% 2% 6% 2%
Resource efficiency (e.g. cost, time) 0% 0% 0% 1% 2% 1%
Systemic side effects 0% 0% 0% 1% 0% 0%
Pain/discomfort at a distance to
treatment
0% 0% 3% 2% 2% 2%
Quality of life/subjective value 0% 0% 0% 0% 0% 0%
Patient behaviour outcomes (e.g.
toothbrushing frequency)
0% 0% 0% 0% 0% 0%
Patient knowledge 0% 0% 0% 0% 1% 0%
Acceptability to operator 0% 0% 0% 0% 0% 0%
Fluoride side-effects 0% 0% 1% 0% 0% 0%
Aesthetics 0% 0% 0% 0% 1% 0%
Service utilisation 0% 0% 0% 1% 0% 0%
Tooth survival 0% 0% 0% 0% 0% 0%
Other 0% 0% 1% 1% 0% 0%
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Figure 4.9 shows the outcomes published in the reports categorised as being carious 
lesion management focused, including secondary prevention. Over half (52.1%) of the 
outcomes published in carious lesion management trial reports relate to the “Clinical 
Performance of the Restoration”. During the 1990s the use of this category of outcome 
peaked at 63.5%. In recent years, this has reduced to 33.6%. “Pulp health related 
outcomes” and “lesion activity” have grown in use since 1968. This is likely to be 
related to the development of more conservative operative management strategies 
where lesion progression and pulpal involvement are a potential risk. Neither Pulp-
health related, nor lesion activity categories were used at all in the 1968-1980 time 
period but by 2015 they account for 9.6% and 13.6% of reported outcomes 
respectively. There is evidence of a shift from operator-centered outcomes to those 
which patients may value more, although the change is modest. In 1968-1980, 9.4% of 
trial outcomes were related to operator preference. Since this peak, this has reduced 
to almost never being reported in the included trials. Patient reaction to treatment 
during the procedure as well as post-operative pain or discomfort are being more 
frequently reported than in 1968-1980. However, quality of life or subjective value of 
the treatment is rarely reported. This category of outcomes was not reported except 
during 1991-2000 and 2001-2010 when is accounted for only 0.9% of reported 
outcomes during this period. Compared to the outcomes reported across both primary 
prevention and management fields, the lesion management outcomes are less focused 
on caries experience and more focused on the quality of restoration of treated lesions. 
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This chart shows the changes over time and the global proportions of outcome types for 
randomised controlled trials investigating the management of carious lesions. 
1968-1980 1981-1990 1991-2000 2001-2010 2011-2015 Total
Clinical performance of the restoration 62.5% 53.3% 63.5% 53.4% 33.6% 52.1%
Caries experience (including DMFT
etc.)
15.6% 16.7% 7.0% 7.1% 13.6% 8.9%
Reaction to treatment during
treatment procedure
3.1% 3.3% 6.1% 10.1% 7.2% 8.5%
Pulp-health related outcomes 0.0% 0.0% 3.5% 6.0% 9.6% 5.7%
Microbiological outcomes 0.0% 6.7% 3.5% 6.5% 4.8% 5.5%
Lesion activity 0.0% 6.7% 4.3% 3.4% 13.6% 5.2%
Resource efficiency (e.g. cost, time) 6.3% 3.3% 4.3% 3.9% 8.8% 4.8%
systemic side effects 0.0% 0.0% 0.0% 3.9% 0.8% 2.5%
Pain/discomfort at a distance to
treatment
0.0% 0.0% 6.1% 2.2% 1.6% 2.5%
Clinical oral hygiene-related outcomes
(e.g. plaque and gingival indices)
3.1% 10.0% 0.9% 1.9% 4.0% 2.5%
Quality of life/subjective value 0.0% 0.0% 0.9% 0.9% 0.0% 0.7%
Acceptability to operator 9.4% 0.0% 0.0% 0.4% 0.0% 0.7%
other 0.0% 0.0% 0.0% 0.0% 1.6% 0.3%
service utilisation 0.0% 0.0% 0.0% 0.2% 0.0% 0.1%
Aesthetics 0.0% 0.0% 0.0% 0.0% 0.8% 0.1%
Tooth survival 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Patient knowledge 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Patient behaviour outcomes (e.g.
toothbrushing frequency)
0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Fluoride side-effects 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
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Across the timeframe of the search, the primary outcomes reported in lesion 
management trials predominantly focused on the clinical performance of the 
restoration (58%). Caries experience was the next most common outcome category 
and was assessed in just 11% of RCTs. Lesion activity and reaction to treatment during 
the procedure were the next most common at 8% and 7% respectively.  
 
Reports of 104 trials included information on sample size calculations. The proportion 
of reports including details of sample size calculations increased over time (Figure 
4.10). In the 2011-2015 time period, 55 (44%) published reports reported a sample size 
or power calculation. Throughout the total timeframe of the analysis the sample size 
calculation was linked to the primary outcome in only 12% of all reports. 
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Red:  related to primary outcome 
Blue: PC not related to primary outcom 
Figure 4.11 shows that of the 104 publications reporting a sample size calculation, 75 
(72%) clearly related this to the primary outcome. The sample size calculation was not 
related to the primary outcome in 9% of publications and there was insufficient 
information in 19% of reports to make a judgement.  
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Only 6% (37) of all reports contained a trial registration commensurate with the 
CONSORT statements (107, 108). In the decade since the publication of the CONSORT 
statement in 2001 (107), 3% of reports included a trial registration. This rose to 21% of 
trial reports in the years (2011-2015) after the publication of the revised CONSORT 
statement in 2010 (108) (Figure 4.12). 
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This figure shows (in blue) the percentage of trials included in this review reporting a trial 
registration since the publication of the first CONSORT statement. It shows an increase in 
compliance with this aspect of the CONSORT statement. However, trial registration reporting 
remains at comparatively low levels. 
 
The outcome categories described so far in this chapter allowed for analysis and 
mapping of the field at a suitable level of granularity to be meaningful. However, for 
the eDelphi survey, these outcome categories were exploded back into the constituent 
outcome domains. The domains and how they were categorised in this chapter are 
shown in Table 4.4. 
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This table shows the outcome domains extracted from included trials and the category to which 
they were assigned. 
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Seventy-six outcome domains were derived from the 19 outcome categories. The 76 
outcome domains were taken forward to the next stage of the COS development 
process which is described in Chapter 5. 
 
This systematic review of published RCTs has identified outcome domains that have 
been used. This meets the primary aim set out at the start of this chapter and 
completes section 4(i) of the COS development framework, Identify Existing Knowledge 
(Figure 4.1). Seventy-six outcome domains have been identified which form the basis 
of the consensus process described in the chapters that follow.  
 
Differences in outcome selection over time have also been described. These 
demonstrated a developing focus and conduct of clinical trials in cariology. The 
outcomes that have been investigated show where emphasis has changed, and which 
outcomes have been common in the past and those that are of increasing interest.  
 
Globally, most primary prevention and carious lesion management interventions are 
provided in primary dental care, yet only 15% of the reports (where this information 
could be determined) were conducted in this setting. This review has shown that 41% 
of RCTs were conducted in a secondary care setting, calling into question the 
generalisability of the results. This could represent historic experimental focus on 
efficacy of interventions rather than effectiveness for trials undertaken in University or 
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Hospital clinics. Non-practice settings such as schools provide access to a large and 
fairly static group of participants for caries prevention trials which might explain why 
40% of all reports were of studies conducted here. Furthermore, this might explain 
why most studies are carried out on only children and adolescents (69%) although the 
majority (74%) investigated the permanent dentition.  The generalisability of studies 
carried out on the permanent teeth of young people - with immature enamel, large 
pulp chambers and pulp tissue with greater healing capacity - to the vast majority of 
recipients of oral health care is doubtful.  
 
There was a wide range in the number of participants in each trial with primary 
prevention studies generally larger than lesion management studies.  Overall, the 
median number of participants was 102 and the mean 429 (IQR=284). There was a 
small number of studies which were very large, skewing the total participant’s data 
from a normal distribution. Primary prevention trials were generally larger than 
carious lesion management trials with median participant numbers of 257 and 52 
respectively. This may be because much larger sample sizes are required to show 
differences in the outcomes assessed for primary prevention interventions. In general, 
the primary prevention interventions were more likely to be delivered at a population 
level e.g. school-based toothpaste and tooth brushing programmes. The total number 
of participants involved in all of the included trial reports was 252,099. This does not 
account for duplication due to the dividing of trial data into multiple publications and 
is likely to be an overestimate of the true number. We have not sought to quantify the 
size of this overestimate. What this number shows is that a large number of people 
have voluntarily taken part in published cariology research. As researchers, our 
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responsibility should be to ensure that the conduct and reporting of such studies do 
not contribute to research waste. In stark terms, participants are needlessly put at risk 
in future studies if we do not conduct and report clinical trials well. 
 
Selecting the most appropriate outcome category for each reported outcome 
presented a challenge which is consistent with other findings in oral health (201). This 
was often because of poorly defined outcomes or where they were closely inter-
related (202). Instances of overlap also resulted from the extensive use of composite 
outcome measurement tools in caries research. This could present a significant 
challenge to the development and implementation of a COS for carious lesion 
management, as the measurement tools are stated as if they were an outcome domain 
in itself. For example, restoration performance (e.g Ryge criteria) and further caries 
experience (Decayed Missing or Filled Teeth or Surfaces – DMFT or DMFS) are 
frequently used as stand-alone, undefined outcomes rather than as a tool to measure 
a single and clearly defined outcome domain. This leads us to question whether all 
researchers are clear about the construct they seek to measure. 
 
Across primary prevention and management of carious lesion studies, the most 
commonly investigated outcome domains were “clinical performance of the 
restoration” (assessed by the researcher or clinician) and “caries experience” following 
an intervention.  Combined, these areas accounted for 74% of primary outcomes and 
for 61% of all reported outcomes. However, the use of these domains appears to be 
reducing as a proportion of all reported outcomes with pulpal health related and 
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economic outcomes appearing to be assessed more frequently. This reflects the 
development of, and interest in, minimally invasive approaches to lesion management 
and interest in cost/benefit balance in resource-limited healthcare settings. 
 
The analysis of carious lesion management focused papers demonstrated that “clinical 
performance of the restoration” is the main method of measuring the outcomes of 
treatment in these trials. This highlights the operative focus of such trials, with the 
performance of the technology, rather than the biology, as the priority. Typically, this 
was measured as a simple survival rate or using the USPHS (United States Public Health 
Service) guidelines developed from 1964 and published by Jack Cvar and Gunnar Ryge 
in 1971 (203, 204). These are sometimes called “Ryge Criteria” in the literature. This 
was developed using a primitive consensus methodology in the Materials and 
Technology Branch, Division of Dental Health within the USPHS Hospital in San 
Francisco. They prioritised what should be assessed for appraisal of the success of 
restorative materials. In this respect, I believe, they could be one of the earliest 
examples of Core Outcome Set development in Dentistry, if not in healthcare more 
broadly (204). However, these were developed at a time when the expectations of 
materials and their performance were different from today. As such, criteria for 
restoration “success” should perhaps be revisited. The Ryge criteria was frequently 
utilised to describe the clinical attributes and performance of restorative materials 
used in the management of carious lesions. This composite tool includes: a score for 
secondary caries which could also be categorised as “caries experience” or, in the case 
of selective caries removal “lesion activity”; and marginal discolouration, which could 
be considered an aesthetic outcome.  Throughout the process of outcome 
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categorisation, we made consensus-led, clear decisions over how to categorise these 
outcomes into domains, aiming to be clear and consistent. 
 
In most cases, the “caries experience” domain was measured using DMFT, DMFS or 
similar index. Developed by Klein, Palmer and Knutson in 1938, this index has a long 
history of use (205). However, it has been criticised for inherent problems such as 
giving equal weight to missing teeth, untreated lesions at different stages of clinical 
progression, and successfully restored teeth (205). As carious lesion management trials 
focus more on biological control of a lesion rather than operative removal and 
restoration, knowing the caries rate and progression could be important. However, the 
principle method of measuring this outcome (DMFT etc.) is of limited value in this 
respect. The ICDAS II (International Caries Detection and Assessment System) tool has 
been developed to overcome some of the problems with DMFT and others, whilst 
retaining compatibility with these tools to allow synthesis with historic papers (40). 
The DMFT index is often used to describe ongoing caries experience. That is, signs of 
disease experience at the patient level. The components of DMFT are potentially 
individual outcome domains which are not only dependent upon the caries process. 
For example, a missing tooth (M) might not have been lost due to caries. It is surprising 
that tooth survival was never reported as a standalone outcome; that is, apart from its 
inclusion within a composite measure e.g. DMFT. In some cases, the components of 
DMFT were reported individually. A filled tooth (F) may be due to caries but also non 
carious tooth surface loss, trauma or from management of a developmental defect. In 
this review, DMFT and similar indices (such as ICDAS) were assigned to the caries 
experience category.  
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There was a paucity of trials where the outcome domains were patient-focused. 
Relatively few of the outcomes related to patient satisfaction or quality of life (1%), 
anxiety or pain during treatment (5%), discomfort after treatment (2%) or cost 
effectiveness/resource use (3%). This shows that outcomes which are likely to be of 
importance to patients are often not measured at all in RCTs. Surely, this is a great 
criticism of cariology research and represents a lost opportunity to place oral health as 
a central component of general health and wellbeing. Reassuringly, patient-centered 
and patient-reported outcomes are increasingly being seen in published RCTs. There is, 
of course, still more to be done to ensure that research findings are relevant to 
decision making about clinical care. This strengthens the case for a carious lesion 
management COS which includes the patient voice, as well as other stakeholders, in 
the process. 
  
This review has highlighted the problems encountered when handling trial outcomes 
within the caries literature. For example, about one third (32%) of reports did not have 
a discernible primary outcome so it was not possible to establish what the authors 
intended the main assessment of treatment success or failure to be. Even in the 
remaining 68%, the primary outcome was often not explicitly identified, but was the 
primary focus of the report. Since the term “primary outcome” was not routinely used 
throughout the time period of the literature search, we handled this by making a 
judgement based on how focused the report was on a single outcome. This may not 
reflect an a priori primary outcome but may be a result of an emphasis being placed, 
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by the authors, on a significant result from several which were measured where the 
others were less interesting or not significant (outcome reporting bias). Therefore, our 
approach may mask outcome reporting bias. Unfortunately, there was no efficient 
method of reliably assessing outcome reporting bias, particularly for some of the older 
reports where there were no protocols and the authors no longer contactable. If there 
was ambiguity over which outcome was the focus of the paper, all reported outcomes 
were classified as secondary. Therefore, compliance with the CONSORT 
recommendations is likely to be even poorer than these results indicate. That being 
said, a proportion of the included trials predate the first CONSORT statement and so 
would not be expected to meet this reporting standard exactly. 
 
A priori trial registration, as recommended in the CONSORT statement (108), would 
inform reviewers about which outcome was the intended primary outcome, helping to 
identify, and therefore reduce, selective outcome reporting. Overall, only 6% of studies 
reported a trial registration. Even taking a recent timeframe after the publication of 
both CONSORT statements, between 2011 and 2015, only 21% of publications 
reported a trial registration. 
 
Of 605 reports, only 104 reported that a sample size calculation had been undertaken. 
Of these, only 75 (72%) related to the primary outcome.  This means that around nine 
in ten (88%) did not report a sample size calculation at all or reported one that was not 
based on the clear primary outcome. Sample size calculations are important because 
they provide a rational basis for the number of participants required for the study to 
detect important differences in outcomes between interventions at a specified level of 
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statistical confidence. Normally, the power calculation is based upon the detection of 
an important difference in the primary outcome. They are outcome specific and are a 
recommendation in the CONSORT statement, published in 2010 (108). It is 
encouraging to note that, since the revised CONSORT statement was published in 
2010, 33% of publications had a sample size calculation which related to the primary 
outcome. This is quite different to pre-CONSORT statement levels (4%). 
 
There is uncertainty about the most efficient methodology for identifying the full range 
of previously published outcomes prior to the consensus stages of COS development 
(1, 200). It has been suggested that it could be unnecessary to search multiple 
databases and that outcome saturation could be achieved by searching a sub-set of 
the literature or only relevant systematic reviews (1, 206). However, for this review, 
we searched multiple databases and extracted data from all included trials in order to 
make a broader assessment about the caries literature, including the demographics of 
the participants, the teeth investigated, the setting in which the interventions were 
delivered and how outcomes were handled and reported. We did not carry out 
duplicate data extraction as the small gains in detecting errors in outcomes being 
recoded were not proportionate with the effort within our limited resources (207). 
However, to help mitigate this risk and reduce its impact we undertook a 5% data 
check. 
 
It is common practice for researchers to publish multiple reports based on data 
collected from the same clinical trial: A phenomenon sometimes known as “salami 
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slicing” (208). This can sometimes be necessary when reporting the dataset at different 
time points, where publications are released as new follow-up data becomes available. 
However, data collected for different outcomes at the same time point are sometimes 
split across multiple publications. The complex task of linking registered protocols to 
specific reports is difficult and relies on aligning similar authorship and patient 
recruitment numbers. Even with some detective work, it is not always possible to link a 
published protocol to all subsequent reports. The task becomes even more difficult 
when trials are not registered a priori. Whilst it would be preferable to focus on each 
trial as a whole, rather than on reports, this was not an efficient use of resource and 
was likely to have a limited impact on the integrity of the data we obtained and the 
general conclusions derived from the data. 
 
At the time of completion of this review (2016), there was no pre-existing caries 
outcome classification system or general published taxonomy for outcomes (209). We 
derived the categories through an iterative process, refining it until we agreed that the 
structure captured all recorded outcomes but was not so detailed as to make it 
unusable.  The final list of outcome domains and allocation rules was achieved through 
consensus. Alternative classifications may have resulted in differences to the level of 
detail and focus of the findings. The broad scope of some of the categories may have 
resulted in unique outcomes being subsumed into larger categories. However, this was 
not a concern in the consensus process as these domains were exploded to provide 
suitable granularity for that project. Furthermore, participants involved in the COS 
development process have the opportunity to add missing outcomes as part of stage 
4(ii), Fill Gaps in Knowledge (Figure 4.1). 
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Outcomes reported in randomised controlled trials for the prevention and 
management of carious lesions have focused largely upon the performance of 
restorative materials or participant-level caries burden. Outcomes categorised as 
lesion activity, pulpal health and economic have become more commonly reported in 
RCTs. Patient-reported and patient-centred outcomes were found infrequently in trial 
reports but this seems to be changing.  
 
This systematic review identified 605 RCTs from which 1363 outcomes were identified. 
These were classified into 19 over-arching outcome categories which contained 76 
separate outcome domains. The most common categories of outcomes were “clinical 
performance of the restoration” and “caries experience”. This reflects the operative 
focus of carious lesion management trials and the frequent use of DMFT to measure 
present and historic caries experience. There is inconsistency in the use of outcomes 
and the tools used to measure them may be outdated and in need of review (e.g. 
USPHS criteria) to ensure they measure the outcome according to contemporary 
definitions.  
  
This review identified clear problems in the primary literature with respect to outcome 
reporting and consistency. It also highlighted broader concerns about the reporting of 
RCTs in cariology and its contribution to research waste. These results highlight the 
need for a carious lesion management COS. Through analysis of previously published 
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outcomes, a list of 76 unique outcomes has been compiled which forms the basis of 
the eDelphi survey reported in the next chapter.  
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Having identified existing knowledge in Chapter 4, the eDelphi process described in this 
chapter fulfils the stages 4(ii) of filling gaps in knowledge and 4(iii) eliciting views about 
important outcomes in a consensus process defined by the COMET Handbook 1.0 (1) 
(Figure 4.1). 
 
Consensus methods previously used to determine a Core Outcome Set (COS) have 
included expert panel meetings, Delphi surveys, nominal group techniques, focus 
groups, individual interviews and individual questionnaires (1, 200). For this stage of 
the study, an eDelphi method was selected as it is one of the most inclusive and 
pragmatic methods of including stakeholders from diverse settings, geographical 
locations and socioeconomic backgrounds (200, 210). Delphi methodology has gained 
widespread acceptance in the development of COS (1, 200) and has been used to 
establish a COS for several medical conditions from colorectal cancer (211) to non-
specific lower back pain (212). Although many methods have been reported in the 
literature, the most common way of achieving consensus in COS development is the 
combined use of a Delphi survey and a Nominal Group meeting (1). The nominal group 
meeting follows on from the eDelphi survey in this study and is reported in Chapter 6. 
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The Delphi method involves a series of surveys in which participants rate 
statements/outcomes according to their importance in each survey “Round”. In each 
subsequent round of the survey, they receive feedback on their own individual 
response compared to the group response in the previous round. In this way, 
participants are encouraged to reflect on their scores and change them if they wish in 
the light of group scoring. However, there is no requirement to change their scores if 
they still disagree strongly with the group.  
 
A consensus definition for statement inclusion is normally agreed a priori (e.g. 70% 
strongly agree with a statement). The scores from the first round are analysed and 
summarised in advance of Round 2. Delphi surveys also allow for “filling gaps in 
knowledge” by allowing participants to suggest new or previously unused outcomes in 
Round 1. These new statements or outcomes can then be included in the list to be 
scored by all participants in subsequent rounds. Studies differ on whether any 
outcomes are removed between rounds if they do not meet predefined consensus 
criteria (1). In Round 2 participants will see summarised results from Round 1 in what 
is described as “feedback”. The format of feedback is variable between studies and 
there is no agreement amongst COS developers on the best method (1, 213, 214). 
Work is ongoing to develop an evidence to support the selection of Delphi feedback 
methods (213, 214). In some cases, participants will be reminded of their own score 
along with either the group mean or median score for each outcome. In cases where 
there are multiple stakeholder groups, participants may see their own group mean or 
median score, groups combined or both group scores separately. Some will receive this 
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group data as a graph or chart instead of a numerical value. Delphi studies sometimes 
have a consensus definition for each survey round which becomes stricter as the 
rounds progress. That is, a higher percentage must rate it highly to be retained in 
subsequent rounds.  
 
In the past, Delphi methods were carried out using postal questionnaires. Now, 
however, online platforms are available which increase the global reach and 
engagement with the process. Delphi surveys are popular as they capture the views of 
many people whilst not allowing any individual voice to dominate unfairly. This is 
because each participant has an equal vote and they are anonymised. However, Delphi 
surveys risk reaching agreement simply by removing extreme viewpoints, rather than 
by movement of group opinion towards a true consensus. In this case, those who feel 
that their views don’t match fail to complete all survey rounds. The time taken to 
achieve consensus can be several months; allowing time for participants to complete 
the round and for the analysis in between rounds. Both issues can lead to the failure of 
participants to complete the next round of the survey. This is known as attrition. It can 
also be expressed as a retention rate (retention = 100 - % attrition). 
 
Although it is possible that the eDelphi will result in an appropriate number of 
outcomes being selected for the final COS, the authors of the COMET Handbook 1.0 
are unequivocal in their recommendation that a face to face meeting is held after the 
online survey (1). In some cases, this is necessary in order to achieve consensus on a 
smaller number of outcomes than those identified as important in the Delphi survey. 
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In others, it will be to discuss the outcomes from the survey and ensure that all 
stakeholders can agree and “sign up” to the final COS. Although there is limited 
evidence about how these meetings should be conducted, the most common 
methodology used is the Nominal Group Technique (1). Patient involvement in face to 
face meetings is encouraged but the best method of involving them is uncertain and 
may depend upon the condition being discussed and the relative numbers of patients 
and professionals in attendance (1).  
 
To achieve consensus on a COS for carious lesion management effectiveness trials, two 
sequential steps in the process were defined: 
1. An international eDelphi study 
2. Face to face consensus meeting using a modified nominal group technique 
 
To work towards an agreed Core Outcome Set (COS) for effectiveness trials 
investigating interventions for the management of dental carious lesions. 
 
To carry out an international eDelphi survey to fill gaps in knowledge and to begin the 
prioritisation of outcomes by eliciting views about important outcomes. 
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To finalise the core outcome set at a face to face meeting by discussing the list of 
potentially important outcomes carried forward from the international eDelphi survey. 
This will be reported in detail in chapter 6. 
 
Research funding for the use of DelphiManager software and SHARE recruitment 
(Scottish Health Research Register) of patient participants was provided by the 
Tattersall fund within Dundee Dental School (Appendix 4). Funding was also secured 
from the same source for the face-to-face consensus meeting reported in the next 
chapter of this thesis. 
 
The east of Scotland research ethics service (EoSRES) provided confirmation that this 
project did not require NHS ethical approval (Appendix 3). Instead, the University of 
Dundee Schools of Nursing and Health Sciences and Dentistry Research Ethics 
Committee (SREC) provided institutional approval on 15th February 2017 
(Ref:2016034_Levey) (Appendix 5). Potential participants were given a participant 
information sheet (Appendices 6 and 7) and gave informed consent when they signed-
in to the online platform for the eDelphi survey.  
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The international eDelphi process used the COMET initiative DelphiManager 
(University of Liverpool) online platform specifically designed for core outcome set 
development projects (1, 215). This platform allowed for outcome prioritisation for the 
management of dental carious lesions in advance of the face to face consensus 
meeting. An email invitation provided further information to participants with details 
of how to access the platform (Appendix 8).  
 
 
The final core outcome set will be appropriate for application in effectiveness trials 
investigating interventions for the management or treatment of dental carious lesions 
in any setting. It will not be limited by age, dentition, geography or disease status. The 
COS will be relevant for preventively orientated management interventions (secondary 
prevention) such as the application of silver diamine fluoride as well as operative 
interventions such as selective caries removal and restoration. 
 
The core outcome set for the management of carious lesions COS project was 
registered on the COMET database at http://www.comet-
initiative.org/studies/details/694?result=true 
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Potentially relevant outcome domains were identified from a comprehensive 
systematic review of previously published randomised controlled trials for the 
prevention or management of dental caries or carious lesions. The methods and 
results of this are reported in the previous chapter (Chapter 4). The outcomes 
identified in this step were assigned lay and technical definitions developed for each 
domain. The outcome names and definitions were developed through consensus by 
the research team and reviewed by two non-dental members of staff at the University 
of Dundee for clarity and accuracy. These outcomes are shown in table 4.3 in the 
previous chapter. The outcomes and associated definitions are presented in Appendix 
9. 
 
There is no accepted ideal sample size for Delphi surveys given the diversity of issues 
and stakeholders that could be potentially involved (1). Neither is there an established 
means of calculating an appropriate sample size for a given project (1). In this eDelphi 
survey, participants were sought to form two stakeholder groups. 
 
• Patients 
• Clinicians and researchers 
 
Based on other eDelphi studies undertaken for COS development in dentistry we 
aimed to recruit 15 patient participants and 15 clinicians and researchers to complete 
the first round of the eDelphi survey (216). Expecting an attrition rate of up to 30%, 
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this would result in a minimum number of 20 participants to complete all rounds of the 
eDelphi. 
 
Patient participants were recruited in Scotland using the Scottish Health Research 
Register (SHARE). This NHS Research Scotland initiative is a managed register of 
patients in Scotland who are willing to be contacted about research projects which 
they may be eligible to take part in. These projects can range from participation in a 
clinical trial, attendance at meetings to completion of questionnaires or surveys. 
SHARE staff identified patient participants from this register resident in Scotland who 
were 18 years or over, literate and who had access to the internet. Initially, 
prospective participants were contacted by the SHARE team who provided information 
about the project and gained consent to share their contact details with the study 
team. These details were accessed via a safe haven by the study team and email 
invitations were sent out to potential participants. The emails included the study 
patient participant information sheet (Appendices 6, 7 and 8). 
 
Participants were recruited from a variety of sources to ensure that this broad group 
were well represented. Clinical dentists, dental therapists, public health dentists, 
clinical academics and oral health researchers were all potential participants. The 
Scottish Dental Practice Based Research Network (SDPBRN) advertised the study via 
email and this was advertised via Scottish Dental. The Dental Elf published details of 
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the study online and through social media. The Centre for Evidence Based Dentistry 
published details of the study on their website. Cochrane oral health published details 
on its website and advertised via social media. Members of the British Dental 
Association were contacted via a news item in the British Dental Journal (217). The 
Cariology group of the International Association for Dental Research contacted its 
members by email regarding the study. The Lead Researcher (Colin Levey) also 
addressed the opening session of The European Organisation for Caries Research 
(ORCA) meeting in Copenhagen in June 2018, explaining the rationale and protocol for 
the study and inviting members to participate. Authors of the position papers on the 
European and American Cariology curricula were contacted directly by email as were 
the “Global expert panel” of the Alliance for a Cavity Free Future (ACFF). All those 
contacted were encouraged to share the invitation with interested colleagues.  
 
Once willingness to participate was confirmed by the study lead, the participants were 
sent a weblink to access the online eDelphi platform (DelphiManager). The weblink led 
to a homepage for the study which contained a further explanation of the study 
rationale, aims and design (Appendix 10). This ensured that all participants had had the 
opportunity to read the study protocol in detail before enrolling in the eDelphi. Upon 
registration, demographic details were requested about country of residence or 
practice, role description, years of clinical experience, previous participation in Delphi 
methods and how they heard about the study.  
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Outcomes were presented with both their lay and technical definitions. Participants 
were asked to score each outcome using the scale proposed by the GRADE working 
group (www.gradeworkinggroup.org) in which 1-3 signifies an outcome of “not at all 
important”, 4-6 “important but not critical”, and 7-9 “critical” . Participants could 
provide reasons for their scoring in free text boxes if they wanted to. 
 
Panel members were permitted to suggest additional outcomes to be included in the 
next round of the eDelphi process. In doing so, step 4(ii) of the COS development 
process outlined by COMET, Filling gaps in Knowledge (Figure 4.1), was included in the 
project (1). To be included in subsequent rounds, new outcomes had to be identified 
as missing by at least two participants. Items suggested using different terms but the 
same meaning by more than one panel member were allocated a single term and 
definition before being added to the list for the subsequent round. These criteria were 
agreed a priori. Participants were informed of this threshold for inclusion in advance of 
Round 1 of the survey. Before the first round closed, reminders were sent to 
individuals who had expressed interest in participating but who had not yet registered 
or completed the survey. At the close of Round 1, additional outcomes were 
deduplicated and common definitions agreed by two members of the study team (CL 
and DNJR).  
 
Participants who completed Round 1 were invited to complete the second round. 
Round 1 responses were summarised by stakeholder group using histograms 
generated using the statistical programming language, “R” (R: A language and 
environment for statistical computing. R Foundation for Statistical Computing, Vienna, 
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Austria. URL https://www.R-project.org/.). These two histograms were displayed to 
every participant for each outcome scored by the groups in Round 1. In addition to the 
histograms, participants were reminded of how they scored the outcome in the 
previous round. They were invited to rescore each outcome considering the overall 
responses of the group. There was no obligation to change their score if they did not 
change their opinion. Three rounds of eDelphi were planned assuming that the scores 
between rounds changed and moved towards consensus. If the scoring of outcomes 
was stable, or a list of between three and seven outcomes met the criteria after Round 
2, then the survey would be stopped after the second round. Regular email reminders 
were sent to participants who completed Round 1 while Round 2 of the survey was 
open. 
 
Data were extracted directly from the DelphiManager online platform and analysed in 
SPSS (IBM Corp., Armonk, N.Y., USA) and Microsoft Excel (Microsoft Corporation, 
Redmond, WA, USA). For each outcome, the scores were categorised as “not important 
at all” (0-3), “important but not critical” (4-6), and “critical” (7-9). The distribution of 
scores between these groups was expressed as a percentage and compared against 
the thresholds for inclusion defined a priori.  The statistical programming language, R, 
was used to produce histograms used in Round 2 which displayed the distribution of 
scores (0-9 scale) in each stakeholder group back to all participants. An example of 
such a histogram is shown in Figure 5.1.  
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This histogram shows a summary of Round 1 data as it was presented back to participants in Round 
2 for each outcome using “cost of treatment to patient” as an example. 
 
“Stability Scores” were calculated for individual participants and individual outcomes 
as post-hoc analysis after the close of Round 2. This was measured by calculating the 
mean scores in each round for each individual across all outcomes and each outcome 
across all participants. Potentially important changes would be identified by larger 
numbers indicating larger changes in mean scores between Round 1 and Round 2.  
 
Recruitment of patients via SHARE began on 28/06/2018 and professionals were 
recruited from 18/6/2018. Recruitment closed at the end of Round 1 on 11/08/2018.  
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SHARE contacted patient participants by phone using an agreed script (Appendix 11) 
and a total of 74 agreed to be contacted by the study lead and take part in the survey. 
After detailed information was given to these participants, three declined any further 
involvement. Of the remaining 71, a total of 32 registered for the survey and 21 went 
on to complete Round 1.  
 
It is impossible to estimate the number of professionals who received an invitation to 
participate in the study as many were contacted by group email, social media or in the 
dental press. A total of 70 professionals registered and 67 completed Round 1.  
 
A total of 88 participants completed Round 1 of the eDelphi survey from a possible 102 
who registered for the survey via DelphiManager. 
 
All patient participants were resident in the United Kingdom. The age distribution is 
shown in Figure 5.2. One patient was aged 18-30 (5%), eight were aged 31-45 (38%), 
eleven were aged 46-70 (52%) and one was aged over 70 (5%). Ten patients were male 
(48%) and eleven were female (52%).  
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Age demographics for patient participants who completed Round 1 of the eDelphi survey.  
 
From the 67 dental professionals who completed Round 1, 34 were from Europe 
(51%), 12 were from North America (18%), nine were from South America (13%), five 
were from Asia (7%), two were from the Middle East (3%), three were from Africa (4%) 
and two from Australasia (3%).  
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Demographics for participants who completed Round 1. Europe 51%, North America 18%, South 
America 13%, Asia 7%, Middle East 3%, Africa 4% and Australasia 3%. 
 
Years of clinical experience are shown in Figure 5.3. The number of years of 
professional experience varied with five (7%) having <6 years, eleven (16%) 6-10 years, 
nine (13%) 11-15 years, nine (13%) 16-20 years, fourteen (21%) 21-25 years, three (4%) 
26-30 years, six (9%) 31-35 years and ten (15%) >35 years.  
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Dental Professionals were asked to self-select a term which best described their role: 
20 Dentists (30%), two Dental Care Professionals (DCP) (3%), 31 Clinical academics 
(46%), and 13 Researchers (19%). One participant categorised themselves as “other” 
but did not provide any further information. This is shown in figure 5.5. 
 
 
Professional role for participants who completed Round 1 of the eDelphi survey 
 
The first round of the eDelphi survey was closed on 11/08/2018 with 21 patients and 
67 clinicians and researchers having completed the survey. Each stakeholder groups’ 
results were analysed as separate groups and presented as such. The data was 
analysed and 152 histograms in 76 image files generated for Round 2. Figure 5.1 shows 
an example of a histogram image file. 
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Participants could suggest additional outcomes to go forward to Round 2 if they were 
considered to be “missing”. Twenty suggestions were made by ten participants. All 
suggestions were made by dental professionals or researchers. The list of outcomes 
was assessed and deduplicated by two researchers (CL and DNJR). Most of the 
suggestions were either not considered to be an outcome (55%) or could be 
considered a component part of an already included outcome domain (25%). Four of 
the 20 suggestions (20%) were part of the same, new outcome domain. These were 
combined into a new outcome termed “lesion activity”. Although this domain could 
include several previously included domains, it was agreed to add this as a wider 
concept used in the assessment of disease stabilisation. A full list of suggested 
outcomes is presented in table 5.1.  
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Suggested Outcome as 
stated by participant 
Added 
to list? 
New 
outcome 
name 
Reason for exclusion 
Environmental impact of 
material 
No 
  
Not an outcome 
Ease or difficulty of 
interpreting radiographs 
of the restoration 
No 
  Not an outcome but it influences estimates of 
other included outcomes  e.g. caries 
progression 
Compatibility with other 
materials 
No 
  Not an outcome but may influence other 
included outcomes such as restoration 
survival 
Pulpal damage caused by 
placing of restoration 
No 
  Already included under "pulp health related 
outcomes". It would be impossible to 
attribute pulp damage to restoration 
placement alone. 
Stability of material before 
use (use by date) 
No 
  
Not an outcome 
Documented caries risk 
assessment 
No 
  
Not an outcome 
Procedure which does not 
require local anaesthetic 
No 
  Not an outcome but may influence 
acceptability of intervention to patients 
Lesion stable on 
radiograph 
Yes 
Lesion 
activity 
  
Prospect of having the 
same procedure done 
again (e.g. on another 
tooth) acceptable to 
patient (child/anxious/..) 
No 
  
Already included under "reaction to 
treatment". Related to aspects of 
acceptability.  
Biocompatible restoration No 
  Not an outcome but indirectly has an effect 
on pulpal health outcomes 
Comparing dental heath 
and general health 
No 
  
Not an outcome 
Calculating Utilities for 
dental health 
No 
  
Not an outcome 
Lesion arrest Yes 
Lesion 
activity 
  
Is the patient suitable for 
the preferred treatment ie 
are they too anxious; not 
well enough motivated etc 
No 
  
Not an outcome. Related to conduct of the 
trial 
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Does the patient or 
guardian have an 
understanding required to 
make an informed choice 
of treatment  and options 
available  
No 
  
Not an outcome 
The activity of an enamel 
carious lesions 
Yes 
Lesion 
activity 
  
Caries arrestment Yes 
Lesion 
activity 
  
Caries reversal No 
  Already included under remineralisation of 
the lesion 
Tooth loss (on a patient 
level) 
No 
  
Already included under tooth survival 
Adverse effects /risks No 
  Already included under tooth loss, fluorosis, 
pulpal pathology. 
 
Only one new outcome, Lesion activity, was taken forward to Round 2 of the survey. This table 
outlines the rationale for the decisions made by the research team. 
 
During Round 1, participants were invited to comment on individual outcomes as well 
as the list as a whole. This included feedback which suggested that several participants 
found it challenging to interpret or understand the outcomes. One patient said “The 
questions are a little confusing….half of the things seem more knowledge based (such 
as pH, Bacteria etc.); I don’t really know how important they are – if my dentist tells me 
they’re important, then I’d treat them as important.” Another patient questioned how 
patient-focused the survey was by saying “Seems to be more directed at dental 
professionals than patients. Very few questions I could answer with any degree of 
certainty”. These comments perhaps reflect the fact that previously reported 
outcomes tend not to be patient reported or patient focused or represent technical 
aspects of disease progression and presentation. 
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Some of the members of the Professionals group expressed concern about the 
terminology used in the survey. One clinician said “I think we may have different 
definitions of the word treatment with respect to caries. I am unsure what you mean by 
the word treatment in your survey. For me restorations are NOT a caries treatment; 
caries treatments are the non-operative caries control measures such as improving 
cleaning, dietary advice and the use of fluoride; especially in toothpaste – in your letter 
you mention secondary prevention. What do you mean?” Another clinician was unsure 
if they were answering for themselves or on behalf of patients, saying “My main 
comment is about the question asked. Determining the importance of the outcomes 
from whose perspective? In my particular case; I focused on what I can consider 
patient-important outcomes. Not sure others would do that…I am always amazed by 
experts favouring surrogate outcomes to make decisions instead of patient-important 
ones.”  
 
Round 2 of the eDelphi opened on 03/09/2018 and closed on 29/09/18. A total of 57 
participants completed this round; nine patients and 48 clinicians and researchers. This 
represents an overall retention rate of 65% with poorer retention amongst the patient 
group than the professional group (43% and 72% respectively). Reminder emails were 
sent regularly during the time that the second round was open. The survey results, by 
stakeholder group, are shown in Table 5.2. The patient group considered outcomes to 
be “critical” more frequently than the professional group (clinicians and researchers). 
Only four outcomes were considered to be critical by the professional group only.  
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Green: meets consensus (70%) threshold in both groups.  
Yellow: consensus criteria met in professionals’ group only.  
Blue: consensus criteria met in the patient group only. 
Outcome 
Percentage scoring 
outcomes as "critical" 
Professionals Patients 
Abrasion or wear resistance of the restoration 27.1 60.0 
Abscess development (Apical infection) after treatment of caries 100.0 100.0 
Anatomic contour of the restoration 14.3 55.6 
Anxiety during treatment for dental caries 50.0 66.7 
Attendance at dentist after treatment 58.3 88.9 
Attitude of Health Care Professional to process 68.8 100.0 
Attitude to oral health 70.8 100.0 
Bacterial count from the lesion 12.5 55.6 
Bacterial count in saliva 10.4 22.2 
Bacterial species from the lesion 10.4 66.7 
Bacterial species in saliva 12.5 44.4 
Barriers to implementing technique or procedure 66.7 77.8 
Bond strength between the restoration and the surrounding tooth 64.6 77.8 
buffering capacity of saliva in the mouth 29.2 62.5 
Caries increment 95.8 77.8 
Carious pulp exposure during treatment of caries 91.7 100.0 
Cavitation of the carious lesion 89.4 88.9 
Cavosurface marginal discolouration of the restoration 12.2 66.7 
Colour match of the restoration to natural tooth 12.2 77.8 
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Outcome 
Percentage scoring 
outcomes as "critical" 
Professionals Patients 
Compliance with self care regime 72.9 88.9 
Cost of treatment to healthcare provider 51.1 33.3 
Cost of treatment to patient 47.9 44.4 
Cost-effectiveness of caries treatment 70.2 55.6 
Depth of a carious lesion 79.2 88.9 
Depth of bacterial invasion within a carious lesion 56.3 88.9 
Dietary sugars consumed after treatment 56.3 55.6 
Discomfort during treatment of caries 56.3 44.4 
Fluoride levels in tooth tissue 12.5 87.5 
Fluorosis resulting from treatment of dental caries 34.0 37.5 
Gingival bleeding levels 52.1 88.9 
Gross fracture of the restoration 77.1 60.0 
Handling characteristics of material or technique 62.5 77.8 
Interdental cleaning performed by the patient after treatment 47.9 66.7 
Irreversible pulpitis following treatment of caries 100.0 100.0 
Knowledge about caries 52.1 88.9 
Knowledge about caries prevention 64.6 100.0 
Lesion activity 82.2 50.0 
Marginal integrity of the restoration 71.4 70.0 
Neurophysiological changes following treatment of dental caries 54.5 100.0 
New caries adjacent to the restoration 93.8 87.5 
Non carious pulp exposure during treatment 83.3 100.0 
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Outcome 
Percentage scoring 
outcomes as "critical" 
Professionals Patients 
Objective assessment of patient behaviour during treatment  35.4 66.7 
Oral comfort following treatment of dental caries 63.8 77.8 
Oral function following treatment of dental caries 83.0 100.0 
Oral health beliefs 64.6 100.0 
Pain during treatment of caries 70.8 77.8 
Patient (or guardian) satisfaction with treatment 75.0 88.9 
Periapical periodontitis development after treatment of caries 97.9 100.0 
Periodontal health 52.1 100.0 
pH of saliva in the mouth 18.8 55.6 
Planned treatment completed - compliance during procedure 62.5 88.9 
Plaque levels 50.0 100.0 
Post operative discomfort 43.8 66.7 
Post operative pain 60.4 77.8 
Pulp necrosis after treatment of caries 100.0 100.0 
Quality of life after treatment for dental caries 83.0 100.0 
Remineralisation of the carious lesion 77.1 100.0 
Restoration replacement 79.2 70.0 
Reversible pulpitis following treatment of caries 70.8 100.0 
Service utilisation 36.4 77.8 
Subjective experience of the experience of treatment 31.3 77.8 
Subjective view of appearance after treatment - operator 27.1 33.3 
Subjective view of appearance after treatment - patient 77.1 66.7 
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Outcome 
Percentage scoring 
outcomes as "critical" 
Professionals Patients 
Surface area of a carious lesion 45.8 55.6 
Surface colour of the carious lesion 31.3 55.6 
Surface roughness of the restoration 22.4 55.6 
Surface texture of the carious lesion 64.6 66.7 
Survival of restoration 95.8 90.0 
Systemic side effects of treatment of dental caries 62.2 100.0 
The pH of plaque adjacent to the lesion being treated 25.0 55.6 
Time to complete the treatment procedure 54.2 55.6 
Tooth surface survival 89.4 100.0 
Tooth survival following treatment of tooth decay 100.0 100.0 
Toothbrushing behaviour after treatment 72.9 88.9 
Total cost of treatment of caries 51.1 44.4 
Treatment time - duration of treatment plan 25.0 44.4 
Willingness to pay for the treatment 51.1 33.3 
 
The stability of participant scores between rounds was calculated as a post hoc analysis 
for each outcome as well as each participant using methods previously reported 
elsewhere (216, 218). The mean score for each participant and each outcome from 
Round 1 was compared with the mean scores from Round 2. These analyses are shown 
in Tables 5.3, 5.4 and 5.5. The mean score from Round 1 was subtracted from the 
Round 2 score to demonstrate the degree to which opinion was changing between 
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rounds of the eDelphi. These results show that the average score changes amongst 
participants fell mostly within 0.6 points (on a scale of 0-9) with three outliers 
(OUTMA00074, OUTMA00071, OUTMA00073). The differences per outcome domain 
were all less than one point in the clinicians and researchers’ group, with only two 
outcomes (“Fluoride levels in tooth tissue” and “remineralisation of the carious 
lesion”) changing by more than one point amongst the patient group. A positive value 
in these scores indicates an increase in the score given, reflecting movement towards 
“critical” on the GRADE scale (7-9). A negative value indicates a drop in the score, 
reflecting a move towards being “not important” (1-3). Overall, the changes were small 
and well within three points required to change boundaries between “critical”, 
“important but not critical” and “not important” categories.  
 
Patient Participant Stability Scores 
User ID Difference in means 
OUTMA00074 1.84 
OUTMA00071 0.95 
OUTMA00096 0.37 
OUTMA00105 0.08 
OUTMA00059 -0.07 
OUTMA00021 -0.10 
OUTMA00022 -0.10 
OUTMA00068 -0.13 
OUTMA00046 -0.57 
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Professional Participant Stability Scores 
User ID Difference in means  User ID Difference in means  
OUTMA00073 1.29 OUTMA00103 0.11 
OUTMA00060 0.55 OUTMA00005 0.07 
OUTMA00094 0.54 OUTMA00078 0.07 
OUTMA00104 0.54 OUTMA00034 0.07 
OUTMA00042 0.50 OUTMA00053 0.06 
OUTMA00067 0.49 OUTMA00049 0.05 
OUTMA00030 0.42 OUTMA00008 0.03 
OUTMA00041 0.42 OUTMA00007 0.01 
OUTMA00002 0.33 OUTMA00106 0.01 
OUTMA00011 0.33 OUTMA00012 0.00 
OUTMA00093 0.32 OUTMA00085 -0.01 
OUTMA00015 0.32 OUTMA00098 -0.03 
OUTMA00069 0.29 OUTMA00084 -0.04 
OUTMA00107 0.28 OUTMA00076 -0.04 
OUTMA00025 0.28 OUTMA00077 -0.05 
OUTMA00057 0.27 OUTMA00039 -0.07 
OUTMA00088 0.21 OUTMA00003 -0.11 
OUTMA00028 0.21 OUTMA00090 -0.12 
OUTMA00080 0.20 OUTMA00027 -0.14 
OUTMA00040 0.17 OUTMA00013 -0.35 
OUTMA00033 0.15 OUTMA00017 -0.39 
OUTMA00036 0.15 OUTMA00038 -0.44 
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Professional Participant Stability Scores 
User ID Difference in means  User ID Difference in means  
OUTMA00089 0.13 OUTMA00047 -0.48 
OUTMA00083 0.13 OUTMA00009 -1.45 
 
Combined results for patients and professional groups. Lesion activity was only included in round 2 
so there is no stability score for that outcome. 
Outcome 
difference in means  
Professionals Patients 
Abrasion or wear resistance of the restoration 0.08 -0.50 
Abscess development (Apical infection)  0.38 0.37 
Anatomic contour of the restoration -0.27 0.06 
Anxiety during treatment for dental caries -0.18 0.02 
Attendance at dentist after treatment -0.02 0.43 
Attitude of Health Care Professional to process 0.11 0.28 
Attitude to oral health 0.16 0.71 
Bacterial count from the lesion -0.59 -0.09 
Bacterial count in saliva -0.55 -0.61 
Bacterial species from the lesion -0.55 -0.04 
Bacterial species in saliva -0.45 0.02 
Barriers to implementing technique or procedure 0.04 0.22 
Bond strength between the restoration and the  tooth -0.01 -0.57 
buffering capacity of saliva in the mouth -0.28 0.08 
Caries increment 0.26 -0.39 
178 
 
 
Outcome 
difference in means  
Professionals Patients 
Carious pulp exposure during treatment of caries 0.16 0.09 
Cavitation of the carious lesion 0.42 0.45 
Cavosurface marginal discolouration of the restoration -0.22 -0.12 
Colour match of the restoration to natural tooth -0.09 0.24 
Compliance with self-care regime 0.15 0.66 
Cost of treatment to healthcare provider -0.13 -0.39 
Cost of treatment to patient -0.06 -0.35 
Cost-effectiveness of caries treatment 0.02 0.02 
Depth of a carious lesion 0.14 0.34 
Depth of bacterial invasion within a carious lesion -0.17 0.25 
Dietary sugars consumed after treatment -0.18 0.29 
Discomfort during treatment of caries 0.12 -0.57 
Fluoride levels in tooth tissue -0.37 1.00 
Fluorosis resulting from treatment of dental caries -0.14 0.11 
Gingival bleeding levels -0.08 -0.01 
Gross fracture of the restoration 0.20 -0.72 
Handling characteristics of material or technique 0.03 0.22 
Interdental cleaning performed by the patient  0.08 -0.01 
Irreversible pulpitis following treatment of caries 0.31 0.18 
Knowledge about caries -0.02 0.23 
Knowledge about caries prevention 0.00 0.63 
Lesion activity na na 
Marginal integrity of the restoration -0.07 -0.01 
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Outcome 
difference in means  
Professionals Patients 
Neurophysiological changes following treatment -0.13 0.24 
New caries adjacent to the restoration 0.32 0.25 
Non carious pulp exposure during treatment 0.12 0.33 
Objective assessment of patient behaviour during treatment -0.36 0.44 
Oral comfort following treatment of dental caries -0.16 0.01 
Oral function following treatment of dental caries 0.08 0.15 
Oral health beliefs -0.05 0.93 
Pain during treatment of caries 0.01 0.08 
Patient (or guardian) satisfaction with treatment -0.07 -0.04 
Periapical periodontitis development  0.42 0.63 
Periodontal health 0.06 0.28 
pH of saliva in the mouth -0.59 0.11 
Planned treatment completed - compliance during procedure -0.04 0.53 
Plaque levels -0.26 0.91 
Post-operative discomfort 0.06 0.03 
Post-operative pain 0.01 0.06 
Pulp necrosis after treatment of caries 0.33 0.58 
Quality of life after treatment for dental caries 0.07 0.37 
Remineralisation of the carious lesion 0.08 1.03 
Restoration replacement 0.12 -0.31 
Reversible pulpitis following treatment of caries -0.16 0.56 
Service utilisation -0.21 0.47 
Subjective experience of the experience of treatment -0.31 -0.06 
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Outcome 
difference in means  
Professionals Patients 
Subjective view of appearance after treatment - operator -0.10 -0.28 
Subjective view of appearance after treatment - patient 0.04 0.17 
Surface area of a carious lesion -0.35 -0.44 
Surface colour of the carious lesion -0.03 -0.27 
Surface roughness of the restoration 0.06 -0.35 
Surface texture of the carious lesion -0.04 0.53 
Survival of restoration 0.09 0.15 
Systemic side effects of treatment of dental caries -0.15 0.16 
The pH of plaque adjacent to the lesion being treated -0.63 0.45 
Time to complete the treatment procedure -0.06 -0.44 
Tooth surface survival 0.10 0.54 
Tooth survival following treatment of tooth decay 0.40 0.38 
Tooth brushing behaviour after treatment 0.09 0.34 
Total cost of treatment of caries -0.18 -0.35 
Treatment time - duration of treatment plan -0.41 -0.67 
Willingness to pay for the treatment -0.11 -0.57 
 
At the outset of the eDelphi, 76 outcomes were included based on previously 
published RCTs (Chapter 4). At the end of Round 1 of the survey an additional outcome 
was added to so that 77 were considered in the Round 2 of the survey. All outcomes 
were carried through from Round 1 to Round 2. This resulted in 24 unique outcomes 
meeting the a priori consensus definition. These outcomes were eligible to be taken 
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forward for discussion at the face-to-face meeting reported in Chapter 6. This is shown 
in Figure 5.6. 
 
There have been relatively few consensus method-based attempts to harmonise 
outcome choice for clinical trials in dentistry (124, 201, 216, 219). Indeed, this is the 
first for any aspect of dental caries that has involved dentists, researchers and patients 
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in a shared process towards consensus. The eDelphi method was selected for two 
principle reasons. Firstly, it would allow global input in the consensus process, 
broadening the applicability of the COS and raising the profile of the project at an 
international level (1, 210). Secondly, the online platform selected has been specifically 
designed for core outcome set development and was a more efficient way of 
summarising rounds and providing feedback (215). Conventional postal versions are 
more time consuming and data processing is not automated. Unfortunately, the 
software is not able to generate the histograms used to provide feedback and so these 
had to be generated using a separate programme and uploaded individually for each 
outcome domain. This increased the time between the closure of round 1 and the 
opening of round 2. 
 
The scope of the COS was broad in that it would relate to any intervention that was 
used with the aim of managing an existing carious lesion. There is great overlap 
between the prevention and management of dental caries with terminology like 
“caries control” and “prevention” being used to describe interventions which prevent 
new lesions developing as well as arresting those lesions already present (27, 28). 
However, there are several operative interventions that would not be employed in 
prevention studies e.g. placement of a restoration. Part of the management strategy 
for an established carious lesion might be to improve biofilm control and to increase 
the availability of fluoride in the oral environment using toothpaste or professionally 
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applied varnishes. Sometimes the term “secondary prevention” is used to describe the 
application of a prevention-based strategy to an already established carious lesion. 
Another phrase often used for this is “caries control” (27, 28). As the scope of the COS 
was for the management of clinically detectable carious lesion, this would include 
conventional operative or invasive interventions (e.g. a filling or restoration) as well as 
minimally or non-invasive treatments (e.g. secondary prevention). Other researchers 
may have elected to include primary prevention in an overall COS for dental caries. 
This could be focused on “caries control” using its broadest definition. Indeed, the 
overlap between prevention and treatment of lesions was highlighted in the 
comments from one participant. In our view, this would have limited the applicability 
of the COS as the scope would be too broad to be useful. 
 
The stages of a carious lesion from initial enamel changes through to deep dentine 
caries were also included in the broad scope, as were permanent and deciduous teeth. 
We considered the inclusion of both primary and permanent teeth appropriate 
because the interventions are often similar, as are the fundamental hard tissues and 
the biofilm, involved. Whilst differences exist, these were considered to have minimal 
impact upon the eventual COS due to significant commonality. It would also simplify 
the conduct of trials involving the mixed dentition if the outcomes were harmonised. 
An argument also exists for narrowing the COS to cover only operative management 
interventions or to limit it to specific stages of the disease (e.g. dentine carious lesions 
only). In the example of placing limitations on interventions, there is a risk that this 
would emphasise the operative management of caries over preventive approaches 
which is inconsistent with our current understanding of the disease process and the 
184 
 
 
concept of minimal intervention (MI) dentistry (60). There may also be problems 
applying the COS if novel interventions, yet unknown, fall outside the planned scope. 
In the case of separating different stages of a clinically detectable lesion, there is some 
justification for separating enamel and dentine carious lesions, or cavitated and non-
cavitated lesions. However, there are problems identifying the exact point of transition 
in these scenarios. Furthermore, patient priorities were considered to be more global 
and that combining them might result in a high-level COS which might encourage 
researchers to move towards effectiveness type trials rather than narrow efficacy 
trials. 
 
The importance of patient and public involvement in research is gaining traction 
amongst the research community. It is no longer considered appropriate to be 
ignorant of the views of people with lived experience of the disease being studied. It 
was for that reason that we worked with public partners in the development of the 
outcome definitions and with patients in the eDelphi itself (220). Therefore, the non-
professional voice was considered throughout the project.  
 
Patient participant ages ranged from age 30 to 74 which covers a broad range of adult 
ages but was heavily weighted towards the patients in their late 40s to late 60s. This 
may reflect the fact that this generation have had more dental care and have had 
higher rates of disease than younger patients (52, 53). This may also make them more 
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willing to take part in a project designed to improve the quality of associated research. 
It is perhaps a fair criticism of this project that no children were included in the 
consensus exercise despite the COS extending to include children and the primary 
dentition. The decision was made to exclude children from the sample for several 
reasons. Firstly, the methodology required to capture the views of the child would be 
different and the best methods for engaging children in a consensus exercise are still in 
development. In most cases, children and adults do not participate in the same survey 
or face to face meeting. This presents challenges when combining the results either 
before or after the consensus meeting. Where there is a combined meeting, it is often 
parents of affected children that participate rather than the patients themselves (221, 
222). It would have required additional resource to undertake separate surveys and/or 
meetings and this was not available for this study.  
 
The gender balance between male and female was even with 10 males and 11 females 
completing Round 1 of the survey.  
 
There was good global representation amongst the professional group with 
participants from Africa, Asia, Australasia, Europe, North and South America taking 
part. As might be expected from a UK-based study, a skew towards Europe was 
evident. This could be explained by the routes for publicising the survey being through 
organisations based in the UK or Europe. Those outside of Europe heard about the 
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study from three main sources: IADR Cariology group email, ORCA conference and the 
tweets of the Dental Elf. One participant from North America heard about the study 
via Cochrane. There was good representation from professionals with a range of years 
of post-qualification experience. This was relatively evenly distributed. Dentists, DCPs 
and researchers were all represented with a predominance of dentists and clinical 
academics.  
 
During the first round of the survey, participants were given the opportunity to suggest 
outcomes which they felt were missing from the list of outcomes derived from the 
systematic review. This was an important opportunity to add potentially relevant 
outcomes which had not been reported before. There were no restrictions set on the 
number, type and level of outcome that could be suggested by participants. A total of 
20 outcomes were suggested by ten participants. All participants who suggested new 
outcomes scored them as either “very important” (n= 16) or “important” (n=4). None 
of the new outcomes were suggested by patients. It is not clear if this means that all 
patient-important outcomes had been identified in the systematic review, or if 
patients felt disinclined to suggest outcomes for other reasons, for example, being 
unsure about what exactly a trial outcome is, or if the definitions were confusing or 
unclear. Several of the suggestions made by professionals were not outcomes but 
rather demographic details of participants which should be reported or types of 
interventions that should be compared. This raises the question as to how clearly 
participants understood the concept of an outcome domain.  
 
187 
 
 
The eDelphi methodology is an accepted method of developing consensus from a 
geographically dispersed group of people. It is an easy way of identifying outcomes 
which are not important as well as those which are potentially very important. The 
design of the eDelphi, including stakeholder feedback between rounds, is intended to 
develop consensus by encouraging participants to change their score in response to 
the group opinion. However, consensus only emerges if people change their score 
towards the group norm, rather than away from it. In some cases, the second-round 
scoring indicated a move away from consensus. For this reason, stability scores have 
been calculated to assess the extent to which people modify their scores between 
rounds (216, 218). If the stability scores are low, then further eDelphi rounds are 
unlikely to bring the group closer to consensus. If they are positive, then it is likely that 
further rounds will result in more, rather than fewer, outcomes being eligible for 
inclusion in the COS. The stability scores were calculated for each outcome and each 
participant. Differences in means scores between rounds in the range -1 to 1 were 
considered to indicate relative stability. In this study, mean differences in scoring were 
low and so a third round of the survey was considered unlikely to be of benefit and a 
waste of research resources. 
 
A common problem with the Delphi method, whether paper based or electronic, is the 
issue of participant retention between rounds. The concern with poor retention is that 
those with extreme views do not complete the round because they believe their views 
are not reflected in the survey results. Therefore, high attrition rates (i.e. low retention 
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rates) could allow overestimation of the degree of true consensus in the group. 
Another reason for poor retention rates is that participants find the survey confusing, 
too time consuming or boring. This study had many outcomes which could have been 
confusing, boring or too laborious for some participants to sift through (223). This view 
is perhaps reinforced by the fact that a number of people registered for the survey but 
did not complete any round (three professionals and eleven patients). This may 
indicate a reluctance to engage after appreciating the length or complexity of the 
survey. As the rounds progressed, the retention rate for patients was lower than for 
professionals suggesting that there may have been additional barriers for that group. 
This is perhaps reinforced by patient participants being more likely to mark an 
outcome as “not applicable” and provide no score for the outcome. This may indicate 
confusion about the outcome or its definition. Retention rates vary widely in COS 
development studies, with 19.5% to 87.1% retention reported in the literature (212, 
224-232). This is one of the significant problems with an eDelphi method, but this has 
been balanced against the benefits of using such an approach as outlined earlier in this 
chapter. There is evidence that lower retention rates are associated with a large 
number of outcomes to score as well as large panels of participants (223, 230). This 
eDelphi had many items to score which could account for the lower retention rates. 
The authors of the response rate analysis paper suggest that large panel sizes are 
associated with general calls for participants using email lists, widely distributed 
adverts and websites and that this reduces the investment of participants in the study 
(223). In our study, the patient panel was the smallest and all had been directly 
approached by the study team whilst the professional group was larger. Contrary to 
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the analysis undertaken by Gargon et al, the smaller, patient panel had the poorest 
retention rate in this eDelphi (223).   
 
There has been debate within the COS development field about the best way to 
summarise group scoring to participants in subsequent rounds (1, 200, 233). Nested 
within the CORMAC study (Core Outcome Research Measures in Anal Cancer), COS 
developers investigated participant understanding of different methods of presenting 
feedback in each survey round (234). It was this work that informed the use of 
histograms in this study. Histograms were better understood compared with 
conventional reporting of group mean scores or using pie charts. Graphical display, 
including the spread of scoring, was valued by patient participants. This work also 
revealed that, of the eight patients interviewed, none could describe what “median”, 
one conventional type of feedback, meant. The lack of understanding of feedback 
could result in a failure to move towards consensus and compromise the validity of the 
COS. In this study attempts were made to make interpretation of feedback easier for 
participants. However, the possibility that participants found this confusing still cannot 
be ruled out. Particularly, when there were so many charts to review and interpret 
(n=152). 
 
This eDelphi survey prioritised outcomes for effectiveness trials investigating 
interventions for the management of carious lesions. It fulfils stages 4(ii) and (iii), 
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Filling gaps in knowledge and eliciting views about important outcomes in a consensus 
process respectively. Patients, Clinicians and researchers contributed to these aims. 
The outcomes which met consensus criteria were eligible to be included in the face-to-
face consensus meeting, held in Dundee, in March 2019. This is reported in Chapter 6 
of this thesis. 
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The nominal group technique is a structured group meeting commonly used for idea 
generation, problem solving and prioritisation (235, 236). It is an expert group as 
participants have experience in the area under consideration. In the case of core 
outcome set development, experts are those with lived experience of the condition 
itself (patients), or those who treat, manage or carry out research into the disease (1). 
Traditional nominal group meetings are face to face, facilitated sessions with several 
stages which build upon the one before (235). Ground rules are set out at the 
beginning of the meeting to ensure that all participants are assured that their views 
will have equal consideration during discussions and that confidentiality should be 
maintained. The next stage of the meeting involves participants sharing their views, 
each in turn, without interruption to ensure that all voices are heard. This is followed 
by group discussion before moving towards prioritisation and voting (237). Since the 
eDelphi replaced the idea generation stage of the traditional nominal group technique, 
we removed this stage in our modified nominal group meeting as is common practice 
in COS development consensus meetings (1). 
 
Group sizes in such meetings should be small to ensure that views are represented, 
and prioritisation can occur more predictably (238). It is a great advantage of this 
format of meeting, that there is minimal preparation required by participants and that 
consensus can be quickly achieved in a few hours. Unfortunately, there are some 
disadvantages too. This method is complicated by the cost of bringing people together 
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from a broad geographical area and finding time for busy experts to attend the 
meeting in person. 
 
The aim of this part of the study was to develop the final agreed Core Outcome Set 
(COS) for carious lesion management trials. The objective of this face to face consensus 
meeting was to discuss the outcomes brought forward from the international eDelphi 
survey and to finalise the recommended COS. 
 
Research grant funding was obtained from the Tattersall fund, Dundee Dental Hospital 
and School. This funded the eDelphi platform, SHARE services and the face to face 
meeting (Appendix 4). 
 
The East of Scotland Research Ethics Service (EoSRES) provided confirmation that this 
project did not require NHS ethical approval (Appendix 2). Instead, the University of 
Dundee Schools of Nursing and Health Sciences and Dentistry Research Ethics 
Committee (SREC) provided institutional approval (Appendix 5). Participant 
information sheets were provided electronically in advance along with consent forms 
which were developed in conjunction with the Head of Information Governance at the 
University of Dundee (Appendices 12 and 13). The consent forms, along with meeting 
format and objectives, were further explained at the face to face meeting and written 
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consent was obtained prior to the start of the consensus meeting. All documentation 
had been reviewed for clarity and completeness by a patient partner with prior 
experience of COS projects in oral health. 
 
All participants of the international eDelphi were invited to attend the face to face 
consensus meeting held in Dundee at the end of Round 2. In addition, we advertised 
locally to ensure that adequate patient and professional representation was achieved. 
The inclusion criteria did not differ from those of the eDelphi survey. 
 
The face to face consensus meeting followed a modified nominal group technique 
design. The modification to conventional nominal group techniques was that the idea 
generation/identifying existing knowledge and filling gaps in knowledge stages were 
eliminated. This is because they had already taken place in the earlier phases of the 
project reported in Chapters 4 and 5 of this thesis (Figure 4.1).  
 
The meeting took place in the EduZone within the University of Dundee Library and 
Learning Centre on Monday 25th March 2019. It was facilitated by independent chairs 
Katie Gillies (KG) from the Health Services Research Unit at the University of Aberdeen 
and Heather Cassie (HC) from the Dental Health Services Research Unit at the 
University of Dundee. KG and HC have experience of mixed methods research and KG 
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has significant expertise in nominal group methodology in relation to core outcome set 
development. During the meeting the role of Colin Levey (CL) as lead researcher was to 
introduce the problem under discussion, provide background and clarify any 
uncertainties relating to study purpose, scope or outcome definitions throughout the 
meeting.  
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This figure shows the structure of the face-to-face consensus meeting. 
In advance of the meeting, participants were given a timetable for the day as well as 
the list of outcomes arising from the international eDelphi survey. Participants were 
advised to familiarise themselves as far as possible with the outcomes and their 
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definitions and choose a “Top Three” list of the most important outcomes to them. 
This would help start the discussion at the beginning of the meeting. Copies of the 
consent form and information sheet were circulated by email before the meeting. 
These documents had been reviewed for clarity by a patient partner who had 
participated in another COS development project in oral health. 
 
Participants were welcomed to the meeting and thanked for their interest in taking 
part. CL provided an explanation of the background to the problem including the 
nature of the disease (dental caries) and the issues that arise from heterogenous 
outcomes and research waste. The participants were shown a video developed by the 
COMET PoPPIE (PeOple and Patient Participation, Involvement and Engagement) 
working group to help explain the problems surrounding inconsistent outcome 
selection and reporting in trials (239). The overall aims and scope of the consensus 
project were described with reference to the specific role of the face to face meeting. 
Participants were made aware that the list under consideration had been identified 
from an international sample of dentists, researchers and patients and that all could be 
considered as potentially important. The role of the face to face consensus meeting 
was to focus these into a core set of critically important outcomes. Exclusion of an 
outcome did not mean a rejection of its use at all; simply that it was not essential to 
measure in all trials. Participants were encouraged to ask questions before moving on. 
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KG outlined the ground rules for the meeting including mutual respect for all 
participants. All voices carry equal weighting as all are defined as “experts” due to lived 
experience of the condition, experience of treating it or both. Anonymity during 
discussion was not possible. Participants were advised that recordings of discussions 
would be made which, in their recorded form, would be identifiable. Any subsequent 
reports or publications of discussions during the meeting would be anonymised. 
Consent for photography was also obtained for use in associated publications and this 
thesis. 
 
To ensure that each participant felt comfortable expressing their views, the group was 
divided into two smaller groups with patient and professional representation in each. 
Participants were assigned to groups to ensure an even distribution of patients and 
professionals. Each group were seated around a table with a group facilitator (KG or 
HC) whose role was to ensure that all participants had fair opportunity to express their 
views and that the ground rules were observed. Before moving on to discussion of 
outcomes, participants were asked to introduce themselves so that everyone was 
aware of the role of each member of the group. 
 
The groups were provided with the list of outcomes with their definitions which arose 
from the international eDelphi survey. In addition, each outcome was printed on a 
separate sheet of paper with the corresponding plain language definition. The 
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definitions had also been reviewed in advance by the same patient partner who 
evaluated the pre-meeting documentation as well as lay members of University staff 
before the eDelphi. The participants were given 60 minutes to discuss the outcomes in 
whatever approach they preferred to determine which of these were critical. The “Top 
Three” lists served as a starting point for this discussion. There was no limit to the 
number that each group could carry forward to the voting stage, and they did not need 
to rank them in order of importance.  
 
Lunch was provided to allow participants time to reflect, rest and informally discuss 
their thoughts. Meanwhile, the outcomes carried forward were added to the master 
PowerPoint presentation to allow voting using TurningPoint electronic handsets 
(Turning Technologies, Youngstown, Ohio.) 
Following a break for lunch, the combined list of important outcomes was brought 
together and read aloud to the whole group. Participants were asked to ensure that 
they felt represented in the list. If any critical outcomes were missing, anyone could 
suggest it be added back in and discussed with the whole group.  
 
The consolidated list of outcomes carried forward from the group discussions were 
presented on a screen for inclusion or exclusion. Electronic voting handsets were used 
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to vote on each outcome in turn with “yes” for inclusion in the COS, and “no” for 
exclusion. Consensus for inclusion in the final COS was determined in advance as 70% 
of participants voting for an outcome to be included. The results of each vote were 
immediately displayed on the screen (figure 6.2) before moving on to vote on the next 
outcome.  
 
 
 
This example shows the voting result for “irreversible pulpitis” outcome as seen by the participants 
after they had with automatic feedback of results immediately after the anonymous vote on that 
outcome had taken place. 
 
Dissemination plans were presented to the group. 
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Participants were, once again, thanked for taking part and information supplied about 
claiming travel expenses given. Feedback forms were provided which were completed 
before we assembled nearby for a group photograph Figure 6.4). 
 
Descriptive statistics were compiled using the TurningPoint voting software in real 
time. The consensus criteria of 70% “yes” was determined a priori for including in the 
final COS. There was no restriction set on the number of outcomes to be included in 
the final COS. Audio recordings of the discussions were transcribed and relevant 
sections are presented in this thesis to provide a supporting narrative to the final 
agreed COS. 
 
Thirteen participants attended the face to face consensus meeting in Dundee on 25th 
March 2019. There was even representation of both stakeholder groups with seven 
patients and six clinicians and researchers. The six clinicians included one general 
dental practitioner, one dental therapist, two UK qualified clinical researchers and two 
non-UK qualified dentists (South America and Middle East) carrying out research in 
paediatric dentistry in the UK. One professional participant travelled from Liverpool to 
attend the meeting.  
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The patient participants were mostly from the Tayside area and recruited via the 
University of Dundee medical school patient volunteer bank. One patient travelled 
from Glasgow to attend the meeting.  
Participants were divided into two groups with representation as show in table 6.1 
 
Clinician A – Non-UK researcher Clinician D - UK clinical researcher 
Clinician B – Non-UK researcher Clinician E - dental therapist 
Clinician C - general dental practitioner Clinician F - UK clinical researcher 
Patient A Patient E 
Patient B Patient F 
Patient C Patient G 
Patient D 
 
 
The groups were instructed to discuss and prioritise the outcomes from the 
international eDelphi process. Groups were not limited to the number they would 
carry forward to the final vote and were not asked to rank them. Although both groups 
started by asking each group member to say what their “Top Three” were and why, the 
red group did not discuss the outcomes which did not appear on anyone’s list. Instead, 
they only discussed outcomes which appeared in at least one participant’s top three. 
After initial discussion of “Top Three” lists, the green group decided to check that none 
of the missing outcomes were important before finalising their list. At the end of this 
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discussion, the agreed lists were combined into one final list for discussion and voting. 
Figure 6.3 shows the groups in the first phase of discussion. 
 
 
 
Twenty-three outcomes were considered and discussed at the meeting. One outcome 
was omitted due to an error in the analysis of voting thresholds at the end of the 
eDelphi. This was identified after the meeting had been completed and an alternative 
approach to resolving this was developed which is presented later in this chapter.  
 
From the list of 23 outcomes considered at the meeting, the Red group identified six 
important outcomes while the Green group identified 14. There were five outcomes 
common to both groups. These were 
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• Oral function following treatment of dental caries 
• Pain during treatment of caries 
• Patient (or guardian) satisfaction with treatment  
• Quality of life after treatment of dental caries 
• Tooth survival following treatment of tooth decay 
 
In addition to the five outcomes outlined above, the Red group also suggested 
• Caries increment 
 
The Green Group suggested nine outcomes that were not put forward by the other 
group. These were 
• Abscess development 
• Carious pulp exposure 
• Irreversible pulpitis 
• New caries adjacent to the restoration 
• Non carious pulp exposure 
• Periapical periodontitis 
• Restoration replacement 
• Reversible pulpitis 
• Survival of restoration 
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Following introductions and sharing of “Top Three” lists, the red group began with 
“caries increment” which had been listed by the clinicians but not the patients. 
Clinician A started the discussion by saying “there is no point of treating caries if new 
caries will develop….so this is a failure.”. They went on to say that “there is a difference 
between treating caries and treating the lesion itself.”. Patient A asked for clarification 
by saying “can I ask, do you mean by a lesion? the actual hole?...and caries is the 
disease that can cause the hole?”. Clinician A clarified that the lesion is a manifestation 
of the disease process. The group spent time examining the difference and overlap 
between “caries increment” and “new caries adjacent to the restoration”. Clinician B 
said “I also think that caries increment can measure like a behaviour changing of the 
patient. Because if you treat a patient and after six months he or her comes back with 
new lesions, it means that he hasn’t changed that behaviour.” Patient B responded “so 
that’s like a behaviour change isn’t it?...that’s sort of a psychological thing compared to 
a technical, a clinical thing isn’t?”. Clinician B provided the analogy “if you’re allergic to 
something and you keep eating it, you’re going to have some red spots. And if you use 
some cream to treat the red spots but you don’t change what you’re eating, you’re 
going to keep having it.” Considering the impact of patient behaviour and the 
difference between caries and a carious lesion, Patient B said “it’s suddenly gone from 
just caries: it’s gone to a whole different dimension, hasn’t it?”. KG clarified that core 
outcome sets can be targeted at a whole disease or can target types of intervention. 
“So in this section we’re doing the entire disease…which makes it sometimes a bit 
trickier because then the outcomes need to be fairly general.” In a subsequent 
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discussion, the red group agreed to eliminate “new caries adjacent to the restoration” 
because of the overlap with caries increment. 
 
Next, the group considered “Patient or Guardian satisfaction with treatment”. The 
group considered the overlap with other outcomes with clinician C saying “that links in 
quite well with one of the other outcomes….but with regards to oral function. So not 
only is it satisfaction but it’s making sure that you can still eat okay and you can still 
function properly as well…there’s so many I could put in my top three there because 
they all kind of overlaps a wee bit.” The group explored the impact of communication 
with the dentist as part of satisfaction in addition to technical quality of the 
intervention with patient C saying “It’s about communication. And the relationship you 
develop with your dentist. If you don’t have faith in them…it’s not good.” Clinician B 
summarised the discussion well by saying “…sometimes, the (child) patient is really 
satisfied with the treatment we give to them, but the parents or guardians are not. So 
that’s important to see as well…not only parents, not only children but both of them 
together….The treatment might be the best one, the material might be the best one 
that the dentist could put in your mouth, but if you’re not satisfied you’re not going to 
think that the treatment was good. So yeah, I think that’s important.”  
 
The red group then discussed “Quality of life after treatment” with KG explaining that 
“Quality of life is always really difficult one to do because it’s made up of so many other 
aspects.” The group were asked to consider whether overall quality of life was more 
important than the individual components that combine to describe quality of life. 
Patient D explained the complexity of this outcome by saying “it would just depend. I 
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mean it could be an aesthetic thing as well.” Citing a particular experience of a friend “ 
there was a wedding… coming up and everything, and so there was that worry about 
will I get this treatment and then at the end of the day look like myself?”. This 
statement reflects the complex interplay of factors which might undermine self-
confidence and be difficult to attribute to any other outcome domain. They concluded 
“ if the result (of treatment) is that somebody is hiding away, or they never open their 
mouth to speak or smile or laugh because they’re self-conscious, that’s huge.” 
 
Tooth survival was next to be discussed with Clinician C stating that “…from my point 
of view, the survival of the tooth is key. So that’s what we’re trying to do, we’re trying 
to save the teeth.” Clinician A supported this view by saying “and this outcome in kind 
of a way affects all other outcomes.”. A patient offered the counterpoint “ the only 
thing about that is I can see the point if you want to save the tooth. But if aesthetically 
it doesn’t look good then, from a patient point of view, you think well okay, I’ve got 
that tooth but it’s all black you know. So…it’s kind of that’s the balance.”. The group 
reflected that this is where satisfaction outcomes might become useful with clinician C 
remarking “this is what’s difficult with the outcomes is trying to get them in 
isolation…survival of the tooth means we do something to it and we keep hold of the 
tooth. Whether that then fits in with the satisfaction of the treatment or anything like 
that, there is a whole different ball game really.”  
 
Some confusion arose surrounding the outcomes “carious exposure during treatment 
of caries” and “non-carious exposure during treatment of caries” especially amongst 
the patients with one remarking “I have to admit I really don’t know, although I did put 
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that down, I really don’t know if I understand the statement.”. Clinician C elaborated 
on the difference between these two items emphasising that both outcomes indicate 
potential damage to the pulp.  
 
“Pain during treatment of caries” was next to be discussed. The link with good 
anaesthesia for operative treatment was highlighted by patient D when they said “…I 
didn’t know until I was 17 that I could have an injection before I had a filling…but it 
sometimes touch the nerve and as a child you don’t challenge.”. Patient D suggested 
that the anaesthetic injection itself can be the source of pain by saying “ I mean you 
get an injection, but there’s going to be a certain amount, you just have to be sensible. 
Unless he’s really ham-fisted or something and gets it wrong…” they continued “I had a 
phobia against needles which stopped me getting a lot of treatment at the time. Once I 
was a bit older I just shut my eyes…”. KG suggested that this should be included in the 
voting round as it appears to be important, in various ways, to patients in the group. 
 
The issue of “Restoration replacement” was discussed and clinician A highlighted 
changes in the types of intervention for managing carious lesion towards minimal 
intervention. “So managing the lesion for the decay doesn’t necessarily mean having a 
restoration or filling. So this outcome is not always applicable.”. Clinician C added “So 
from my point of view I probably would be happy if it wasn’t included, but understand 
completely if others would like it in.” A debate followed about restoration longevity 
and what could be considered acceptable versus unacceptable with patient C saying “ I 
mean you wouldn’t consider it failure after 10 years…I mean I’ve had crowns for over 
20 years.” KG asked “So it sounds like what you’re talking about though might be more 
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to do with the satisfaction of the treatment?” Patient C responded, “oh possibly…I 
suppose the two are overlapping, yeah”. In a later discussion of the outcome 
“restoration survival”, the red group did not consider this important, with KG asking 
“So have we decided if survival of restoration , do we want it in or out?” to which 
patient C said “I’m not fussed. We don’t need it”.  
 
“Reversible pulpitis following treatment” was the next outcome to be discussed. 
Clinician C quickly contextualised this outcome amongst some of the other which form 
a spectrum of complications arising from treatment of a carious lesion “so there’s 
about 5 of these (outcomes) which are all potential outcomes of doing treatment. So 
reversible, irreversible, abscessing, periodontal…you know, from my point of view, they 
all kind of fall under one group….so I’m more than happy for this not to be included in 
our list simply because I’m looking at the fact we’ve already talked about survival of the 
tooth. Because that’s what a lot of these will have an impact on. So if the nerve starts 
dying off, well then does that the mean that the tooth is going to be saveable or not.” 
Patient D suggested that this could also fall under satisfaction with treatment. 
 
The recording of the green group discussion failed after the first 20 minutes of 
recording and so transcripts were only available for the first part of the discussion. HC 
later submitted a summary of the unrecorded discussion based on notes taken at the 
time. 
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The green group similarly struggled with the degree of overlap of the outcome 
domains with Patient E commenting “quality of life after treatment for dental caries. 
Now I struggled with that because I thought it was similar to the oral function, but then 
that presumably would also cover being pain-free. Because your mouth can still 
function but not necessarily be pain-free and I think, as a patient, that’s one of the 
basic things, you don’t want to have pain. So I would say that would be the second 
one.” Patient F reinforced this view by saying “Yes this was difficult. I thought there 
was a degree of overlap here and there but I think patient satisfaction with treatment. 
… Again, quality of life, a measure of the patient’s quality of life related to their mouth. 
I mean if my bite is going to be affected, for instance, after treatment that would 
definitely have an impact on my quality of life.”. Quality of life was felt to be important 
to both patients and clinicians despite the overlap with other outcomes and the all-
encompassing nature of the definition. Clinician D said “A lot of you have mentioned 
quality of life and I put that as one of my top three as well. I sort of took this one out 
and in a few times because if we were to ask ourselves what does quality of life actually 
mean? And I think it probably means … there are probably things that feed into that. 
So, pain after the treatment probably influences quality of life. Tooth survival will 
influence quality of life. A lot of you mentioned oral function. That will feed into quality 
of life. So, I think that sort of covers a lot of these other really, really important ones. 
And also, I suppose, whatever we do in dentistry it should be to improve people’s 
quality of life. That is important” 
 
In an attempt to deal with the overlapping domains, Clinician E suggested “Yes because 
those that overlap we should probably combine by coming to an agreement on which 
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of those that overlap …”. Clinician F responded “You could if you were talking about 
trying to group them, the irreversible pulpitis following caries, the reversible pulpitis 
following caries … the treatment of caries, sorry. The periapical periodontitis after 
treatment of caries. They’re all after treatment of caries so you could group them all as 
under pain after treatment of caries.” Clinician D also suggested “And abscess 
development we’ve got as well.” Causing Clinician F to respond “Oh yeah. Yeah. None 
of us picked it but that is a category there you could, like consequences of treatment of 
caries.” 
 
Clinician D considered the overlap with other domains again “And maybe that actually, 
all of that, is combined in quality of life.”  Clinician F added “And patient satisfaction 
possibly as well, because …Because if you come to the dentist with no pain in a tooth, 
but we see there is decay there, you’ve had no pain in it before we put the filling in, 
that’s cause pain, because of the decay that was in there, it’s also kicked something off. 
That’s going to decrease your satisfaction sort of thing. But then if you think about it 
too much you could put loads of these together …”  
  
In contrast with the other group, after discussing the top 3 lists, Clinician D suggested 
discussing the ones that had not been in any top 3 list to check that the group were 
content to exclude them. This discussion resulted in 5 outcomes being added to the list 
carried forward. In some cases, the group could not agree to exclude and were 
therefore carried forward by default. This approach accounts for the green group 
carrying many more outcomes forward to the voting compared with the red group. 
 
211 
 
 
After the groups had been brought together and the list of 15 outcomes read aloud to 
the whole group, there were no calls made for inclusion or exclusion of any outcomes. 
As a result, all 15 outcomes were taken forward to the anonymous voting (stage 8). 
 
The outcome discussion and voting commenced and table 6.2 shows the results of the 
votes. (Green shows outcomes which met consensus for inclusion in COS, blue shows 
outcomes which >70% of patients included but did not meet overall criteria for 
inclusion in COS).  
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Green rows highlight the outcomes which met consensus for inclusion in the COS. Light Blue 
indicates outcomes of importance which narrowly missed inclusion in the COS. 
 Total  Patients  Clinicians 
Outcome Yes (n=) No (n=) Yes (n=) No (n=) Yes (%) No (n=) 
abscess 
development after 
treatment of caries 
69% (9) 31% (4) 86% (6) 14% (1) 50% (3) 50% (3) 
Caries increment 54% (7) 46% (6) 57% (4) 43% (3) 50% (3) 50% (3) 
Carious pulp 
exposure during 
treatment of caries 
31% (4) 69% (9) 29% (2) 71% (5) 33% (2) 67% (4) 
 Irreversible pulpitis 
following treatment 
of caries 
77% (10) 23% (3) 
100% 
(7) 
0 (0) 50% (3) 50% (3) 
New caries adjacent 
to the restoration 
69% (9) 31% (4) 71% (5) 29% (2) 67% (4) 33% (2) 
 Non carious pulp 
exposure during 
treatment 
31% (4) 69% (9) 29% (2) 71% (5) 33% (2) 67% (4) 
Oral function 
following treatment 
of dental caries 
77% (10) 23% (3) 86% (6) 14% (1) 67% (4) 33% (2) 
 Pain during 
treatment of caries 69% (9) 31% (4) 
100% 
(7) 
0 (0) 33% (2) 67% (4) 
Patient (or 
guardian) 
satisfaction with 
treatment 
100% (13) 0 (0) 
100% 
(7) 
0 (0) 100% (6) 0 (0) 
Periapical 
periodontitis 
development 
(Apical 
inflammation) after 
treatment of caries 
54% (7) 46% (6) 71% (5) 29% (2) 33% (2) 67% (4) 
 Quality of life after 
treatment for dental 
caries 
100% (13) 0 (0) 
100% 
(7) 
0 (0) 100% (6) 0 (0) 
Restoration 
replacement 
46% (6) 54% (7) 43% (3) 57% (4) 50% (3) 50% (3) 
Reversible pulpitis 
following treatment 
of caries” 
46% (6) 54% (7) 29% (2) 71% (5) 67% (4) 33% (2) 
 Survival of 
restoration 
85% (11) 15% (2) 86% (6) 14% (1) 83% (5) 17% (1) 
Tooth survival 
following treatment 
of tooth decay 
85% (11) 15% (2) 71% (5) 29% (2) 100% (6) 0 (0) 
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CL gave a summary of the plans for analysis and dissemination of the results of the 
face to face consensus meeting. In particular, the role of presenting this work in 
academic papers and research conferences. 
 
Participants were thanked for taking part and for their time. A group photograph was 
then recorded in the Frankland Garden on the University Campus (Fig 6.4). 
 
 
 
Several months after the meeting was held, the data from the eDelphi was reviewed 
again and it was noted that one outcome (remineralisation of the lesion) met the 
consensus criteria at the close of the eDelphi survey but was not carried forward to the 
meeting for discussion due to a data analysis error. In fact, 77% of the professional 
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group and 100% of the patient group considered it to be a critical outcome (scored 7-9 
on the scale). Given the high level of agreement, it was proposed that this be included 
in the final COS and that the consensus group would be consulted by email as a 
pragmatic means of establishing their views. This email was sent on 18/03/20 and two 
responses were received from the group. Both responses were from patients and 
strongly supported the inclusion of the outcome in the COS. 
 
Consideration was given to reconvening the meeting, however the cost of this was 
high and level of inconvenience for participants, prohibitive. Furthermore, with the 
outbreak of novel coronavirus (Covid-19), the logistics of such a meeting became 
impossible. 
 
The final core outcome set for carious lesion management effectiveness trials is shown 
in Table 6.3. 
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Outcome % voting “Yes” at consensus meeting 
Patient satisfaction 100 
Quality of life 100 
Survival of restoration 85 
Tooth survival 85 
Irreversible pulpitis 77 
Oral function 77 
Remineralisation of the lesion n/a 
 
Note Remineralisation of the lesion does not have a score as it was not voted upon the consensus 
meeting. 
 
Face-to-face consensus meetings are an established component of the COS 
development process (1). They allow discussion of concepts and negotiation of 
opinions in a way that is difficult to achieve in an online survey. In this way, 
participants can share their personal viewpoint and have this considered by the whole 
group. However, as COS development methodology is an evolving field, there is a lack 
of clear standardised approaches for conducting consensus meetings (235). Some 
authors recommend that stakeholder groups are separated for the consensus meeting 
(240). The main reason for this is to allow the patients to discuss their views 
comfortably without contamination from other groups which may, traditionally, be 
considered unquestionable (240, 241). Other COS developers have brought all 
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stakeholder groups together for the final meeting with success (242). In such cases, 
having professionals present can help with explaining some of the concepts behind the 
outcomes in groups without relying excessively on the facilitators or organisers for 
this, which might inhibit continuous and relaxed dialogue within the group. A good 
example of this in the Red group was when Clinician B said “I also think that caries 
increment can measure like a behaviour changing of the patient. Because if you treat a 
patient and after six months he or her comes back with new lesions, it means that he 
hasn’t changed that behaviour.” Patient B responded “so that’s like a behaviour 
change isn’t it?...that’s more of a psychological thing compared to a technical, a clinical 
thing isn’t?”. Clinician B provided the analogy “if you’re allergic to something and you 
keep eating it, you’re going to have some red spots. And if you use some cream to treat 
the red spots but you don’t change what you’re eating, you’re going to keep having it.”. 
In this example, the clinician provided a helpful analogy to allow the patient participant 
to understand a previously unclear dimension of caries management. This facilitated a 
deeper understanding of the issues faced by both stakeholder groups which developed 
throughout the course of the meeting. Overall, both groups functioned very well, with 
all members comfortable in contributing to the discussion of ideas. Dividing the 
meeting into two groups at the beginning resulted in a more comfortable size of group 
for people to develop rapport and share opinions. Participants quickly gained a 
confidence to share which was carried through when the group was brought together 
later in the meeting. This was especially important as there were many outcomes to 
consider. 
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The professionals in the consensus meeting represented areas of oral healthcare 
performed in different settings and for different patient groups, including children. 
There was representation drawn from primary and secondary care, dental care 
professionals and clinical researchers. The clinically qualified participants have 
experience of providing dental care in England, Scotland, Brazil and Syria, providing 
wide-ranging perspectives within the context of a small number of participants. 
Several also had experience of clinical research. 
 
The patient group was more homogenous and consisted primarily of participants from 
the local area. All were from Scotland and all were older adults. This is a potential 
limitation of this study as there were no young adults or children speaking from a 
patient perspective alone. Additionally, since we know that caries is not evenly 
distributed across society and affects those in lower socioeconomic groups (5, 51, 54), 
it is a further limitation that we did not manage to sample more significantly from 
across that spectrum. The risk to the findings of this meeting are, however, mitigated 
to a degree by the eDelphi which preceded it. This had representation from a broader, 
albeit skewed, age range. Future review and revalidation of this COS should 
incorporate novel methods to reach these groups to ensure that the ongoing COS is of 
relevance to all patient groups. 
 
The COMET Initiative encourages COS developers to involve patients in their consensus 
process to increase the applicability of the COS to real world settings. There are many 
general challenges facing COS developers in this regard. However, the disease under 
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consideration will affect how easy this is to engage patients and there are issues 
particular to caries that should be considered. Although caries affects much of the 
global population and most people have experienced the disease in some form (54), 
the perceived ubiquitous nature of it may hinder patient participation in projects like 
this one. Many of the other conditions for which a COS has been developed involve 
diseases where patients might identify as someone who “suffers from XX disease”. 
That is, the disease is a part of their identity and they want to help people like them or 
people who may suffer like they do. Examples of this might be anal cancer (243), 
prostate cancer (213), psoriatic arthritis (244) or eczema (245). It is doubtful that most 
people would feel the same way about dental caries. Furthermore, there are no 
patient societies or organisations to support sufferers. These are often useful places 
for researchers to find willing patient partners in improving the evidence base. For 
caries, these issues may inhibit the motivation to take part in research, particularly 
when the inconvenience of time away from normal activities, such as work, and travel 
to the meeting is considered. 
 
Further problems with engaging patients are found when the disease under 
consideration is one with a socioeconomic gradient related to severity. It is more 
challenging to reach this group for care, let alone to involve them in research which 
might involve access to an internet connected computer (such as the eDelphi) or 
significant travel (such as the face to face meeting). Since costs were reimbursed for 
travel, the participants need to have the funds to travel in the first place. Although we 
would have accommodated this if required, none of the participants asked us to 
arrange the travel for them in advance. 
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A concern of the participants throughout the meeting was the issue of how many 
outcomes were required in the final COS. Concerns about not having enough or having 
too many were expressed. As the meeting progressed, the participants began to 
appreciate the challenges of selecting too many outcomes. That is, pragmatically, this 
would be very challenging for the researchers to implement. The concept of “core” 
outcomes became clearer as the discussion continued. This demonstrated the value of 
the interaction between participants in the context of a meeting, rather than a simple 
online survey or vote without discussion.  
 
We successfully employed anonymised electronic voting in this face to face consensus 
meeting. Anonymity is desirable as participants can vote based on their own view 
without undue influence of others. Researchers conducting similar work have reported 
problems operating some of these systems, causing them to break the anonymity 
(216). Significant planning, preparation and practice ensured that we were able to use 
the electronic voting system in such a way that the results were displayed in their 
anonymised format, but that the research team could see how different stakeholders 
voted on each outcome. Participants voted and were able to see the results for each 
outcome before moving on to the next. It is unclear what impact this had, compared 
with only seeing the results once all the voting had been completed. Allowing 
participants to reflect on the results as they came through may have caused them to 
moderate their voting on subsequent outcomes. Again, it is not clear if voting on the 
outcomes in a different order would have had an impact on the final COS. Further 
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research into the method of presenting outcomes in eDelphi surveys has been 
undertaken (213). Similar work should be undertaken to assess the impact of this in 
consensus meetings. 
 
Face to face meetings provide the opportunity for participants to seek clarification on 
issues related to the general conduct of trials and where outcome choice sits within 
that. Considering the experience of other COS development projects within dentistry, 
the introduction highlighted the concepts of effectiveness and efficacy as this is a 
common source of confusion (216). Participants successfully reminded one another 
throughout the discussion that the focus of this COS was on effectiveness trials. 
 
A significant problem with conducting a face to face meeting is the cost of bringing a 
representative sample of participants from across the world, or even the country, to 
one place for the meeting. Several non-UK participants of the eDelphi expressed an 
interest in attending via video link or teleconference. Unfortunately, due to the 
traditional method of the nominal group technique as well as the nature of the voting, 
this was not thought practicable. A few researchers tried to secure their own funding 
via their home institutions to attend but were unsuccessful in doing so. A possible 
route to overcome this challenge would be to hold the meeting alongside a caries 
research-related conference. However, this has additional limitations. Firstly, the travel 
costs for the patient participants could rise significantly depending upon the location 
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of the meeting. These would need to be covered somehow. Furthermore, it may not 
be possible to attract clinicians such as GDPs and DCPs to these events without also 
securing additional funding. In the meeting reported in this chapter, we were fortunate 
to have a sample of clinicians from beyond the UK. These were researchers 
undertaking their postgraduate studies in the UK at the time. This helped to mitigate 
the risk of a UK bias as far as possible. In order to overcome this, methodologies 
should be developed which allow for successful remote discussion and anonymous 
voting. Otherwise, the funding for COS development should be increased to allow for 
travel of stakeholders to meetings. In the light of the Covid-19 outbreak in 2020, such 
remote consensus meeting methodologies may become established by necessity.  
 
The addition of “remineralisation of the lesion” to the COS after the consensus 
meeting was not planned and was due to an error in the analysis of thresholds 
following the completion of the eDelphi survey. Duplicate checking of data by multiple 
researchers would have reduced the risk of this occurring. Unfortunately, this was not 
undertaken due to resource limitations and should be considered in important stages 
of data analysis such as the threshold level to be included in the next part of the study. 
As this was clearly not planned, the solution to the problem had to be pragmatic. As 
indicated earlier, consideration was given to reconvening the group to discuss and 
debate this additional outcome. To do so would have doubled the cost of this final 
stage assuming all participants could attend another meeting. In addition, the travel 
restrictions imposed as a result of the novel coronavirus (Covid-19) outbreak in early 
2020 rendered this impossible. It was agreed in consultation with CL, KG, JC and DNJR, 
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that the group should have the opportunity to express their views on this outcome. As 
expected, a small proportion of the group responded to this email. Given the high level 
of agreement in the eDelphi for its inclusion, we decided to incorporate it into the COS 
subject to review and discussion at COS reappraisal meetings in the future. These are a 
required feature of COS development to maintain and assure the ongoing validity of 
the COS (1). Remineralisation of the lesion is perhaps a narrower concept than other 
outcomes in the COS and is likely to be more suited to secondary prevention studies 
where lesion arrest and remineralisation is targeted. However, it could be applied in 
some operative studies to sealed lesions under restorations, although the method of 
measurement may be more complex in this case.  
 
The COMET initiative’s recommended stages of (ii) Filling gaps in knowledge, (iii) eliciting 
views about important outcomes in a consensus process and (iv) holding a face to face 
meeting to finalise the recommended COS have been met through a combination of 
eDelphi and a modified nominal group meeting. We brought together key oral health 
stakeholders to discuss what outcomes should be considered important for the 
management of carious lesions. The participants proposed that the outcomes of 
Irreversible pulpitis, oral function, patient (or guardian) satisfaction, quality of life, 
survival of restoration (if involving a restoration), remineralisation of the lesion, and 
tooth survival should be the minimum set of outcomes reported by all effectiveness 
trials investigating the management of carious lesions. 
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The process for the development of the Core Outcome Set (COS) for carious lesion 
management trials has been described in the preceding section of this thesis. This 
evidence-based list of important outcomes has been agreed by patients, clinicians and 
researchers across the three stages of its development. Core Outcome Sets are a 
critical component in attempts to reduce research waste and improve the efficiency 
and relevance of primary research. If they were to be used throughout the GEEOH, 
including at the level of systematic reviews, they would further improve the 
productivity of the ecosystem. In this chapter, this COS will be compared against the 
outcomes reported in current “best evidence” (74, 75), namely Cochrane Systematic 
Reviews, to assess the discrepancy between these prioritised outcomes and what is 
currently being investigated. This will quantify the gap that may exist between the 
outcomes which have been considered most important at the evidence synthesis stage 
and those which have been prioritised in the COS. 
 
The COS that has been reported in this thesis will be compared with the outcomes 
reported in Cochrane Systematic reviews related to interventions for the management 
of established carious lesions. That is, reviews of RCTs which fell within the scope of 
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the COS. As outlined in the introductory chapters, systematic reviews are often 
considered to be “best evidence”, with Cochrane reviews considered to be the 
pinnacle of the methodology (74, 75, 85). This is owing to a robust approach for the 
appraisal of primary research which is subject to ongoing development and review 
(104). This comparison will allow assessment of discrepancies, should they exist, 
between what has been measured in the past and what should be measured in the 
future at this stage in the GEEOH.  
 
To map the COS for carious lesion management to outcomes used in current “best 
evidence”. 
 
The objectives of this part of the research are to: 
1. Identify the outcomes selected for analysis in Cochrane systematic reviews 
focused on the management of established carious lesions. 
2. Compare and map these outcomes to the COS developed in this thesis. 
 
Cochrane systematic reviews focusing on the management of carious lesions were 
identified through the Cochrane library browse tool 
(https://www.cochranelibrary.com/search). Only Cochrane reviews related to the 
management of already established lesions were included. Cochrane systematic 
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reviews investigating the prevention of caries (primary prevention) or interventions 
related to caries diagnostic tests, endodontics or tooth replacement were excluded. 
Cochrane reviews found in either the “management” or “prevention” subheadings of 
the caries tab on the Cochrane library were assessed to ensure that no reviews which 
focused on secondary prevention were inappropriately excluded. Cochrane reviews 
which were relevant but had been “Withdrawn” were included as the outcome domain 
data would still be relevant to the scope of the COS. However, only the most recent 
version of a relevant Cochrane review was included. Review protocols were excluded. 
The outcomes reported in each of these Cochrane reviews were extracted verbatim 
from the methods section of each review. For the purposes of this analysis, the a priori 
outcomes have been used for this mapping exercise. These were then compared with 
the COS and 3 additional outcomes which did not meet consensus for inclusion by a 
narrow margin (table 7.1).  For clarity, these additional outcomes are referred to as 
“other important outcomes” throughout this chapter. 
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Outcome % voting “Yes” at consensus meeting 
Patient satisfaction 100 
Quality of life 100 
Survival of restoration 85 
Tooth survival 85 
Irreversible pulpitis 77 
Oral function 77 
Remineralisation of the lesion n/a 
Abscess development 69 
Pain during treatment procedure 69 
New caries adjacent to the restoration 69 
 
This table shows the outcomes included in the COS in the blue boxes. Other important outcomes 
which narrowly missed inclusion in the COS are in the grey boxes. The a priori threshold for inclusion 
in the COS was 70% agreement. Remineralisation of the lesion does not have a score as it was not 
discussed at the consensus meeting. The reasons for the inclusion of this item are described in 
Chapter 6. 
 
If the verbatim outcomes could not be assigned to one of the outcomes shown in table 
7.1, they were categorised as “no match”. This categorisation of outcomes was 
undertaken independently and in duplicate by two researchers (CL and DNJR). 
Allocations were compared and discrepancies discussed and resolved by three 
researchers (CL, DNJR and JC). 
 
Two of the outcomes included in the COS are not applicable to all types of 
interventions in established lesion management RCTs or SRs: survival of the restoration 
and remineralisation of the lesion. Non-operative interventions (i.e. where no 
restoration is placed) are growing in use and this means that there is no restoration to 
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be assessed for survival. Remineralisation of the lesion is most likely to be relevant to 
these types of non-operative interventions. However, it may be used to assess certain 
operative interventions where carious tissue is left under restorations, such as in 
selective caries removal. Each Cochrane review was assessed for applicability of these 
two outcomes before assessing the level of agreement with the COS.  
 
Fifteen relevant Cochrane reviews were identified (table 7.2) with publication dates 
between 2003 and 2019. All included Cochrane reviews were considered relevant to 
include survival of the restoration as an outcome. Remineralisation of the lesion was a 
potentially relevant outcome in one of these Cochrane reviews (Review 5: Ozone 
therapy for the treatment of dental caries) (246).  
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Article 
number 
Title of Cochrane Review Year 
1 
Atraumatic restorative treatment versus conventional restorative 
treatment for managing dental caries (247) 
2017 
2 
Pulp management for caries in adults: maintaining pulp vitality 
(248) 
2007 
3 Preformed crowns for decayed primary molar teeth (117) 2015 
4 Operative caries management in adults and children (69) 2013 
5 Ozone therapy for the treatment of dental caries (246) 2004 
6 
Micro‐invasive interventions for managing proximal dental decay 
in primary and permanent teeth (116) 
2015 
7 
Lasers for caries removal in deciduous and permanent teeth 
(118) 
2016 
8 
Adhesively bonded versus non‐bonded amalgam restorations for 
dental caries (121) 
2016 
9 
Dental fillings for the treatment of caries in the primary dentition 
(249) 
2009 
10 
Direct composite resin fillings versus amalgam fillings for 
permanent or adult posterior teeth (119) 
2014 
11 Ceramic inlays for restoring posterior teeth (250) 2003 
12 
Replacement versus repair of defective restorations in adults: 
amalgam (251) 
2014 
13 
Replacement versus repair of defective restorations in adults: 
resin composite (252) 
2014 
14 
Dental cavity liners for Class I and Class II resin‐based composite 
restorations (253) 
2019 
15 
Rubber dam isolation for restorative treatment in dental patients 
(120) 
2016 
 
The included titles are the most recently published version of each Cochrane review. 
 
The included Cochrane reviews had between 4 and 11 outcomes identified in the 
methods section. As these were selected a priori, not all Cochrane reviews presented 
data for each of these outcomes where the primary research did not report it. The 
fifteen Cochrane reviews had a total of 98 verbatim outcomes. A deduplicated list of 
these is shown in table 7.3. The median number of outcomes was seven, which is 
consistent with current Cochrane recommendations for the maximum number in the 
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Summary of Findings tables (85). Only three Cochrane reviews identified more than 
seven outcomes for analysis (69, 118, 249). 
 
Deduplicated verbatim outcomes reported in included Cochrane Reviews 
Adverse events 
Colour match 
Ability to remove carious tissue 
Change in decayed, missing and filled (DMF for permanent dentition/dmf for primary 
dentition) figures at surface, tooth and whole mouth level. S 
Clinical evaluation of restoration's quality 
Clinical success 
Cost 
Discomfort associated with procedure 
Durability of restoration: survival time of restoration  
Duration of treatment. 
Economic data: direct costs of materials and any reported associated indirect costs 
Episodes of pain (during and after treatment) 
Exposure of the dental pulp during caries removal 
Extraction 
Failure rate (or survival rate) of the restorations 
Freedom from symptoms of pain and sensitivity 
Further restoration (repair, restoration, placement of crown inlay; root filling) required 
Health economic measures 
Major failure: this outcome is a composite measure of signs and symptoms 
Marginal deterioration of the restoration and fracture of the remaining tooth tissue 
Marginal integrity of restoration 
Material deficiency (e.g. retention loss, or number of re‐treatments 
Need for anaesthesia  
Operator preference/fatigue in operator 
Oral health related quality of life 
Pain 
Pain (during and immediately after treatment expressed as intensity of pain or presence or 
absence of pain) 
Pain or discomfort associated with the procedure 
Participant acceptance/satisfaction 
Participant and operator perception, as measured by standardised/validated questionnaires 
Participant discomfort 
Participant experience 
230 
 
 
Participant preference 
patient satisfaction 
Patient satisfaction with aesthetics  
Patient/carer and dentist perceptions of treatment 
Post‐insertion sensitivity or pain assessed by a validated pain scale 
Postoperative hypersensitivity to hot, cold, biting, chewing, and/or sweets 
Postoperative pain/discomfort  
Presence of clinical symptoms (pain, swelling, diagnosis of pulpitis, abscess formation). 
Progression of caries 
Progression of existing carious lesion into enamel or dentine 
Progression/regression of caries in unrestored cases 
Pulpal inflammation or necrosis 
Reasons for failure 
Recurrent caries 
Restoration failure 
Satisfaction with treatment 
Secondary caries 
Signs or symptoms of pulpal disease 
Sleep habits following intervention 
Success or failure of restoration, as defined by the USPHS criteria. 
Surface changes (changes in texture) 
Survival of the restoration 
Time to restoration failure/retreatment 
Wear and staining (colour changes) of restoration 
Weight gain/loss after intervention 
Deduplicated list of unique verbatim outcomes from the 15 included Cochrane Systematic reviews 
The included Cochrane reviews identified a total 98 different outcomes of which 38 
(39%) could be mapped to the COS. A further 10 outcomes from the Cochrane reviews 
mapped to two other important outcomes which narrowly missed inclusion for the 
COS, namely; pain during treatment procedure, and new caries adjacent to the 
restoration. Abscess development did not directly map to any of the Cochrane 
outcomes but did appear in some composite measures of post-operative pain. For the 
purposes of the analysis presented in this chapter, the single best match was chosen 
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only if the outcome in the COS fully encompassed the outcome in the Cochrane 
review. Composite measures were not subdivided to match to multiple items from the 
COS or other important outcomes.  
 
Figure 7.1 shows how the 98 verbatim outcomes from the Cochrane reviews mapped 
to the COS. This shows that the majority of outcomes (61%) did not map to the COS. 
The most common item from the COS to be included in the Cochrane reviews was 
survival of the restoration, which represented 20% of the total number of outcomes 
reported in the included Cochrane reviews. Satisfaction and irreversible pulpitis each 
matched to 7% of the outcomes. Tooth survival, quality of life and remineralisation 
made up 7%, 1% and 1% of the outcomes respectively. Oral function was not included 
in any Cochrane review.  
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This figure shows how each item of the COS mapped across all outcomes reported in the Cochrane 
reviews (n=98). Most outcomes from Cochrane reviews did not map to the COS. 
 
Figure 7.2 shows the mapping to the COS and other important outcomes by Cochrane 
review. The Cochrane review titles and numbering are shown earlier, in table 7.2. The 
red dotted line indicates the number of outcomes from the COS that are relevant to 
each Cochrane review. This figure shows that none of the Cochrane reviews matched 
completely with the COS. Overall, mapping of Cochrane review outcomes with the COS 
was poor. Most of the Cochrane reviews (n=9, 60%) matched to less than half of the 
COS. Three Cochrane reviews (20%) matched to only one item from the COS. 
Notwithstanding this, all Cochrane reviews included at least one item from the COS. 
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Two of the Cochrane reviews contained 5 out of 6 relevant items from the COS (251, 
252).  
The total height of the stacked bar shows the number of outcomes reported in each review. The 
blue section of the bar indicates how many outcomes mapped to the COS while the orange band 
indicates a match with other important outcomes. The grey section indicates outcomes which did 
not match to the COS or any of the other important outcomes. The red line indicates the number of 
outcomes from the COS that are relevant for each review. Therefore, a blue bar meeting the dotted 
red line indicates a complete match to the COS. The closer the blue bar is to the red line, the better 
the mapping to the COS. 
 
Eight of the Cochrane reviews (53%) included the other important outcomes from the 
COS development work reported in chapter 6. Although these outcomes are not 
considered to be “core” or “critical” by the consensus groups, they were considered to 
be significant. The inclusion of these items shows that Cochrane review authors have 
investigated outcomes that are of some importance to patients and clinicians. 
However, these are now known to be of secondary importance to the outcomes 
contained within the COS. 
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Figure 7.3 shows the number of Cochrane reviews which used outcomes in the COS in 
descending order of consensus agreement in the face to face meeting. This 
demonstrates that patient satisfaction is considered important by 47% (n=7) of 
Cochrane review authorship teams. Despite quality of life being identified for inclusion 
in the COS by 100% of face to face meeting participants, only one Cochrane review has 
used this outcome. Survival of the restoration dominates the Cochrane reviews, with 
only one not using this as an outcome. Irreversible pulpitis is reported in six of the 
reviews (40%) which reflects the aim of many interventions to preserve pulp vitality 
and prevent episodes of pain. 
 
  
This figure shows that all but one of the reviews reported survival of the restoration. 
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The results of this analysis of outcomes published in carious lesion management 
Cochrane reviews has demonstrated a high level of outcome heterogeneity in evidence 
syntheses. There were 98 outcomes reported which, when deduplicated, resulted in 57 
different outcomes across the 15 Cochrane reviews. Although there was often a 
degree of overlap or a subtle difference in meaning, this finding confirms a degree of 
inconsistency in outcome selection in high quality secondary research. It underscores 
the importance of establishing consensus on clear definitions of outcomes with 
consistent methods of assessment or measurement.  
 
Composite measurement tools may be required to assess other well-defined and 
important concepts such as quality of life but should be avoided unless there is broad 
agreement on a clear and consistent definition. During the mapping of verbatim 
outcomes to the COS and other important outcomes, composite outcomes caused 
some difficulty. A common problem was “clinical success” or similar. In this case, 
definitions can vary markedly in and between primary and secondary research. While 
these composite outcomes may be defined and justified in individual publications, they 
may undermine comparisons between studies if there is no accepted consensus 
definition. This ultimately reduces the ability to perform appropriately powered meta-
analysis. In the context of the COS defined in this thesis, there are domains that are 
broad concepts which will require a cluster of sub-outcomes (e.g. quality of life) to 
adequately assess. Researchers should focus on identifying high quality measurement 
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tools, gaining consensus on their definitions and use, rather than creating new 
composite measures for an individual study or review. As described in Chapter 2, these 
tools must be reliable, valid, responsive, interpretable and feasible (Table 2.1). 
 
None of the included Cochrane reviews mapped completely to the COS. Eight of the 
Cochrane reviews contained other important outcomes arising from the COS 
development process reported in chapters 4, 5 and 6 (section C) of this thesis. Even 
taking these outcomes into account, there was still a clear mismatch between what 
authors of secondary research consider important and what patients and clinicians 
have prioritised with respect to key outcomes.  
 
The management of carious lesions has traditionally involved operative treatment with 
restorative-focused outcomes. Even minimally invasive (MI) management of deeper 
lesions can require a restoration of some kind to be placed and assessed. As a result, it 
is not surprising that almost all (93%) of Cochrane reviews used survival of the 
restoration as an outcome of interest. The results presented in chapter 4 of this thesis 
show that outcomes related to the performance (including survival) of the restoration 
are also highly prevalent in primary research in this area. With focus moving towards 
non-operative and minimal intervention, this outcome will continue to have relevance. 
However, one would hope that it would not remain the dominant reporting item from 
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the COS and that other items such as Quality of life and Tooth survival and 
Remineralisation would be reported more frequently in future. 
 
A positive finding from this research was a higher than expected use of patient 
satisfaction, which was an item in the COS and poorly represented in primary research 
(Chapter 4). Seven (47%) of the Cochrane reviews identified this as an outcome of 
importance. This shows that this aspect of the patient experience has been considered 
significant by authors of relevant Cochrane reviews. However, this finding does not 
mean that data for this outcome was found in the primary research. Indeed, Cochrane 
encourage the use of patient reported outcomes such as satisfaction in protocol 
development, even when data is not expected from primary research (254). This may 
explain why it was frequently identified in the included Cochrane reviews. Whether 
data from primary studies was found in each Cochrane review was not assessed as part 
of the analysis presented in this chapter. The analysis of RCTs presented in Chapter 4 
found low levels of patient reported outcomes, therefore it is unlikely that all included 
Cochrane reviews were able to find data for this outcome. Despite attempts by 
Cochrane to stimulate the use of patient reported outcomes in primary research by 
encouraging their use in Cochrane reviews, there is still a lack of data available for 
synthesis. If there is to be outcome alignment between these stages of the GEEOH 
there must be improved communication between trialists and reviewers with agreed 
standards in place.  
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No attempt was made to assess whether data could be found in primary research trials 
for the outcomes selected in the included Cochrane reviews. The aim of this research 
was to identify the outcomes of importance to researchers involved in synthesis rather 
than assess the direct mismatch with primary studies within each Cochrane review. 
Since the existence of a mismatch has already been established, further analysis is 
unlikely to add value to the present analysis and could be considered research waste 
for this enquiry. Analysis of this mismatch may be useful when determining the extent 
to which different measurement instruments result in problems with meta-analysis. 
This may be a valuable analysis as part of the COSMIN process for standardising 
outcome assessment methods. 
 
The use of composite measures, and the problems they create, is discussed earlier in 
the discussion section of this chapter. When allocating verbatim outcomes to 
categories in this research, we did not divide composite measures into individual 
domains for categorisation. That is, each outcome from the review could only be 
matched once. Where the outcome was a composite measure of a broad concept that 
included a part of the COS, this was considered “no match”. For example, post-
operative pain was not allocated to the irreversible pulpitis domain unless it specifically 
related to this. Where a broader definition of post-operative pain was used, including 
reversible pulpitis, abscess development and periradicular periodontitis, this was 
considered “no match”. Another example of this is “clinical success” of a restoration. In 
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this case, this was considered to be “no match” to the COS. Clinical success as a broad 
concept may include the survival of the restoration but will often include other 
concepts such as marginal integrity and colour match (203, 204). In some reviews, 
success and survival were reported separately in any case. Other researchers may have 
grouped these outcomes another way resulting in slightly different levels of matching 
to the COS. Indeed, the problem of identifying unique outcomes has been described in 
the COS literature (255). Similar issues are encountered by researchers engaged in COS 
development when identifying and deduplicating outcomes at the outset of the 
process. However, we sought to control and minimise variability by using independent 
allocation, followed by consensus discussion to reduce the impact of inter-rater 
differences. Agreed rules for allocation were developed and adhered to in order to 
maintain a consistent approach. It is unlikely that differences in allocation would 
markedly change the overall conclusions of this research. That is, outcomes chosen in 
carious lesion management Cochrane reviews are heterogeneous and map poorly to 
the COS. 
 
A high degree of outcome heterogeneity was found in carious lesion management 
Cochrane reviews. The outcomes identified as important in this sample of evidence 
syntheses map poorly to the COS. Only 39% of outcomes in Cochrane systematic 
reviews are found in the COS developed in chapters 4, 5 and 6 (Section C) of this thesis. 
The items from the COS which were most commonly reported in Cochrane reviews 
were survival of the restoration, patient satisfaction and irreversible pulpitis.  
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Adherence to the COS in future Cochrane reviews, whether conventional or “living” 
methodology is used, would reduce the level of outcome heterogeneity found 
between Cochrane reviews. It will also ensure that the results of such reviews inform 
clinical decision making by using important measures of intervention effects. 
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The work reported in this thesis sought to identify and address sources of avoidable 
waste. In particular, this was focused on issues resulting from inappropriate outcome 
selection and reporting in carious lesion management research. This analysis led to the 
development of a COS to harmonise outcome selection and reporting across primary 
and secondary research within the context of the Global Evidence Ecosystem for Oral 
Health (GEEOH). 
 
Dental caries is the most prevalent disease in humans and yet we know that it is 
preventable. Once clinically detectable lesions arise, they can progress to have a 
significant impact on individuals and populations. Despite the significant global impact 
of this disease, there remains uncertainty about which treatments for existing carious 
lesions work best in the context where most care is provided, primary care. A number 
of problems have been identified with the primary and secondary research in this area 
which require concerted efforts to resolve. This included failure to identify a priori 
primary outcomes, conduct appropriate power or sample size calculations based on 
these, and to register the trial protocol. This may only be a reporting issue however it 
is likely that this also betrays an underlying problem in the conduct of RCTs. The effort 
to improve the conduct and reporting of this research should be proactive and 
coordinated within the Global Evidence Ecosystem of Oral Health (GEEOH). Areas of 
concern should be targeted and addressed collaboratively by the stakeholders in the 
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GEEOH. This thesis focused on one area where improvements can be made in RCTs and 
SRs: Outcome selection and reporting. 
 
To provide an overview of the current understanding of the aetiopathogenesis and 
epidemiology of dental caries as well as current treatment methods to manage the 
disease.  
The aetiopathogenesis of dental caries was outlined in chapter 1 of this thesis 
including relationship between the disease process occurring in cariogenic dental 
plaque (caries) and the development of clinical signs of the disease (carious lesion). A 
growing understanding of the disease process and how it may be modified has led to 
new methods of managing the lesions that arise from dental caries. Biofilm control, by 
various means, is now understood to be fundamental to preventing and managing the 
clinical manifestations of the disease. The focus of clinical care is moving towards an 
understanding of the need for disruption of the carious process, coupled with 
minimally invasive operative interventions. However, there remains a need to establish 
firm evidence on when to intervene operatively in the life course of a carious lesion 
and how much, if any, of the lesion should be removed. To do this, further well-
conducted effectiveness trials in real-world settings, such as primary care, will be 
required. Another challenge to be overcome is the clear socioeconomic gradient of 
disease prevalence. As with many diseases, the most deprived are most affected by 
the condition itself and suffer the most serious consequences. This presents challenges 
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in delivering appropriate primary prevention and disease management interventions. 
It also presents challenges for conducting clinical trials with an appropriate and 
representative population and adequate follow up.  
 
To describe the problem of avoidable waste in healthcare research and set it within 
the context of the proposed Global Evidence Ecosystem for Oral Health (GEEOH). 
In Chapter 2 of this thesis, the proposed ecosystem of evidence production and 
implementation was described, and a model to reduce research waste, presented. The 
Lancet series on research waste challenges all stakeholders in the evidence ecosystem 
to address systemic faults to increase the value of research and reduce avoidable 
waste. Specifically, the issues arising at the interface between primary (clinical trials) 
and secondary research (evidence syntheses) were described. The case for 
harmonisation of research priorities and methodologies was explained and justified. 
This endeavor will require concerted effort by all engaged in the research economy to 
address. All researchers in the ecosystem should work collaboratively in this effort. In 
some areas, the culture of the research community will need to be changed to enable 
new types of research (e.g. living systematic reviews). However, improving research 
methodologies by conducting methods research (or research on research) must also be 
supported and enabled. The need to investigate and harmonise outcome selection and 
reporting is one part of that process and provides the justification for the COS 
development work that follows in Section C. 
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To investigate evidence syntheses within cariology for signs of research waste. 
Chapter 3 described a systematic search of the evidence syntheses in caries research 
to investigate sources of research waste at this stage of the GEEOH. The analysis in this 
chapter shows that there are likely to be too many SRs being published and these are 
rarely updated. The rate of publication of SRs has increased markedly in the last 
decade raising questions about their usefulness. Where reviews are updated, the 
contribution of new primary research to the review conclusions appears to be limited. 
Instead, evolution of the review methodology has had a greater impact on review 
conclusions. This raises questions about the volume and quality of primary research 
being undertaken and how well it aligns with secondary research priorities. Again, the 
need to harmonise these priorities, including outcome selection and reporting, was 
highlighted. The advantages of moving towards living network meta-analyses was 
discussed and presented. To achieve this, digital technologies and machine learning 
could be exploited increase the efficiency of the review process and more rapidly 
identify gaps for further primary research. Examples of such technologies were 
described. Cochrane Oral Health are ideally placed to lead these developments and 
play a central role in the GEEOH. Once living reviews have been established, other 
researchers should stop conducting further, potentially uninformative, systematic 
reviews.  
 
To develop a core outcome set for effectiveness trials investigating the management 
of established carious lesions.  
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The Core Outcome Set (COS) for investigating interventions to manage established 
carious lesions was developed through a sequential process proposed by the COMET 
Initiative (1). This is reported in Section C (Chapters 4-6). Chapter 4 reported the 
results of a systematic review of RCTs investigating the prevention and management of 
carious lesions. The results of this search identified 76 unique outcomes taken forward 
into the consensus process to agree the final COS. This fulfilled step 4(i) of the COS 
development process; “identification of existing knowledge”. In Chapter 5, an 
international eDelphi survey of patients, researchers and clinicians was reported which 
sought to fulfil steps 4(ii) “filling gaps in knowledge” and 4(iii) “eliciting views about 
important outcomes in a consensus process” from the COMET process. This identified 
24 potentially important outcomes for consideration in the final stage of the COMET 
framework, 4(iv) “Hold a Face-to-Face meeting to agree the final COS”. This stage is 
reported in chapter 6. The final COS for carious lesion management was agreed by the 
face to face group of clinicians, researchers and patients. This represents the most 
important outcomes to patients, clinicians and researchers and their reporting should 
be mandatory. It is important to restate that this is not intended to be a restrictive list. 
Other outcomes, in addition to the COS, may be selected and reported in primary 
research if the researchers consider them to be important for the aims and objectives 
of their trial. The final agreed COS for carious lesion management interventions is: 
Patient satisfaction; Quality of life; Survival of restoration; Tooth survival; Irreversible 
pulpitis; Oral function; and Remineralisation of the lesion. 
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To map the COS developed in objective 4 to current “best evidence” to assess the 
scale of the challenge of implementation.  
This objective is addressed in Chapter 7 of this thesis. In this chapter, the COS for 
carious lesion management was mapped to outcomes identified as critical in relevant 
best evidence; Cochrane systematic reviews. A high level of outcome heterogeneity 
was identified between Cochrane reviews. This chapter also highlighted differences in 
outcome choice between the COS and Cochrane SRs with only 39% of outcomes in 
Cochrane SRs mapping to outcomes in the COS. There is clearly a need to disseminate 
this COS to researchers engaged in the primary and secondary research phases of the 
GEEOH. 
 
In contemporary clinical practice, most clinicians seek to provide evidence-based care. 
This incorporates patient values and professional experience with the best available 
evidence. Despite growing evidence for biofilm control and minimal intervention, 
much of modern caries management in primary care is destructive and operatively 
focused. This represents a collective failure of the research community, policy makers, 
and healthcare funders and providers to generate, synthesise, disseminate and 
monitor compliance with best evidence. In order to overcome this, the performance of 
each stage of the GEEOH must be optimised and integrated with the next. Indeed, 
much work is already ongoing to improve this. Accepting that research methods are 
never static, and that they continue to evolve and mature, integration and 
development must be joined-up within the GEEOH. Incremental improvements add 
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together to produce the step-change in the overall ecosystem that is required. The 
marginal gains philosophy introduced to the British Olympic Cycling Team in 2012 
contributed to the improvement in the number of medals that the UK team amassed 
during the games. The marginal gains, or 1% improvement, theory states that small, 
achievable changes in every stage of a process are made. These accumulate through 
the process to produce a great overall improvement. This is what is required in for 
healthcare research in general, and caries research in particular. 
 
The added value of this thesis has been to contribute to this marginal gains model for 
caries research by developing a Core Outcome Set (COS) for carious lesion 
management trials and reviews. The development of this followed the guidelines of 
the COMET Initiative who provide methodological support for such projects.  
 
In order to do this, work was conducted to demonstrate the problem of research 
waste in caries research with a particular focus on outcome selection and reporting in 
RCTs (Chapter 4). Primary research outcomes are heterogenous and often focused on 
the result of operative treatment. Further, items of the CONSORT statement related to 
the appropriate use of outcomes are not adhered to. These include pre-specified 
outcomes including primary outcomes, any changes to outcomes (compared with 
registered protocol), and sample size calculations. Journal editors and reviewers, as 
part of the evidence ecosystem, have a responsibility to ensure that research adheres 
to these reporting guidelines. This review identified 76 unique outcomes from 
previously published research. This mapped, for the first time, the outcomes which 
researchers have historically considered to be of greatest importance in cariology (2).  
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In the next phase of the COS development process, patients, clinicians and researchers 
took part in an international eDelphi prioritisation exercise (Chapter 5). Although no 
definitive evidence exists, we provided feedback by stakeholder group to better 
understand patient and professional priorities. This survey was the first in oral health 
to use histograms as the method of feedback. This is in line with current best evidence 
for the conduct of eDelphi surveys in COS development projects. 
 
In Chapter 6, a face-to-face consensus meeting was held to agree the final COS. This 
meeting was the first in dentistry to successfully use anonymous electronic voting in 
real-time. A patient partner with experience of participating in COS development work 
in oral health helped to develop the meeting documentation; checking for clarity and 
accuracy. 
 
The mapping of the COS to the outcomes identified in relevant Cochrane reviews (see 
Chapter 7), is a novel method of assessing the implementation gap that must be 
bridged. Since Cochrane is one of the organisations that is best placed to co-ordinate 
aspects of the GEEOH, this work highlights the change that is required at the relevant 
stage of the cycle. If Cochrane adopted the COS for future reviews that would 
represent an important first step in harmonising outcome selection and reporting 
within the GEEOH.  
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The levels of outcome specification described in Chapter 2 (Figure 2.5) highlights the 
complexity of outcome assessment in clinical research. Through the COS development 
process, this thesis has identified important “outcome domains” (level 1) within the 
framework described in Chapter 2. Now there is a need to address levels 2-4 of the 
specification described. This means that existing measurement instruments should be 
identified and appraised for each item in the COS according to the COSMIN taxonomy 
shown in Table 2.1. If no validated instruments exist, or if the existing tools are 
deficient, then new tools should be developed in line with this taxonomy. This is not an 
insignificant amount of work to undertake due to the large number of tools that have 
been developed with some being tailor made for specific trials and only being used in 
one publication. Indeed, there may be additional barriers to consensus owing to the 
personal attachment that some researchers have to instruments, especially when they 
themselves have devised them. It is often said in COS development circles that 
researchers are more likely to use each other’s toothbrush than each other’s outcome 
measure. The reasons for this are many and varied but must be accounted for when 
assigning or developing tools. Failure to engage important stakeholders in this process 
will result in poor uptake of the COS and the agreed measurement instruments 
leading, ultimately, to more research waste. In the same way that the COMET Initiative 
provides guidance for COS development, COSMIN supports improvements in the 
selection of outcome measurement instruments both in research and practice through 
the development of methods and practical tools for selecting the most suitable 
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outcome measurement instrument. Any future work to harmonise measurement 
instruments should be aligned to the COSMIN framework and involve a broad range of 
stakeholders to gain maximum consensus and agreement. 
 
Evidence gaps still exist in how best to manage carious lesions once they develop. As a 
result, further high-quality studies in primary care should be undertaken, making use 
of the COS developed in this thesis, to answer those questions. One such study 
currently recruiting, and training dentists is the SCRIPT trial (Selective Caries Removal 
in Permanent Teeth). This £2.5m HTA funded trial is being undertaken to compare 
selective caries removal and complete caries removal within the general dental service 
in the UK. The lead researchers of this study incorporated the COS from this thesis into 
the funding application and research protocol. While most of the items were 
incorporated in some form in the initial trial design, it is the results of this thesis that 
led directly to the use of “Patient Satisfaction” as a trial outcome.  
 
In addition to this, “Patient Satisfaction” has been added as an outcome to the PiP Trial 
(Pulpotomy for Irreversible Pulpitis). This is another HTA funded trial, comparing 
pulpotomy and conventional root canal treatment in permanent teeth. Although the 
scope of the COS developed in this thesis does not extend to endodontic treatment, 
the lead researchers considered this to be an important, but missing, outcome which 
could equally apply to the interventions being compared in this trial. Since there is no 
agreed COS for endodontic treatment in permanent teeth, this COS was used to infer 
what may be important to patients, clinicians and researchers. The involvement of 
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patients in COS development lent credence to the importance of an outcome like 
patient satisfaction. 
 
Further primary research should also be planned and conducted with evidence 
synthesis in mind. This means that primary researchers should be aware of the 
challenges facing researchers who synthesise research and actively help to overcome 
these. All researchers should recognise their place and role within the GEEOH and 
work collaboratively to reduce research waste.  
 
Evidence synthesis is a key step in the GEEOH. Even when high quality primary 
research appears to be clear, it must still be filtered and combined with other relevant 
data in the field. Cochrane should establish living systematic reviews in oral health 
(including cariology) as soon as practicable and should aim to develop a network meta-
analytic approach (NMA) to interventions. This will help to identify interventions that 
still need to be directly compared with each other in primary research. Furthermore, 
use of the COS in systematic reviews would encourage trialists to undertake RCTs 
which also use the COS. 
 
A further benefit of Cochrane Oral Health moving towards living systematic reviews 
(LSRs) would be that other researchers would be discouraged from publishing wasteful 
SRs and meta-analyses as the synthesis is kept up to date. Trialists planning new 
primary research should identify existing knowledge to assess the need for more 
primary research.  The key difference is that instead of the trialists doing another SR 
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themselves, Cochrane would have an up to date map of the field readily available. This 
would reduce waste at the level of secondary research by preventing over-publication 
of systematic reviews of questionable importance or quality. While LSRs and NMA are 
being developed, primary researchers should use tools like Epistemonikos and 
PROSPERO to avoid duplication of effort at this point in the GEEOH.  
 
The COMET initiative provides clear recommendations and issues to consider when 
planning COS development projects (1, 200). They also highlight several areas where 
definitive evidence is lacking about which methods or approaches are optimal. These 
include where to source a list of previously published outcomes; what constitutes a 
minimum sample size for eDelphi surveys; how to present outcomes to participants; 
how to order the presentation of outcomes in the eDelphi; how and when to combine 
views of different stakeholder groups; how to combine the views of adults and 
children and how to reduce attrition in eDelphi surveys. Several COS development 
studies have incorporated methodological studies within them (213, 234, 243). Further 
such work is needed to optimise the performance of the method and to scope the 
acceptable limits of each stage. When planning this COS development work, we 
identified an area where a nested methodological study could be undertaken (order of 
items presented in the eDelphi) but found that the providers of the eDelphi software 
(DelphiManager) were unable to modify the programme to do this. This was 
disappointing since the COMET Initiative have highlighted areas for methodological 
research but do not enable researchers to do this using the programme they 
themselves have created and recommend. DelphiManager should be reviewed and 
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upgraded to provide the option of conducting such methods research. Furthermore, 
evidence now supports the use of histograms or other charts to provide feedback to 
participants in subsequent round. Unfortunately, DelphiManager requires the 
researcher to have a knowledge of ‘R’ programming to deliver this as graphical data 
display options are not available within the programme.   
 
At the level of face to face meetings, further research is required to optimise the 
methodology for COS development. The effects of order of outcome voting should be 
explored with methods research in a similar way to order of presentation for eDelphi 
surveys. Related to this, is an exploration of whether real-time display of the results 
has an effect on voting intention for subsequent items.  
 
Several participants in the eDelphi expressed an interest in taking part in the face to 
face meeting but could not attend the meeting in person. In the light of this and 
lockdown restrictions arising from the Covid-19 pandemic, the COMET initiative should 
support the investigation of alternative means of conducting these meetings at a 
distance.  
 
The COS was developed and agreed before the global Covid-19 pandemic in 2020. At 
the time of writing, dental services in the UK have not re-opened to pre-pandemic 
scope and capacity. It is possible that public and professional priorities for dental care, 
including treatment of carious lesions, have shifted following the cessation of all but 
emergency dental services during the Covid-19 pandemic. However, the scope of the 
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COS accounts for minimally invasive (MI) treatment approaches which are likely to 
become more important in a post-pandemic context. As acknowledged earlier in this 
thesis, COS development is an ongoing process, requiring regular review. Limitations of 
the methodology in this COS, such as sampling of predominantly European 
participants, could be overcome by this, if carefully planned and co-ordinated. As this 
COS is reviewed, any changes in patient priorities will be reflected in those 
developments. Implementation challenges can also be addressed as part of this review 
process. For example, the application of all COS outcomes in every setting may prove 
to be undeliverable or undesirable in some contexts. The development of appropriate 
measurement instruments in the COSMIN framework may help but should be regularly 
reviewed. 
 
The global disruption caused by coronavirus pandemic of 2020 has led to calls to “build 
back better” and to embrace a “new normal” in a variety of aspects of life. Working 
patterns and societal priorities seem to have changed. In healthcare research, we also 
need to move towards a new normal. Research in this new normal must serve the 
interests of patients and the public first. It should not enable avoidable research waste 
as the current system appears to do. Researchers must be willing and permitted to do 
less research. However, this research must be of higher value and integrated in a 
structured ecosystem of evidence production. This will require radically different ways 
of working including living systematic reviews and network meta-analyses. Some of 
these new ways of working will increase the impact of research on society but reduce 
the number of publications a research team produces. New ways of recognising and 
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rewarding this type of work will need to be developed. In caries research, advocates 
for this new way of working are needed. Researchers conducting primary research 
should be willing to use standardised methods and outcomes to facilitate its synthesis 
into living network meta-analyses. Methods research initiatives should be encouraged 
and consensus on common methodologies supported by the GEEOH. Evidence gaps 
should be addressed by broad global collaborations rather than narrow, competing 
attempts to be the first to publish results in a commercially driven publication. 
Researchers at all levels must become more willing to share knowledge and skills with 
each other and be less protective of their own interests. Revisiting the metaphor from 
that COS developer’s adage “researchers are more likely to use each other’s 
toothbrush than each other’s outcome measure”: we must be more willing to give up 
our old toothbrushes. Researchers investigating carious lesion management 
interventions in effectiveness trials should consider implementation of the Core 
Outcome Set developed in this thesis as a first step in harmonising methods in the 
evidence ecosystem and provides researchers with an evidence-based list of important 
outcomes to measure. These outcomes, agreed by patients and professional 
stakeholders are: Patient satisfaction; Quality of life; Survival of restoration; Tooth 
survival; Irreversible pulpitis; Oral function; and Remineralisation of the lesion 
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Additional study data tables available at  
https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-017-2256-1 
under “additional file 1” and “additional file 2” 
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From: Lorraine Robertson (Staff) 
Sent: 15 June 2017 14:31 
To: Colin Levey (Staff); Thomas Lamont (Staff) 
Subject: Tattersall application 
 
Dear Both 
The Tattersall Committee met on Monday when yours was one of the applications 
considered. The Committee agreed to fund the majority of your proposal but felt, at 
this stage it could not support the dissemination costs. Further detail in included in the 
relevant extract from the minute below: 
 
3.2 T Lamont/C Levey - Improving patient care: development of essential dental 
core outcome sets to increase the impact and delivery of the best evidence 
based practice [£8500] 
 
Funds were requested to support a project to identify core outcome sets for dental 
caries and periodontal disease. This included costs for specialist software, access to the 
SHARE network, Safe Haven costs, nominal group meetings and dissemination of 
findings. The Committee considered the costs for nominal group meetings and 
dissemination to be quite high. There was no reference to the International Consortium 
for Health Outcomes Measurement (ICHOM), which now included oral health. Feeding 
the outcomes of this project into ICHOM would be prestigious. 
 
The Committee was comfortable to support the study but felt the dissemination costs 
were uncertain at present and there were other potential sources of support for these, 
eg the University’s central fund. It would welcome, however, a future application when 
further detail and results were available. 
 
Resolved: to support the application minus dissemination costs, ie £5500. 
 
The Committee would be happy to consider a future application for dissemination 
costs in due course if appropriate. 
 
I will now liaise with Finance to set up a cost centre against which the costs associated 
with this project should be charged and will let you know when this is available. 
 
Please get back to me if you require any further information. 
 
Best wishes 
Lorraine 
  
  
Lorraine Robertson  
School Manager 
School of Dentistry, University of Dundee 
+44(0)1382 381649 | l.j.y.robertson@dundee.ac.uk 
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Colin Levey 
Dundee Dental School 
        University of Dundee 
        Park Place 
        Dundee, Scotland 
        DD1 4HN 
         Tel: +44 (0)1382 381 
728 
        E-mail: 
c.levey@dundee.ac.uk 
 
 
What are the important issues for you regarding the treatment of tooth decay 
(dental caries)? 
 
To help patients and dentists make choices about oral healthcare, research is carried 
out to provide evidence (information) as to what works best. To do this, researchers 
need to look at the effects of the treatments, by measuring an ‘outcome’ e.g. how long 
the filling lasts. Choosing which ‘outcomes’ to measure is very important to ensure the 
information is relevant to patients and dentists.  
 
Previous dental research has tested lots of different outcomes normally chosen by 
researchers. There is currently no agreed list or ‘consensus’ as to the best outcomes to 
use when testing treatments. This makes it difficult to compare treatments or compare 
different research trials and results in ongoing confusion as to the best treatment 
options for tooth decay. 
 
The Core Outcome Measures in Effectiveness Trials initiative (http://www.comet-
initiative.org) was launched to bring patients, dental professionals and researchers 
together in order to work out the most important and relevant outcomes. This will 
improve future research and help patients and dentists make decisions about their oral 
healthcare.  
 
Why have you been invited? 
Previous dental research has assessed interventions on outcomes chosen by dentists 
and researchers. To make sure that future research is relevant and useful to patients 
we want to hear your opinions as well. We want to know what issues are important to 
you. 
 
How do we decide what outcomes are the most important? 
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To make sure that the outcomes chosen are relevant to everyone involved there 
should be an agreement or “consensus” reached. To do this we will carry out a 
“consensus exercise”. One way of doing this is a Delphi study, that involves groups of 
people who are “experts” in a health condition e.g. patients, dentists and researchers. 
Everyone taking part in the study is asked their opinion and the results are anonymous 
to make sure everyone has an equal say.  
 
What do you need to do? 
Everyone involved in the study will be sent a list of outcomes used in the past and 
asked if, in their opinion, there are any key outcomes missing. You can suggest other 
outcomes anonymously and if others agree, those new outcomes will also be added to 
the list. Each person will then be asked to rate how important they think each of the 
outcomes are via an online website. This is stage one of the Delphi. 
 
The scores will be collected together and summarised before stage 2. Stage 2 is similar 
to the first but you will be reminded how you rated each outcome as well as knowing 
how the overall group rated each outcome. There are no right or wrong answers. No 
one in the group can see another individual’s scores; they can only see overall results 
for the group. Using this information, you are asked to reflect on your own views and 
the views of the groups and decide whether to stick with the original score or change 
it. You will be given the chance to change your rating, but do not have to if you do not 
want to.  
 
The scores of stage 2 are collected and summarised again. Studies differ in how many 
stages take place, but usually two or three ‘rounds’ are sufficient. Each time the idea is 
that the experts review their previous score based on what the group rated in their last 
stage. You will be provided information on what the other patients involved scored, as 
well as what the group of dentists scored. 
 
At the end of the process the research team produce a report on what the experts 
have agreed as the most important outcomes. These will be called the ‘core outcomes’ 
for the treatment of dental caries (tooth decay). 
 
How much time will it take? 
Each stage should take no more than 20 minutes to complete. You do not need to 
complete at one time and can save progress made. There will be approximately four to 
five weeks in between each stage with the whole study taking place over four months. 
All identifiable data will be held securely within the survey programme. Analysis of the 
final results by the research team will not allow you to be identified. This study has 
been approved by the University of Dundee Schools of Nursing and Health Sciences 
and Dentistry Research Ethics Committee (SREC). 
 
Yours sincerely, 
 
Colin Levey   Prof. David Ricketts  Prof. Jan Clarkson 
Clinical lecturer  PhD supervisor  PhD supervisor 
PhD Student/Study lead 
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Colin Levey 
Dundee Dental School 
        University of Dundee 
        Park Place 
        Dundee, Scotland 
        DD1 4HN 
         Tel: +44 (0)1382 381 
728 
        E-mail: 
c.levey@dundee.ac.uk 
 
 
What are the outcomes that influence your clinical decision making when managing 
dental caries? 
 
To help patients and dentists make informed decisions regarding oral healthcare, 
research is carried out to provide an evidence base as to what works best. To assess 
prevention and treatment options, researchers need to look at the effects of these 
interventions, by measuring an ‘outcome’ e.g. pulpal pain. Choosing which ‘outcomes’ 
to measure is very important to ensure that the evidence base is relevant and useful 
for patients and the dental professionals delivering care.  
 
Previous dental research has assessed interventions using a wide variety of different 
outcomes and measures. Traditionally, these have been chosen by researchers. There 
is currently no agreed list or ‘consensus’ as to the best outcomes to use when testing 
treatments. This makes it difficult to compare treatments or compare different 
research trials and results in ongoing confusion as to the best treatment options for 
dental carious lesions. 
 
The Core Outcome Measures in Effectiveness Trials initiative (http://www.comet-
initiative.org)  was launched to bring patients, dental professionals and researchers 
together in order to work out the most important and relevant outcomes. This will 
improve future research and help patients and dental professionals make informed 
decisions about their oral healthcare.  
 
Why have you been invited? 
Previous dental research has assessed interventions on outcomes chosen by dental 
researchers. To ensure that future research is relevant and useful to patients and 
dental professionals we want to hear the opinions of dentists, hygienist & 
hygiene/therapists, academics and dental researchers. 
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How do we decide what outcomes are the most important? 
To make sure that the outcomes chosen are relevant to everyone involved there 
should be an agreement or “consensus” reached. To do this we will carry out a 
“consensus exercise”. One way of doing this is a e-Delphi study, which involves groups 
of people who are “experts” in a health condition e.g. patients, dentists and 
researchers. Everyone taking part in the study is asked their opinion and the results are 
anonymous to make sure everyone has an equal say.  
 
The process aims to reach consensus on ‘what’ outcomes should be measured, not 
‘how’ those outcomes should be measured. 
 
What do you need to do? 
Everyone involved in the study will be sent a list of outcomes used in dental caries 
studies the past and asked if, in their opinion, there are any key outcomes missing. You 
will be encouraged to suggest other outcomes anonymously and if others agree, those 
new outcomes will also be added to the list. Each person will then be asked to rate 
how important they think each of the outcomes are via an online website. This is stage 
one of the Delphi. 
 
The scores will be collected together and summarised before stage 2. Outcomes that 
most people agree are not relevant will not be included in the next stage. Stage 2 is 
like the first stage but this time you will be reminded how you rated each outcome as 
well as being shown how the group rated each outcome overall in stage one. There are 
no right or wrong answers. No one in the group can see another individual’s scores; 
they can only see overall results for the group. Using this information, you are asked to 
reflect on your own views and the views of the groups and decide whether to stick 
with the original score or change it. You will be given the chance to change your rating, 
but do not have to if you do not want to.  
 
The scores of stage 2 are collected and summarised again. Studies differ in how many 
stages take place, but usually two or three ‘rounds’ are sufficient. Each time the idea is 
that the experts review their previous score based on what the group rated in their last 
stage. You will be provided information on what the other patients involved scored, as 
well as what the group of dentists scored. 
 
At the end of the process the research team produce a report on what the experts 
have agreed as the most important outcomes. These will be called the ‘core outcomes’ 
for the management of carious lesions. 
 
How much time will it take? 
Each stage should take no more than 20 minutes to complete. You do not need to 
complete at one time and can save progress made. There will be approximately four to 
five weeks in between each stage with the whole study taking place over four months. 
All identifiable data will be held securely within the survey programme and will not be 
available to the study team. Analysis of the final results will not allow you to be 
identified. This study has been approved by the University of Dundee Schools of 
Nursing and Health Sciences and Dentistry Research Ethics Committee (SREC). 
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Yours sincerely, 
 
 
 
Colin Levey   Prof David Ricketts  Prof Jan Clarkson 
Clinical lecturer  PhD supervisor  PhD supervisor 
PhD Student 
Study lead 
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Dear Sir/Madam, 
 
We need your help! We want to find out what matters to YOU and other dental 
patients when it comes to treating tooth decay. We are interested in finding out 
what you think researchers should measure in trials of new treatments for tooth 
decay.  
  
You will have already received a phone call from SHARE with some of the background 
to this study. More detail about the project is contained in the letter attached to this 
email. If you are still willing to participate after reading the attached information, you 
can access the survey at the following link: 
https://delphimanager.liv.ac.uk/cariesCOS/Delphi 
 
The first round of the eDelphi is now open until 10thAugust 
 If you have any questions, please do not hesitate to contact me 
on c.levey@dundee.ac.uk for more information. 
Regards, 
Colin Levey 
Project lead 
Clinical Lecturer in Restorative Dentistry 
Dundee Dental School 
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Many thanks for your interest in taking part in this eDelphi consensus excercise. Please read the 
information below before beginning.  
 
What are the important issues for you regarding the treatment of tooth decay (dental carious lesions)? 
To help patients and dentists make choices about oral healthcare, research is carried out to provide evidence 
(information) as to what works best. To do this, researchers need to look at the effects of the treatments, by 
measuring an ‘outcome’ e.g. how long the filling lasts. Choosing which ‘outcomes’ to measure is very important to 
ensure the evidence is relevant to patients and dental care providers (e.g. dentists). An outcome is an endpoint which 
is measured in a study to assess the effect of a treatment or intervention. It is not the same as the tool or metric used 
to measure the outcome. In this study we are interested in the outcome itself and not the method by which the 
outcome is measured. 
Previous dental research has measured lots of different outcomes, normally chosen by researchers. There is currently 
no agreed list or ‘consensus’ as to the best outcomes to use when testing treatments of tooth decay (carious lesions). 
This makes it difficult to compare treatments or compare different research trials, resulting in ongoing confusion as to 
the best treatment options for tooth decay.  
The Core Outcome Measures in Effectiveness Trials initiative (http://www.comet-initiative.org)was launched to bring 
patients, dental professionals and researchers together in order to work out the most important and 
relevant outcomes. This will improve future research and help patients and dentists make decisions about their oral 
healthcare.  
Why have you been invited? 
Previous dental research has assessed outcomes chosen by dentists and researchers. To make sure that future 
research is relevant and useful to patients we want to hear the opinions of patients as well. We also want to hear the 
opinions of dentists, hygienist & hygiene/therapists, academics and dental researchers active in their field. We want to 
know what issues are important to you. 
  
How do we decide what outcomes are the most important? 
To make sure that the outcomes chosen are relevant to everyone involved there should be an agreement or 
“consensus” reached. To do this we will carry out a “consensus exercise”. One way of doing this is a Delphi study, that 
involves groups of people who are “experts” in a health condition e.g. patients, dentists and researchers. Everyone 
taking part in the study is asked their opinion and the results are anonymous to make sure everyone has an equal 
say.  
  
What do you need to do? 
Everyone involved in the study will be sent a list of outcomes used in the past and asked if, in their opinion, there are 
any key outcomes missing. You can suggest other outcomes anonymously and if others agree, those new outcomes 
will also be added to the list. Each person will then be asked to rate how important they think each of the outcomes 
are via an online website. This is stage one of the Delphi. 
The scores will be collected together and summarised before stage 2. Stage 2 is similar to the first but you will be 
reminded how you rated each outcome as well as knowing how the overall group rated each outcome. There are no 
right or wrong answers. No one in the group can see another individual’s scores; they can only see overall results 
for the group. Using this information, you are asked to reflect on your own views and the views of the groups and 
decide whether to stick with the original score or change it. You will be given the chance to change your rating, but do 
not have to if you do not want to.  
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The scores of stage 2 are collected and summarised again. Studies differ in how many stages take place, but usually 
two or three ‘rounds’ are sufficient. Each time the idea is that the experts review their previous score based on what 
the group rated in their last stage. You will be provided information on what the other patients involved scored, as well 
as what the group of dentists scored. 
At the end of the process the research team produce a report on what the experts have agreed as the most important 
outcomes. These will be called the ‘core outcomes’ for the treatment of dental caries (tooth decay). 
  
How much time will it take? 
Each stage should take no more than 20 minutes to complete. You do not need to complete at one time and can save 
progress made. There will be approximately four to five weeks in between each stage with the whole study taking 
place over four months. All identifiable data will be held securely within the survey programme. Analysis of the final 
results by the research team will not allow you to be identified. This study has been approved by the University of 
Dundee Schools of Nursing and Health Sciences and Dentistry Research Ethics Committee (SREC). 
 
Thank you for taking part. 
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SHA RE / 068  OUTMAC 
Hello, May I speak with xxxx?  
I’m phoning from SHARE, the Scottish Health Research Register at Ninewells Hospital and 
Medical School Dundee, and my name is xxxxxx I am the SHARE administrator. 
You signed up to SHARE to say you were interested in hearing about research projects in the 
area that might be relevant to you.  We have a new study which we think may be of interest 
to you.  
May I please just check your date of birth to make sure I am speaking with the right person?  
It is possible that you may not have the condition under investigation, please note that the 
selection has been undertaken to identify participants and control subjects.  
Would you like me to continue….. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Would you be interested in hearing more about this and speaking with the researchers? 
 (If yes, continue, if no thank and end call). 
A member of staff from the research team will be in touch shortly to explain the study in 
more detail and answer any questions you may have.  Do you have a preferred time for the 
researcher to phone you?  Please remember, even if you have said “yes” to taking part in 
this study, you may feel that once you have spoken to the researcher and you have more 
details of what the study involves, you may feel you no longer wish to take part.  If so please 
just advise the researcher and she will record that you are not to be contacted further. 
(If yes, continue, if no thank and end call). 
What are the important issues for you regarding the treatment of tooth decay 
(dental caries)? 
To help patients and dentists make choices about oral healthcare, research is 
carried out to provide evidence (information) as to what works best. To do this, 
researchers need to look at the effects of the treatments, by measuring an 
‘outcome’ e.g. how long the filling lasts. Choosing which ‘outcomes’ to measure 
is very important to ensure the information is relevant to patients and dentists.  
Previous dental research has assessed interventions on outcomes chosen by 
dentists and researchers. To make sure that future research is relevant and 
useful to patients we want to hear your opinions as well. We want to know what 
issues are important to you. 
 
Ev ryone taking part in the survey is asked their opinion and he results are 
anonymous to make s re everyone has an equal say. This will take place in the 
form f a series of online sur ys. 
 
Everyone involved in the study will be sent a list of outcomes used in the past 
(via the online survey) and asked if, in their opinion, there are any key outcomes 
missing. You can suggest other outcomes anonymously and if others agree, those 
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Thank you so much for your time. If you have any questions my name is xxxx and my 
telephone number is xxxx xxxxx - End 
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Colin Levey 
Dundee Dental Hospital and School 
University of Dundee 
Park Place 
Dundee 
Scotland 
DD1 4HR 
Tel: +44 (0)1382 381 728 
Email: c.levey@dundee.ac.uk 
 
 
 
What is important to you when having treatment of decay in your teeth? 
Research is carried out to work out which treatments work best and is expected to help 
patients and dentists make informed choices about care or treatment. To do this, researchers 
measure “outcomes” at the end of the study (e.g. whether the decay has continued to 
progress or whether the tooth had to be removed). These outcomes must be relevant to 
patients and dentists. 
 
Why have YOU been invited? 
We want to understand what issues are important to you when considering treatment for 
tooth decay. To be sure that future research answers your questions, we want to hear your 
opinions.  
 
How do we decide which outcomes are most important? 
We have already undertaken an online survey (eDelphi) to narrow down the list of potentially 
important outcomes. We now need to work out which of these are the most important. 
 
What do you need to do? 
We are arranging a meeting in to agree which are the most important outcomes to be used 
in future research projects. The meeting will be held in Dundee on Monday 25th March 2019 
for 3-4 hours starting from 11am. Lunch will be provided. We will send you the list of 23 
outcomes that we will discuss at the meeting. It may be helpful for you to consider what your 
“Top 3” are before the meeting. We will provide an introduction and explanation on the day. 
This will be followed by group discussion and voting on the outcomes. 
 
How your responses are recorded and used 
The meeting will be audio recorded. The recording will be transcribed. The audio recording 
will be retained securely until the study reports (including my PhD thesis) have been finalised, 
at which point it will be securely destroyed and the anonymised transcript only will be 
retained.  
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The University of Dundee shared storage facility Box has ISO 27001 security certification and 
is compliant with that standard. Data is backed up across multiple sites. Access to your 
personal data will be strictly controlled and monitored by the research lead and restricted to 
research team members.  
 
Excerpts of the anonymised transcripts and photographs taken during the meeting may be 
published in academic journals and in a publicly available academic thesis, but only with your 
consent. 
 
At the end of the project, following the award of the thesis, only anonymised information will 
be retained by the University research team. Identifying information will be securely 
destroyed.   
 
 
Voting 
The voting process will remain confidential during the meeting however the research team 
will de-anonymise the results to compare differences between participants. De-anonymised 
responses will only be made available to the research team and bonafide researchers under 
controlled access. They will not be made publicly available. 
 
Lawful Processing of Data 
The University asserts that the lawful basis for the processing of your personal data in this 
research is that 'processing is necessary for the performance of a task carried out in the public 
interest or in the exercise of official authority vested in the controller'. Any special category 
data you disclose (i.e. concerning your health/dental circumstances) will be processed in 
accordance with Article 89(1) of the General Data Protection Regulation. 
 
Additionally, in this project, we have asked you for your explicit consent to take part in 
different aspects of the research. You are free to withdraw that consent at any time by 
contacting the study lead. 
 
Your rights  
The University respects your rights and preferences in relation to your data. If you wish to 
update, access, erase, or limit the use of your information, please let us know by emailing 
c.levey@dundee.ac.uk.  It may not be possible to erase your responses when the research 
project is complete and information required to de-anonymise the responses has been 
destroyed. 
 
If you wish to complain about the use of your information please email 
dataprotection@dundee.ac.uk. You may also wish to contact the Information Commissioner’s 
Office. 
 
 
Yours Sincerely, 
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Colin Levey 
Clinical Lecturer  
PhD student 
Study Lead  
 
Prof. David Ricketts 
Professor of Cariology 
University of Dundee 
PhD Supervisor 
 
Prof. Jan Clarkson 
Professor of Clinical Effectiveness 
University of Dundee 
PhD Supervisor 
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